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ABSTRACT 
The three-dimensional organization of the human genome is non-random 
in interphase cells. Heterochromatin is highly clustered at the nuclear periphery, 
adjacent to nucleoli, and near centromeres. These localizations are reshuffled 
during mitosis when the chromosomes are condensed, nucleoli disassembled, 
and the nuclear envelope broken down. After cytokinesis, heterochromatin is re-
localized to the domains described above. However, the mechanisms by which 
this localization is coordinated are not well understood.   This dissertation will 
present evidence showing that both CAF-1 p150 and Ki-67 regulate nuclear 
structure throughout the human cell cycle.   
Chromatin Assembly Factor 1 (CAF-1) is a highly conserved three-subunit 
protein complex which deposits histones (H3/H4)2 heterotetramers onto 
replicating DNA during S-phase of the cell cycle. The N-terminal domain of the 
largest subunit of CAF-1 (p150N) is dispensable for histone deposition, and 
instead regulates the localization of specific loci (Nucleolar-Associated Domains, 
or “NADs”) and several proteins to the nucleolus during interphase.  One of the 
proteins regulated by p150N is Ki-67, a protein widely used as a clinical marker 
of cellular proliferation. Depletion of Ki-67 decreases the association of NADs to 
the nucleolus in a manner similar to that of p150.  Ki-67 is also a fundamental 
component of the perichromosomal layer (PCL), a sheath of proteins that 
surrounds all condensed chromosomes during mitosis.  A subset of p150 
localizes to the PCL during mitosis, and depletion of p150 disrupts Ki-67 
 vii 
localization to the PCL. This activity was mapped to the Sumoylation Interacting 
Motif (SIM) within p150N, which is also required for the localization of NADs and 
Ki-67 to the nucleolus during interphase.  Together, these studies indicate that 
p150N coordinates the three-dimensional arrangement of both interphase and 
mitotic chromosomes via Ki-67 
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CHAPTER I: INTRODUCTION 
 
1.1:  Abstract  
This dissertation is focused on the interplay of two proteins that contribute 
the structure and function of the human cell nucleus. Chromatin Assembly Factor 
1 (CAF-1) is an evolutionary conserved three-subunit complex responsible for 
depositing histone (H3/H4)2 heterotetramers onto newly-replicated DNA.  As a 
result, CAF-1 contributes to the maintenance of histone modifications related to 
heterochromatic gene silencing.   Ki-67 is a protein that has long been used as a 
clinical marker of cell replicative activity for grading neoplastic growths.  Ki-67 
also affects heterochromatin structure; however, the molecular mechanisms of 
Ki-67 action remain poorly understood.  My thesis work described in the later 
chapters in this dissertation will provide evidence that the largest subunit of CAF-
1, p150, and Ki-67 both regulate the 3-dimensional localization of the human 
genome.   
My studies showed that CAF-1 and Ki-67 are especially important at 
genomic regions that interact directly and frequently with the nucleolus. These 
loci are termed Nucleolar Associated Domains (NADs), and are enriched in 
repetitive elements, the inactive X chromosome (Xi), and several different RNA 
polymerase III-transcribed genes. NADs are often marked by chromatin 
modifications characteristic of heterochromatin, including H3K27me3, H3K9me3, 
and H4K20me3, and artificial targeting of genes to this area is correlated with 
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reduced expression. Therefore, it has been postulated that NAD localization to 
the perinucleolar region contributes to the establishment and maintenance of 
heterochromatic silencing at these loci.  Recently published studies from several 
multicellular eukaryotes have begun to reveal the trans-acting factors involved in 
NAD localization, including the insulator protein CTCF, several nucleolar 
proteins, and two long non-coding RNAs (lncRNAs). The mechanisms by which 
these factors coordinate with one another in regulating NAD localization and/or 
silencing are still unknown.  This chapter will summarize recently published 
studies, discuss where additional research is required, and speculate about the 
mechanistic and functional implications of genome organization around the 
nucleolus.   
 
1.2:  Chromatin Assembly Factor 1 (CAF-1)  
In eukaryotic cells, DNA is bound by histones and other proteins in a 
complex macromolecular assembly known as chromatin.  The fundamental 
subunit of chromatin is the nucleosome, comprised of 146 bases of DNA 
wrapped around a heterotetramer of Histones H3 and H4, flanked by H2A/H2B 
heterodimers (Luger et al., 1997).   The structure of chromatin can dictate both 
the localization of the DNA within the nucleus and the transcriptional activity of 
the associated DNA.  Elucidating the mechanism and regulation of chromatin 
assembly has been a primary interest of biology as it is invariably tied to global 
nuclear structure.  In 1986, Bruce Stillman discovered that nuclear extracts from 
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human 293T cells induced in vitro chromatin assembly of SV40 viral plasmid 
DNA (Stillman, 1986).  Three years later, the chromatin assembly activity of the 
nuclear fraction was traced back to a three subunit complex named Chromatin 
Assembly Factor 1 (CAF-1) (Smith and Stillman, 1989).  Since its initial discovery 
as a factor required for replication-dependent chromatin assembly, CAF-1 has 
been shown to play a role in regulating DNA damage repair (Gaillard et al., 1996; 
Green and Almouzni, 2003; Polo et al., 2006), heterochromatin silencing 
(Houlard et al., 2006; Huang et al., 2010; Loyola et al., 2009; Murzina et al., 
1999; Quivy et al., 2004, 2008; Roelens et al., 2016), stem cell identity (Cheloufi 
et al., 2015; Hatanaka et al., 2015; Ishiuchi et al., 2015), and multicellular 
organism development (reviewed in (Yu et al., 2015).  These roles, in addition to 
novel roles outlined in later chapters, will demonstrate that CAF-1 is a major 
regulator of human nuclear structure.    
  
1.2.1:  CAF-1 Structure  
CAF-1 is an evolutionarily conserved complex comprised of three subunits 
in 1:1:1 stoichiometric ratio (Verreault et al., 1996). Smith and Stillman first 
named the human subunits p150, p60, and p48, after the approximate molecular 
weight of each subunit (Smith and Stillman, 1989) (Kaufman et al., 1995).  The 2 
smaller subunits, p60 and p48, are both members of the tryptophan-aspartate 
(WD) repeat family of proteins (Kaufman et al., 1995; Verreault et al., 1996).  
This family of proteins contains repeats of approximately 40 amino acids rich in 
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WD residues, and both p60 and p48 contain 7 distinct WD repeat domains.  The 
largest subunit of the complex, p150, is 938 amino acids in length and acts a 
binding scaffold for the other subunits of the CAF-1 complex (Kaufman et al., 
1995).  p150 contains a highly charged KER domain rich in lysine (K), glutamic 
acid (E), and arginine (R) within amino acids 311-445, and a negatively charged 
ED domain rich in E and aspartic acid (D) within amino acids 564-641 (Kaufman 
et al., 1995).  Both p150 and p60 contain a canonical PEST domain (Kaufman et 
al., 1995) which is involved in regulating the half-life of many proteins in vivo 
(Rogers et al., 1986).  While p48 has been implicated as a subunit in other 
nuclear complexes such as the NURF remodeling complex (Martínez-Balbás et 
al., 1998), the NuRD remodeling/deacetylase complex (Zhang et al., 1999), and 
polycomb repressor complex PRC2 (Anderson et al., 2011), no evidence exists 
that p60 or p150 are constituents of chromatin-associated complexes other than 
CAF-1. However, the fly homolog of p60 has a CAF-1 independent role during 
sperm chromatin formation (Doyen et al., 2013), and my studies described below 
have elucidated a CAF-1 independent role for p150 in organization of nucleolar 
proteins and associated NADs.  
 
1.2.2:  CAF-1 Couples Chromatin Assembly with DNA Replication and 
Repair 
The primary function of CAF-1 is to deposit histone (H3/H4)2 
heterotetramers onto replicating DNA during S-phase of the cell cycle (Krude, 
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1995; Shibahara and Stillman, 1999; Smith and Stillman, 1989).  During DNA 
replication, proliferating cell nuclear antigen (PCNA) forms a ring-like homotrimer 
around replication forks, to which DNA polymerases and other components 
required for DNA replication and chromatin assembly are tethered (reviewed in 
(Moldovan et al., 2007)).  CAF-1 associates with replication forks via direct 
interaction between PCNA and a PCNA interaction peptide (PIP) box located 
within the KER domain of p150 (Rolef Ben-Shahar et al., 2009; Shibahara and 
Stillman, 1999).  A 2nd PIP box also exists within the N-terminus of p150 that 
features greater binding affinity to PCNA in vitro.  However, the N-terminal PIP is 
dispensable for in vivo chromatin assembly activity, and thus its true function 
remains unknown (Rolef Ben-Shahar et al., 2009).  CAF-1 acquires newly 
synthesized H3/H4 heterodimers from histone chaperone Asf1, which directly 
interacts with a C-terminal region of the p60 subunit (Mello et al., 2002; Tyler et 
al., 2001).  Asf1 has the ability to interact with H3/H4 dimers comprised of all 
histone 3 variants: H3.1, H3.2, and H3.3 (Latreille et al., 2014).   Despite this, 
CAF-1 preferentially binds to dimers containing histone variants H3.1 (Tagami et 
al., 2004) or 3.2 (Latreille et al., 2014).  Variants H3.1 and H3.2 are nearly 
identical, as both are primarily synthesized during S-phase and differ structurally 
by a single cysteine – serine residue at amino acid 96 (Franklin and Zweidler, 
1977).  In contrast, variant H3.3 is continuously synthesized throughout the cell 
cycle (Ahmad and Henikoff, 2002; Wu et al., 1982), and differs in structure from 
H3.1 by 5 residues (Volk and Crispino, 2015).  H3.3 is primarily associated with 
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actively transcribed chromatin (Ahmad and Henikoff, 2002) and deposited onto 
DNA by the histone chaperone HIRA (Tagami et al., 2004).  Evidence that CAF-1 
interacts with histone H3 variants synthesized during S-phase further supports 
the hypothesis that the primary function of CAF-1 is to establish chromatin 
structure in a replication-dependent manner.  However, several studies have 
demonstrated that CAF-1 does have at least some chromatin assembly activity 
outside of S-phase.  For example, CAF-1 localizes to sites of UV-induced DNA 
damage outside of S-phase, and deposits H3.1 onto repaired DNA (Gaillard et 
al., 1996; Green and Almouzni, 2003; Polo et al., 2006).  It is hypothesized that 
replication-independent CAF-1 mediated chromatin assembly occurs 
mechanistically similar to replication-dependent chromatin assembly, as PCNA 
and Asf-1 are also present at sites of UV-induced DNA damage (Green and 
Almouzni, 2003; Mello et al., 2002).                       
  
1.2.3:  CAF-1 Regulates the Establishment and Maintenance of 
Heterochromatin   
The discovery that CAF-1 does not chaperone the H3.3 variant, which is 
deposited largely at transcriptionally active euchromatin outside of S phase, is 
consistent with data from multiple organisms implicating CAF-1 in maintaining 
transcriptionally silent heterochromatin.  The first evidence of this was found in S. 
cerevisiae lacking CAF-1 subunit gene homologs, which display less stable 
silencing of genes adjacent to heterochromatic telomeric regions (Enomoto et al., 
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1997; Kaufman et al., 1997).  This derepression was later correlated with a loss 
of enrichment of heterochromatin-associated SIR (Silent Information Regulator) 
proteins (Huang et al., 2007).  In multicellular organisms, two hallmarks of 
transcriptionally inactive heterochromatin are the presence of tri-methylation on 
lysine 9 of histone 3 (H3K9me3) and the association of heterochromatin protein 1 
(HP1).  CAF-1 directly regulates the association of HP1 to silenced regions within 
the genome during both replication-dependent and independent chromatin 
assembly (Houlard et al., 2006; Huang et al., 2010; Murzina et al., 1999; Quivy et 
al., 2004, 2008; Roelens et al., 2016).  This is accomplished through direct 
interaction between HP1 and the N-terminus of p150 (Murzina et al., 1999).  
p150 also interacts with the sumoylated form of the methyl-CpG binding protein 
MBD1, which is commonly enriched on pericentric heterochromatin (Sarraf and 
Stancheva, 2004; Uchimura et al., 2006).  HP1 and/or MBD1 facilitates the 
recruitment of histone methyltransferase SETDB1 into a complex containing 
CAF-1 during replication-coupled chromatin assembly (Loyola et al., 2009; Sarraf 
and Stancheva, 2004; Uchimura et al., 2006).  Through this complex, SETDB1 
mono-methylates lysine 9 on non-nucleosomal H3 (Loyola et al., 2009), 
presumably in preparation for further bi- and tri-methylation by the Suv39H1/H2 
(Loyola et al., 2006).  Consistent with these processes being particularly 
important during multicellular organism development, CAF-1 is required for 
normal development of diverse eukaryotes, including both plants and animals 
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(Fischer et al., 2007; Houlard et al., 2006; Kaya et al., 2001; Quivy et al., 2001; 
Song et al., 2007; Yu et al., 2013). 
 
1.2.4:  CAF-1 Regulates Chromatin Structure Early in Development 
Chromatin structure begins to change as soon as the sperm and oocyte 
genomes fuse to form the novel zygote genome, which begins the process of 
spatial and temporal regulation of development (reviewed in (Maeso et al., 
2016)).  After the zygote divides and enters the 2-cell (2C) stage, each daughter 
cell retains the ability to differentiate into any cell type, a property known as 
totipotency.  While embryonic stem cells (ESCs) retain the ability to differentiate 
into most cell types (pluripotency), very few retain totipotency.  However, a recent 
study found that partial depletion of p150 and p60 in mouse ESCs resulted in a 
reacquisition of characteristics inherent to cells at the 2C stage (Ishiuchi et al., 
2015).  Some of these characteristics include the derepression of genes 
transcribed during the 2C stage, including the heterochromatic repeat elements 
MERVL and the major satellite repeat.  Depletion of CAF-1 subunits in early 
mouse embryos also resulted in derepression of retrotransposon elements, a 
decrease in enrichment of heterochromatic silencing marks such as H3K9me3, 
and an increase in H3.3 enrichment on endogenous retrotransposons (Hatanaka 
et al., 2015).  This suggests that in the absence of CAF-1, the transcriptionally 
active histone variant H3.3 is deposited onto endogenous retrotransposon 
elements, resulting in a failure to replicate epigenetic histone silencing marks and 
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reactivation of expression.  To further emphasize the importance of CAF-1 in 
mouse development, deletion of p150 results in developmental arrest at the 16 
cell stage and ablation of the heterochromatic chromocenters characteristic of 
differentiating mouse cells (Houlard et al., 2006).  Cells in the 2C stage lack 
chromocenters and feature endogenous retrotransposon activity, further 
suggesting that CAF-1 is important in maintaining the chromatin structure 
required of differentiated cells.  Additionally, depletion of either p150 or p60 in 
mouse increased the efficiency of reprogramming fibroblasts to induced 
pluripotent stem cells (iPSCs) by several orders of magnitude (Cheloufi et al., 
2015).  While these discoveries are important in terms of advancing the ability to 
study early stages of development, they also demonstrate that CAF-1 is critical in 
regulating chromatin structure early in development.    
   
1.2.5:  Clinical uses of CAF-1  
Cancer cells often feature accelerated proliferation rates negatively 
correlated with clinical prognosis (reviewed in (Evan and Vousden, 2001)).  One 
of the most reliable methods to grade the proliferation rate of neoplastic tissue is 
to probe the tissue for a marker associated with cellular proliferation.  The 
expression of a proliferation marker is positively correlated to the growth rate of 
the neoplastic tissue, and thus negatively correlated with the clinical prognosis.  
In 2004 Almouzni and colleagues proposed using the subunits of CAF-1 as 
proliferation markers, as both p150 and p60 are expressed throughout the cell 
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cycle and minimally expressed during senescence (Polo et al., 2004).  
Expression of p150 and p60 strongly correlated with other established 
proliferation markers, including PCNA and Ki-67 (Polo et al., 2004), and several 
studies have successfully used CAF-1 subunits in grading cancer growth rates in 
prostate cancer, melanoma, and several types of oral cancers (Mascolo et al., 
2010, 2012a, 2012b; Polo et al., 2010; Staibano et al., 2007).  One study even 
showed that expression of p60 is statistically the best independent predictor of 
cancer development in benign salivary gland growths and metastasis in 
malignant salivary gland tumors (Staibano and Mascolo, 2011).  Despite the 
promise that these studies have shown, CAF-1 subunits have not been widely 
adopted as proliferation markers in grading neoplastic growths.  However, the 
increased usage of tissue microarrays (Mascolo et al., 2012b) may encourage 
the expanded use of novel proliferation markers, including CAF-1 subunits, and 
further facilitate the clinical study of cancer.  
 
1.3:  The Nucleolus 
The nucleolus was first described by Wagner (1835) and Valentin (1836) 
through light microscopy observations, highlighting the prominence of the 
nucleolus as a sub-nuclear body visible under crude light microscopy conditions 
(Valentin, 1836, 1839; Wagner, 1835).  In the early 1930s, Heitz and McClintock 
independently discovered that the nucleoli are organized around specific 
genomic loci, which were later termed nucleolus organizer regions (NORs) 
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(Heitz, 1931; McClintock, 1934).  An explosion of discoveries were made in the 
mid 1960’s, culminating in the landmark discovery that nucleoli are the sites of 
ribosomal biogenesis (reviewed in (Pederson, 2011)).  In addition to its primary 
role as the site of ribosomal transcription and maturation, the nucleolus hosts 
many other biological processes, including replication of various viruses (Boyne 
and Whitehouse, 2006; Li, 1997; Sonntag et al., 2010), signal recognition particle 
biosynthesis (Ciufo and Brown, 2000; Grosshans et al., 2001; Jacobson and 
Pederson, 1998; Pederson and Politz, 2000; Politz et al., 2000), sequestration of 
cell cycle regulators such as p53 and mdm2 (Weber et al., 1999), and 
sequestration of the transcription factor Hand1 prior to stem cell differentiation 
(Martindill et al., 2007).  This section of this chapter will focus on how the 
periphery of the nucleolus contacts particular regions of the genome and will 
outline what is known about the functionality of these interactions. 
 
1.4:  Organization of the Genome via Association with Specific Sub-Nuclear 
Regions 
1.4.1:  Lamina-Associated Domains (LADs) 
With the advent of high-throughput sequencing, scientists have devised 
several genome-scale methods to test whether nuclear structures associate with 
the genome in a random or non-random manner.  One important method, termed 
Dam-ID, was developed by Bas van Steensel and Steven Henikoff (van Steensel 
and Henikoff, 2000).  Dam-ID involves the fusion of selected proteins with E. coli 
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DNA adenine methyltransferase (Dam), followed by isolation and deep 
sequencing-based identification of DNA containing methylated adenine. 
Eukaryotes lack adenine methylation; therefore genome-scale mapping of this 
orthologous mark reveals genomic loci that were in close proximity to the fused 
protein of interest.  Studies in a D. melanogaster embryonic cell line (Pickersgill 
et al., 2006) and human fibroblasts (Guelen et al., 2008) fused B-type lamins with 
Dam to detect peripherally-localized genomic regions, which were termed 
lamina-associated domains (LADs). LADs tend to be gene-poor and enriched for 
heterochromatic silencing marks such as H3K9me2 (Kind et al., 2013).  Mouse 
and human genomes contain up to 1,400 LADs encompassing approximately 
40% of the genome, ranging in size from 40 kilobases to over 30 megabases 
(Kind and van Steensel, 2010; Peric-Hupkes et al., 2010).   
The mechanisms that govern tethering of LADs to the nuclear periphery 
are still largely unclear, but recent studies suggest this tethering may be crucial in 
regulating the transcriptional status of the LADs.  This was tested by using a 
LacO array proximal to a reporter gene and expressing a LacI fused to a protein 
which directly interacts with the inner nuclear membrane, such as EMD or Lap2β 
(Dialynas et al., 2010; Finlan et al., 2008; Reddy et al., 2008). In these 
experiments, targeting various reporter genes to the nuclear lamina (NL) resulted 
in decreased reporter expression. Likewise, in a comparison of LADs in mouse 
embryonic stem cells (ESCs) and neural precursor cells (NPCs), an increase in 
NL association was correlated with a decrease in expression level.  Conversely, 
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gene ontology (GO) analysis revealed that ~20% of genes that featured 
decreased association with the NL during ESCNPC differentiation were 
required for neural physiology.  These neural physiology genes generally 
displayed increased expression during neural differentiation, suggesting that 
release from the NL is an important step during the induction of lineage-specific 
gene expression (Peric-Hupkes et al., 2010). In summation, these studies 
suggest that positioning of LADs at the NL is an important method for physically 
and functionally compartmentalizing eukaryotic genomes. 
 
1.4.2:  Nucleolar Associated Domains (NADs) 
In 2010, two independent studies isolated and sequenced the genomic 
DNA associated with purified nucleoli (van Koningsbruggen et al., 2010; Németh 
et al., 2010).  Both studies found that these nucleolar-associated domains 
(NADs) are relatively gene-poor compared to the rest of the genome and are 
highly enriched for satellite DNA repeats.  Additionally, both studies also found 
enrichment for specific types of genes including those coding for the 5S rRNA, 
immunoglobulins, olfactory receptors, and zinc-finger proteins.  These gene 
classes often exist as multigene arrays, however it remains unknown to what 
extent primary sequences contribute to perinucleolar localization (see concluding 
remarks below). 
Along with these similarities in the two NAD datasets, there are several 
notable differences that may be attributable to the different cell types or 
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experimental procedures used (notably, the use of crosslinking).  The Längst 
group isolated nucleoli from formaldehyde-crosslinked HeLa cells and observed 
that NADs were significantly enriched for tRNA genes, which are transcribed by 
RNA polymerase III (Németh et al., 2010).  This finding is compatible with 
previous observations that RNA polymerase III is especially active around the 
nucleolar periphery (Haeusler and Engelke, 2006; Matera et al., 1995; Thompson 
et al., 2003). The Lamond group analyzed NADs in non-crosslinked HT-1080 
fibrosarcoma cells and emphasized that the majority of the NAD peaks overlap 
with previously published LADs (van Koningsbruggen et al., 2010).  To explore 
this overlap, the Lamond group photoactivated a GFP-tagged histone around the 
periphery of the nucleolus and then tracked the localization of that chromatin 
through the cell cycle.  It was found that after mitosis, the photoactivated 
chromatin could localize to either the perinucleolar (PN) region or the NL, 
indicating that the PN and the NL may be interchangeable addresses for some 
loci. These data are consistent with other studies which found that LADs often re-
localize to the PN region after mitosis (Kind et al., 2013). LADs can also 
redistribute to either the PN or pericentromeric (PC) heterochromatin regions 
upon a short treatment with actinomycin D at a dose that selectively inhibits 
transcription by RNA polymerase I (Ragoczy et al., 2015).  However, the 
transcriptional activity of the relocalized loci were not altered during this 
treatment, suggesting that the PN and NL serve as dynamic, functionally 
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overlapping regions for genome organization and silencing (reviewed in 
(Padeken and Heun 2014)).   
 
1.4.3:  The Perinucleolar Compartment (PNC) of Cancer Cells 
The HeLa and HT-1080 cells used by the Lamond and Längst laboratories 
(van Koningsbruggen et al., 2010; Németh et al., 2010) both contain a cancer-
specific sub-nuclear structure known as the perinucleolar compartment (PNC) 
(Norton et al., 2008). The PNC is localized on a portion of the nucleolar surface 
(Huang et al., 1997) and thus may copurify with nucleoli. This suggests that 
some of the NADs described in the previous section may be cancer cell-specific. 
The presence of the PNC is correlated with metastasis and inversely correlated 
with patient survival and relapse (Kamath et al., 2005).  The PNC is enriched in 
proteins that regulate the splicing and polyadenylation of RNA polymerase II 
transcripts (Ghetti et al., 1992; Hall et al., 2004; Matera et al., 1995; Timchenko 
et al., 1996). This compartment also contains specific RNA polymerase III 
transcripts, including RNase P, RNAse MRP, Y RNAs (Matera et al., 1995), Alu 
RNAs, and signal recognition particle RNA (Wang et al., 2003).  These RNA 
species are not actively transcribed within the PNC (Matera et al., 1995; Wang et 
al., 2003) and the compartment is devoid of most RNA polymerase III transcripts, 
notably tRNAs (Matera et al., 1995).  The function of the PNC is still unknown, 
but is of great interest to the field of cancer biology (reviewed in (Pollock and 
 16 
Huang, 2010)). In the interest of space, the remainder of this section will focus on 
NAD associations which occur in both primary and cancer cells.   
 
1.5:  NAD Function:  PN Localization Linked to Heterochromatin Silencing 
1.5.1:  The Inactive X Chromosome 
In 1949 Barr and Bertram described a “nucleolar satellite” which protruded 
from the nucleolus of female cat motor neurons (Barr and Bertram, 1949). This 
structure was later identified as the inactive X chromosome. During embryonic 
development of female mammalian cells, one of the X chromosomes is silenced 
in order to provide dosage compensation, ensuring that female cells with two X 
chromosomes do not overexpress X-linked genes (Lyon, 1961).  During 
gastrulation and after most of the DNA methylation imprints from the parents are 
erased, the two X-chromosomes pair and each chromosome is randomly 
assigned to become active (Xa) or inactive (Xi).  The designated Xi then 
transcribes a long non-coding RNA (lncRNA) known as Xist (Brown et al., 1991), 
which spreads across the Xi in cis (Clemson et al., 1996).  Xist recruits Polycomb 
Repressive Complexes 1 and 2 (PRC1 and PRC2), which induce methylation of 
histone H3 lysine 27 and silence the transcriptional activity of most of the genes 
on the Xi ((Plath et al., 2003, 2004); reviewed in (Lee, 2012; Lucchesi et al., 
2005; Thorvaldsen et al., 2006)). Thus, X inactivation is a prominent example of 
gene regulation via alteration of chromatin state. 
 17 
Several studies have shown that the Xi can associate with either the NL or 
PN regions of the nucleus (Barton et al., 1965; Bourgeois et al., 1985). A study 
by the Lee laboratory found that Xi association with nucleoli is most prevalent 
during mid-late S-phase of the cell cycle (Zhang et al., 2007). This study also 
showed that the interaction is dependent upon the X inactivation center (Xic), the 
region encoding the Xist locus, because autosomes bearing Xic translocations 
also preferentially associate with nucleoli. Conversely, deletion of Xist reduces 
nucleolar association, H3K27 methylation, and derepression of Xic-proximal 
genes in some cell lines analyzed. This PN localization occurs during mid-late S-
phase when heterochromatin is replicated, suggesting that replication in the PN 
region helps to maintain the silent state of the Xi. Additional tools to perturb Xi-
nucleolar associations without having to delete central silencing factors such as 
Xist will be important to further test this hypothesis. However, it seems likely that 
the Xi-PN association by itself is not essential for maintaining the bulk of Xi 
silencing, consistent with previous observations of a large degree of functional 
overlap between Xist and other factors (Csankovszki et al., 2001). 
 
1.5.2:  The 5S rDNA  
Eukaryotic ribosomes are comprised of large (60S) and small (40S) 
subunits.  The major RNA species found in mature ribosomes (28S, 18S, and 
5.8S rRNA) are encoded within the 47S rRNA primary transcripts that are 
produced from repeated templates on the short arms of the five acrocentric 
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chromosomes in humans (reviewed in (Boisvert et al., 2007; Németh and Längst, 
2011; Sirri et al., 2008)).   An additional rRNA species is encoded by an array of 
approximately 100 RNA polymerase III-transcribed 5S rDNA genes located on 
Chromosome 1 (Steffensen et al., 1974; Stults et al., 2008).  As noted above, 
several studies have found that RNA polymerase III transcribed genes, including 
the 5S rDNA, are enriched in the PN region in a variety of different species and 
cell types (van Koningsbruggen et al., 2010; Matera et al., 1995; Németh et al., 
2010; Thompson et al., 2003). For example, the 5S array-nucleolar association in 
humans was described in HeLa cells, and its localization was noted as being 
outside of the PNC region (Matera et al., 1995).  One possible rationale for the 
close proximity of the 5S array to nucleoli would be to increase the efficiency of 
ribosome assembly (Haeusler and Engelke, 2006).  However, a study by the 
Magnuson lab suggests instead that nucleolar localization of 5S rDNA repeats 
may facilitate transcriptional silencing. In this study, the 119-bp 5S rDNA and a 
reporter gene were randomly inserted into the genome of mouse ES cells, and 
these transgenes frequently associated with nucleoli.  This association was 
correlated with reduced reporter gene expression and increased H3K9me3 
enrichment.  Furthermore, endogenous mouse 5S pseudogenes, which maintain 
internal RNA polymerase III transcription factor binding sites but do not produce 
a functional transcript, also frequently associate with the PN region. ChIP-qPCR 
analysis demonstrated that many of these pseudogenes feature low RNA 
polymerase III transcription factor occupancy, suggesting that the 5S rDNA 
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sequence and not the RNA Polymerase III transcription machinery is responsible 
for PN localization (Fedoriw et al., 2012a). The cis-acting sequences and trans-
acting factors required for these types of higher-order genome interactions are of 
major interest, and specific examples related to nucleoli are discussed below 
(Table 1.1).
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Table 1.1:  Summary of Known Perinucleolar Region Regulators 
 
This table lists all known proteins and lncRNAs which regulate the structure or 
localization of known NAD elements.  References for each item given in 
parenthesis.  
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Table 1.1  Summary of Known Perinucleolar Region Regulators 
 
Protein or 
RNA 
Known Interphase Nuclear 
Localization 
Regulation Target (Species) 
CTCF Insulator Elements (Kim et al., 
2007) 
Insulators (H. sapiens)(Yusufzai et 
al., 2004) 
 
Clustered Centromeres (D.  
melanogaster) (Padeken et al., 2013) 
 
Xi (M. musculus) (Yang et al., 2015) 
NLP (NCL) Nucleolar Fibrillar 
Centers(Lischwe et al., 1981; 
Spector et al., 1984) 
 
Nucleolar Dense Fibrillar 
Component (Escande et al., 
1985; Spector et al., 1984) 
 
Nucleolar Granular 
Component (Escande et al., 
1985) 
Clustered Centromeres (D. 
melanogaster)(Padeken et al., 2013) 
Modulo 
(NPM1) 
Nucleolar Granular 
Component (Spector et al., 
1984) 
Clustered Centromeres (D. 
melanogaster) (Padeken et al., 2013) 
Ki-67 Satellite DNA (Bridger et al., 
1998) 
 
Nucleolar Dense Fibrillar 
Component (Kill, 1996) 
47S rDNA (H. sapiens) (Chromosome 
13p) (Booth et al., 2014) 
Kcnq1ot1 Kcnq1 Locus (Pandey et al., 
2008) 
Kcnq1 locus (H. sapiens, M. 
musculus) (Mohammad et al., 2008; 
Pandey et al., 2008) 
Firre 6 gene-containing loci (Firre, 
Slc25a12, Ypel4, Eef1a1, Atf, 
Ppp1r10), and 34 non-gene 
loci (Hacisuleyman et al., 
2014) 
Xi (M. musculus) (Yang et al., 2015) 
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1.6:  Protein Regulators of PN Structure and Function 
Tethering of NADs to the PN region is now known to require several trans-
acting factors, which presumably directly or indirectly bind to NAD DNA.  These 
NAD-bound factors must either interact with the ribosomal DNA of the nucleolus 
or with nucleolar proteins in order to facilitate nucleolar localization.  The 
following sections will briefly introduce the protein and RNA factors thus far 
discovered to be involved in NAD localization. 
 
1.6.1: CTCF 
The CCCTC-Binding Factor (CTCF) is a DNA-binding protein with 
between 55,000-65,000 sites of enrichment throughout the human genome 
(Chen et al., 2012b).  CTCF is particularly enriched on insulator elements 
(DeMare et al., 2013; Kim et al., 2007; Song et al., 2011), which block interaction 
between promoters and enhancers. Importantly, CTCF regulates the three-
dimensional interaction of these regulatory elements with distal promoters, 
thereby regulating transcription (Sanyal et al., 2012; Shen et al., 2012).  Insulator 
occupancy by CTCF is cell-type specific (Barski et al., 2007; Chen et al., 2008; 
Cuddapah et al., 2009; Kim et al., 2007; Shen et al., 2012), suggesting that 
CTCF contributes to regulatory networks responsible for changes in cell-lineage 
specific nuclear architecture.  
One study in human leukemia cells showed that CTCF binding sites within 
an exogenous insulator conferred a higher propensity to associate with nucleoli. 
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This study further showed that CTCF interacts with the nucleolar protein 
nucleophosmin (NPM1/B23), and that NPM1 enrichment on the exogenous 
insulator was dependent on the presence of CTCF binding sites (Yusufzai et al., 
2004).  One plausible model to explain this tethering would be that CTCF links 
insulator elements to the nucleoli via interaction with the nucleolar protein NPM1. 
Later sections in this review will discuss the role of CTCF in regulating the 
nucleolar localization of clustered centromeres and the Xi.  
  
1.6.2: The Nucleophosmin Homolog NLP and the Nucleolin Homolog 
Modulo 
Nucleolin (NCL/C23) is a multifunctional protein that primarily localizes to 
the nucleolus (Bugler et al., 1982), interacts with snoRNAs (Sáez-Vasquez et al., 
2004), regulates the folding and assembly of ribosomes (Ginisty et al., 1998), 
and regulates 47S rDNA transcription (Rickards et al., 2007; Roger et al., 2002).  
NPM1 is also a multifunctional nucleolar protein (Michalik et al., 1981) that 
interacts with several ribosomal proteins (Lindström and Zhang, 2008; Yu et al., 
2006) and has multiple roles in nucleolar biology including acting as a pre-rRNA 
endoribonuclease (Herrera et al., 1995; Savkur and Olson, 1998) and facilitating 
40S and 60S nuclear export (Maggi et al., 2008).  NPM1 interact with a wide 
variety of proteins, including the centromere-specific histone variant CENP-A 
(Foltz et al., 2006).  Centromeres often cluster together and localize to the 
nucleolus in many species and cell types (Weierich et al., 2003).  The Heun 
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laboratory showed that depletion of NLP, a Drosophila homolog of NPM1, or the 
Drosophila CTCF insulator protein resulted in de-clustering of centromeres and a 
decrease in centromere association with nucleoli.  Depletion of Modulo, the 
Drosophila homolog of NCL, also resulted in de-clustering of centromeres and 
disruption of nucleolar structure, making it difficult to determine whether Modulo 
is required for PN positioning.  NLP or Modulo depletions also resulted in de-
repression of several classes of transposable elements and cells showed signs 
of genomic instability, including increased double stranded breaks and lagging 
chromosomes during mitosis (Padeken et al., 2013). These data are consistent 
with the idea that the frequent nucleolar localization of centromeres is functionally 
important for maintaining a chromatin structure optimal for proper chromosome 
segregation.  
 
1.6.3:  Ki-67 
 Ki-67 was first identified as an epitope recognized by a monoclonal 
antibody raised against nuclei from a Hodgkin lymphoma cell line (Gerdes et al., 
1983).  Since its initial discovery, Ki-67 has been used as a cell proliferation 
marker in thousands of clinical studies in order to grade the proliferative rates of 
various types of cancers.  Despite this, relatively little is known about the 
molecular functions of Ki-67.  In interphase cells Ki-67 primarily localizes to the 
nucleolus (Cheutin et al., 2003; Kill, 1996), is enriched on the 47S rDNA gene 
(Bullwinkel et al., 2006), and is required for normal levels of 47S rDNA 
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transcription (Booth et al., 2014; Rahmanzadeh et al., 2007).  In early G1, Ki-67 
localizes to distinct foci which co-localize with several different classes of repeats 
enriched within the NADs, including centromeric alpha satellite, telomeric 
repeats, and Sat III (Bridger et al., 1998). Several studies have found that Ki-67 
is required for the formation of the human perichromosomal layer (Booth et al., 
2014; Sobecki et al., 2016), a proteinaceous sheath that coats condensed 
chromosomes during mitosis (reviewed in (Van Hooser et al., 2005)).  While the 
function of the PCL is still being explored, one recent study suggests that the 
presence of Ki-67 at the PCL may serve to create a surfactant layer to keep 
mitotic chromosomes dispersed (Cuylen et al., 2016).  Two recent studies have 
also found evidence that Ki-67 is important in regulating the PN localization of 
two different classes of NADs.  The first showed that Ki-67 is required for normal 
nucleolar association of an rDNA-proximal NAD sequence containing a LacO 
reporter array (Booth et al., 2014).  This is especially intriguing because nucleoli 
are constructed around the rDNA repeat arrays, and so this evidence suggests 
Ki-67 may also regulate the reconstruction of the nucleoli at the beginning of G1.  
A second study found that Ki-67 is required for nucleolar association of the 
centromeric histone variant CENP-A (Sobecki et al., 2016).  CENP-A is enriched 
on all centromeres within the human genome, therefore this suggests that Ki-67 
is required for the localization centromeric satellite repeat elements to the PN 
region.  While there are now two examples of Ki-67 regulating NAD localization, 
future studies should take an unbiased approach and perform NAD-seq upon Ki-
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67 depletion in order to determine which classes of NADs are specifically 
regulated by Ki-67.  Future studies should examine whether Ki-67’s role in 
regulating PCL structure and NAD localization are interrelated. 
 
1.7:  lncRNAs as Regulators of PN Structure and Function 
1.7.1:  Kcnq1ot1 
The Kcnq1 locus in mouse and human cells is regulated through maternal 
imprinting.  While genes within this locus are expressed on the maternal 
chromosome, the paternal chromosome expresses an antisense lncRNA known 
as Kcnq1ot1 in order to facilitate silencing of the paternal genes (Mancini-
DiNardo et al., 2006; Pandey et al., 2004, 2008; Thakur et al., 2004).  In contrast 
to the paternally-derived chromosome, Kcnq1ot1 expression on the maternal 
chromosome is inhibited due to imprinted methylation of the Kcnq1ot1 promoter 
(Fitzpatrick et al., 2002). The Kanduri laboratory discovered that the Kcnq1ot1 
locus is often enriched for heterochromatic histone silencing marks in mouse 
placenta cells, but not in fetal liver cells.  In placenta cells, the Kcnq1ot1 locus is 
also associated with nucleoli twice as frequently as observed in fetal liver cells 
(Pandey et al., 2008), supporting the correlation between nucleolar localization 
and the establishment and/or maintenance of heterochromatin.  Another study 
found that an 890-bp region near the 5’-end of the human Kcnq1ot1 transcript is 
required for silencing of the other Kcnq1 locus genes.  Furthermore, when this 
silencing domain was inserted into an episomal vector, the vector localized to 
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nucleoli during mid S-phase and a flanking reporter gene was silenced. When the 
silencing domain was inserted in reverse orientation, the vector failed to localize 
to nucleoli and the reporter gene was expressed (Mohammad et al., 2008).  
These results support the hypothesis that the transcribed Kcnq1ot1 lncRNA and 
not the DNA sequence encoding it is required for localization to the PN region 
and silencing of the vector reporter genes.   
 
1.7.2:  Firre 
One of the X-linked genes which escapes silencing during X-inactivation 
encodes the lncRNA Firre (Yang et al., 2010).  Firre is important for long-range 
chromosomal interactions, interacting with the RNA-binding protein hnRNPU to 
facilitate localization of the Xi to regions from five different chromosomes 
(Hacisuleyman et al., 2014).  Firre is also required for normal association of the 
mouse Xi with nucleoli, as the frequency of PN localization of the X-linked Firre 
and DXZ4 macrosatellite loci decrease upon depletion of the Firre lncRNA (Yang 
et al., 2015).  Firre depletion also decreases the enrichment of the 
heterochromatic silencing mark H3K27me3 on the Xi without decreasing the 
expression levels of Xist.  However, depletion of Firre did not result in significant 
transcriptional changes on the Xi. Future experiments will be required to 
distinguish whether these data result from functional redundancy among 
repressive factors which govern Xi silencing, or because transcriptional 
regulation is not a major functional consequence of NAD localization.  
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The Firre and DXZ4 loci also feature enrichment of the insulator protein 
CTCF (Hacisuleyman et al., 2014; Yang et al., 2015).  CTCF depletion 
decreased PN association of both the Firre and DXZ4 loci, reduced expression of 
the Firre lncRNA, and diminished levels of H3K27me3 on the Xi (Yang et al., 
2015).  Therefore, CTCF may regulate PN localization and silencing of the Xi as 
both a direct interaction factor and as a transcriptional regulator of Firre 
expression. Additional studies should explore whether the trans-chromosomal 
interactions regulated by Firre also localize to the periphery of the nucleolus and 
are regulated by CTCF.   
 
1.8:  Concluding Remarks 
1.8.1:  What defines the NADs?  
One possible determinant of NAD localization is genomic DNA sequence.  
Primary DNA sequence is likely critical for some classes of NADs, as is the case 
for 5S pseudogenes, which can associate with the nucleoli independently of RNA 
polymerase III machinery (Fedoriw et al., 2012a).  However, primary DNA 
sequence cannot be the only determinant of all nucleolar localization. For 
example, in the case of Firre-dependent PN localization of the inactive Xi 
chromosome (Figure 1.1)(Yang et al., 2015), the primary sequences of the Xi 
must be insufficient for nucleolar association because the Xa chromosome does 
not localize to the PN region.  The discovery that lncRNAs are required for some 
NAD associations is an exciting development, as over 100,000 lncRNAs have 
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been annotated in the human genome (Volders et al., 2013), and the functions of 
most of these molecules remain unknown.  Additional research is required to 
elucidate how proteins and lncRNAs coordinate NAD-PN interactions.  One likely 
possibility is that the lncRNAs directly interact with nucleolar targeting proteins, 
and recent advances in high throughput RNA-binding protein identification will be 
instrumental in determining the binding partners for Kcnq1ot1and Firre (Chu et 
al., 2015; McHugh et al., 2015).  In the case of Firre, a particularly relevant 
interacting protein is the RNA binding protein hnRNPU.  hnRNPU binds to Firre 
and is required for the inter-chromosomal interactions mediated by Firre 
(Hacisuleyman et al., 2014).  Another protein of interest, CTCF, binds to both the 
Firre RNA and DNA (Hacisuleyman et al., 2014; Yang et al., 2015) and this 
interaction may be mediated by hnRNPU. Many more contributing factors are 
likely to be discovered as investigations of these higher-order interactions 
continue.
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Figure 1.1:  Schematic of lncRNAs Facilitating Trans-Chromosomal 
Interactions in Mouse.  
 
The Kcnq1ot1 lncRNA tethers the Kcnq1 locus to the nucleolus (Mohammad et 
al., 2008), while the lncRNA Firre mediates nucleolar association of the Firre and 
DXZ4 loci (Yang et al., 2015).  Firre also mediates transchromosomal 
interactions of the Firre locus with 5 other loci, including the Atf4 locus on 
chromosome 15 and the Ppp1r10 locus on chromosome 17 (Hacisuleyman et al., 
2014).   
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Figure 1.1:  Schematic of lncRNAs Facilitating Trans-Chromosomal 
Interactions in Mouse.  
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1.8.2:  What is the functional significance of NADs? 
The major question to be answered is whether nucleolar localization 
affects the biological activities of NAD sequences.  Multiple studies have 
correlated localization of NADs to the PN region with heterochromatin formation 
and transcriptional silencing (Fedoriw et al., 2012a, 2012b; Mohammad et al., 
2008; Pandey et al., 2008; Yang et al., 2015; Zhang et al., 2007).  In the example 
of the Xi, failure to localize to the PN region during S-phase results in decreased 
heterochromatic silencing marks (Yang et al., 2015; Zhang et al., 2007) without 
changes in gene expression at most Xi loci (Zhang et al., 2007).  Likewise, loci 
which failed to associate with the nucleolus often re-localize to the NL or PC 
regions and transcriptional silencing is maintained (van Koningsbruggen et al., 
2010; Ragoczy et al., 2015). Together, these data are consistent with the idea 
that PN localization is one of several functionally overlapping mechanisms for 
transcriptional repression, although there is a lack of data for a unique role of 
NAD localization in regulating gene expression. It should be considered that 
transcriptional regulation may not be the only or even a major outcome of NAD 
localization to the PN region. In contrast, the data from the Heun laboratory in the 
Drosophila system points to genome stability as a critical outcome of proper NLP 
(NPM1) and Modulo (NCL) function (Padeken et al., 2013). There is precedent 
for deleterious hyper-recombination phenotypes within the rDNA upon chromatin 
perturbation in budding yeast (Cesarini et al., 2012; Ide et al., 2013; Lindstrom et 
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al., 2011), but these types of events have not been examined in conjunction with 
NAD analysis in metazoans. 
We do not presently understand how NADs migrate among different 
repressive nuclear regions, nor is it likely that we know all of the proteins and/or 
RNA factors involved in these transitions.  Further study is needed to determine 
whether and how association of NADs with the nucleolus affects nucleolar 
structure and function.  These questions will be especially challenging to explore 
because many of the proteins required for NAD localization also regulate rDNA 
transcription and/or nucleolar structure.  For example, CTCF (Huang et al., 2013; 
van de Nobelen et al., 2010), NCL (Cong et al., 2012; Rickards et al., 2007; 
Roger et al., 2002), NPM1 (Murano et al., 2008), and Ki-67 (Booth et al., 2014; 
Rahmanzadeh et al., 2007) all regulate rDNA transcription. Likewise, depletion of 
Modulo (NCL) in flies disrupts nucleolar structure as demonstrated by 
immunofluorescence (Padeken et al., 2013), and Ki-67 depletion  in human cells 
results in fewer and smaller nucleoli (Booth et al., 2014).  However, not all 
perturbations necessarily affect all structural aspects of the nucleolus. For 
example, depletion of CAF-1 p150 causes mislocalization of multiple nucleolar 
proteins (Smith et al., 2014) but does not appear to alter the macrostructure of 
the rDNA (videos 1.1 and 1.2). Therefore, it remains to be determined whether 
the structure or function phenotypes observed in the depletion of these proteins 
is caused by mislocalization of NADs or merely correlated with it, and mutations 
that separate these functions will be required to assess this.   
 34 
 
Understanding the structure of the genome is critical for understanding 
human disease, as many diseases are dependent upon genomic three-
dimensional structure (reviewed in (Misteli, 2010)).  For example, translocations 
are associated with a variety of different cancers, and these translocation events 
occur most frequently between genomic elements in close proximity to one 
another (Zhang et al., 2012).  This has been particularly well documented in the 
case of ABL-BCR translocations that drive chronic myeloid leukemia, because 
the BCR gene on chromosome 9 is often found in close proximity to the ABL 
gene on chromosome 22 in hematopoietic cells (Lukášová et al., 1997; Neves et 
al., 1999).  Although the periphery of the nucleolus is a small fraction of nuclear 
volume, many higher order chromosomal interactions occur there.  Discovering 
the extent to which this organizational hub is coordinated with other nuclear 
elements will be critical in comprehending the three-dimensional structures of 
metazoan genomes, and how these structures are perturbed in disease states. 
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Videos 1.1 and 1.2  Three-Dimensional Rendering of HeLa S3 Nucleus with 
and without CAF-1 p150 Depletion. 
 
Video 1.1 shows a HeLa S3 nucleus after 72 hours of expression of a control 
shRNA directed against luciferase. DAPI staining is in blue (A), the nucleolar and 
Cajal body protein Nopp140 in green (B) and the ribosomal rDNA in red (C).  
Video 1.2 shows a HeLa S3 nucleus after 72 hours of expression of an shRNA 
directed against CAF-1 p150 with the same channels as in Video 1.  Note that 
Nopp140 does not localize to the nucleolus in video 2C, but does maintain 
localization to two different Cajal bodies. In contrast, the morphology of the 
nucleolus visualized by rDNA hybridization is not significantly different. (Methods, 
probes, and antibodies described in (Smith et al., 2014) . The Nopp140 antibody 
(RS8) was a generous gift of U. Thomas Meier, Albert Einstein College of 
Medicine, New York, NY (Kittur et al., 2007).  Z-stack images were taken on a 
Leica TCS SP5 II  Laser Scanning Confocal Microscope and videos were 
generated using the Leica Application Suite AF version 2.5.1.6757) 
Please visit http://link.springer.com/article/10.1007/s00412-015-0527-8 to view 
the videos. 
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CHAPTER II:  A SEPARABLE DOMAIN OF THE P150 SUBUNIT OF HUMAN 
CHROMATIN ASSEMBLY FACTOR-1 PROMOTES PROTEIN AND 
CHROMOSOME ASSOCIATIONS WITH NUCLEOLI 
 
Note about authorship:   
This chapter was previously published (Smith et al., 2014) as a collaboration 
between the following authors:  Corey L. Smith, Timothy D. Matheson, Daniel J. 
Trombly, Xiaoming Sun, Eric Campeau, Xuemei Han, John R. Yates III, and Paul 
D. Kaufman.  I was personally responsible for Figures 2.14-2.17, methods 
sections 2.5.11-2.5.12, and for editing the manuscript.  I chose to include the 
entire manuscript within this chapter because the presented evidence is 
imperative in understanding chapters III, IV, and the molecular mechanism of 
p150 in regulating nuclear structure.  
  
2.1:  Abstract 
Chromatin Assembly Factor-1 (CAF-1) is a three-subunit protein complex 
conserved throughout eukaryotes that deposits histones during DNA synthesis. 
In this chapter we present a novel role for the human p150 subunit in regulating 
nucleolar macromolecular interactions. Acute depletion of p150 causes 
redistribution of multiple nucleolar proteins and reduces nucleolar association 
with several repetitive element-containing loci. Notably, a point mutation in a 
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SUMO-interacting motif (SIM) within p150 abolishes nucleolar associations, 
whereas PCNA or HP1 interaction sites within p150 are not required for these 
interactions. Additionally, acute depletion of SUMO-2 or the SUMO E2 ligase 
Ubc9 reduces alpha-satellite DNA association with nucleoli. The nucleolar 
functions of p150 are separable from its interactions with the other subunits of 
the CAF-1 complex, because an N-terminal fragment of p150 (p150N) that 
cannot interact with other CAF-1 subunits is sufficient for maintaining nucleolar 
chromosome and protein associations. Therefore, these data define novel 
functions for a separable domain of the p150 protein, regulating protein and DNA 
interactions at the nucleolus.  
 
2.2:  Introduction 
In eukaryotes, histones are deposited onto DNA by nucleosome assembly 
proteins, including Chromatin Assembly Factor-1 (CAF-1) (reviewed in (Ransom 
et al., 2010)). CAF-1 is a three-subunit protein complex conserved throughout 
eukaryotes. In humans, the three CAF-1 subunits are named based on their gel 
migration (Smith and Stillman, 1989). The largest subunit, p150, is the platform 
that binds the other two subunits, the WD-40 repeat proteins p60 and p48; all 
three subunits are required for in vitro nucleosome assembly activity (Kaufman et 
al., 1995; Verreault et al., 1996). CAF-1 deposits histones during DNA synthesis, 
and interacts with DNA replication protein proliferating cell nuclear antigen 
(PCNA) and the replication-linked histone isoform H3.1 (Shibahara and Stillman, 
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1999; Tagami et al., 2004). Throughout the eukaryotes, CAF-1 is required for 
normal S phase progression, heterochromatin formation (Houlard et al., 2006; 
Klapholz et al., 2009; Quivy et al., 2008; Takami et al., 2007), and chromatin 
restoration after DNA repair (Gaillard et al., 1996; Green and Almouzni, 2003). 
Consistent with its role in chromosome duplication, CAF-1 protein levels correlate 
with cell proliferation and cancer prognosis (Mascolo et al., 2010; Polo et al., 
2004; Staibano et al., 2009).  
In all eukaryotes, a dedicated polymerase, RNA polymerase I (Pol I), 
transcribes the large ribosomal RNAs (rRNAs; 18S and 28S in humans) as long 
precursor species (47S in humans) from repeated ribosomal DNA (rDNA) 
templates. The 47S rRNA-encoding repeats cluster to form the nucleolus, a 
specialized, non-membrane-bound sub-nuclear compartment (McStay and 
Grummt, 2008). Pol I transcription constitutes the majority of RNA synthesis in 
cells and is regulated by cell growth and energy supply, differentiation, cell cycle 
progression, tumor suppressors (p53 and Rb) and oncoproteins (c-myc) (McStay 
and Grummt, 2008; Murayama et al., 2008). Additionally, the nucleolus is a 
dynamic hub where many nuclear proteins (Emmott and Hiscox, 2009) and 
genomic loci (van Koningsbruggen et al., 2010; Németh et al., 2010) are tethered 
(Padeken et al., 2013). Notably, nucleolar alterations can be important for cancer 
diagnoses (Maggi and Weber, 2005). However, our understanding of the 
structure and function of nucleolar macromolecular networks remains incomplete. 
Here, mass spectrometric analysis of the human CAF-1 p150 subunit led us to 
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discover previously unrecognized roles in regulating macromolecular interactions 
at the nucleolus.  
 
2.3:  Results 
2.3.1:  p150 interacts with nucleolar proteins  
To find novel protein interaction partners, we generated a human HeLa S3 
cell line expressing an N-terminal tandem affinity tagged-CAF-1 p150 subunit 
(NTAP-p150). NTAP-p150 localizes normally to PCNA-labeled DNA replication 
foci during S phase (Campeau et al., 2009), indicating functionality in vivo. 
Nuclear extracts from asynchronous HeLa S3 cells either containing or lacking 
the NTAP-tagged p150 gene were subjected to affinity purification under mild 
(200 mM NaCl) buffer conditions that included 50 μg/ml ethidium bromide to 
avoid co-precipitation of proteins via bridged nucleic acid interactions (Lai and 
Herr, 1992). Gel analysis of the purified proteins demonstrated that NTAP-p150 
complexed with the other two CAF-1 subunits, p60 and p48 (Figure 2.1, B), and 
that this tagged complex was recovered in a tag-dependent manner. Proteins 
from two independent preparations were identified by mass spectrometry (Figure 
2.1, A, and Table 2.1). In the tagged but not untagged samples, we detected all 
three CAF-1 subunits, as well as known CAF-1-binding proteins such as core 
histones, histone deposition factor Asf1 (Sharp et al., 2001; Tang et al., 2006; 
Tyler et al., 2001), and HP1 (Murzina et al., 1999; Quivy et al., 2004). 
Additionally, the tagged samples contained multiple nucleolar proteins that were 
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not previously known to associate with p150. These included Ki67, a large, 
proteolytically sensitive protein that is commonly used to mark proliferative cells 
in pathology studies (Yerushalmi et al., 2010). Notably, Ki67 prominently 
localizes to nucleoli (Espada et al., 2007; MacCallum and Hall, 1999; Takagi et 
al., 2001) (Figure 2.1, C) This interaction is functionally important, because 
inactivation of Ki67 inhibits rRNA synthesis (Rahmanzadeh et al., 2007). The 
p150-associated proteins also included NPM (also known as B23), and NCL, 
which are both nucleolar histone chaperones that assist Pol I transcription 
(Angelov et al., 2006; Murano et al., 2008; Rickards et al., 2007).  Our affinity-
purified NTAP-p150 preparations additionally included Nucleolar Protein 58 
(Nop5/Nop58), a snoRNA-binding protein whose nucleolar localization is 
regulated by SUMOylation (Westman et al., 2010), DDX17, a DEAD-box protein 
that contributes to rRNA processing and nucleolar protein localization (Jalal et 
al., 2007), and RRP1B, a nucleolar targeting protein implicated in metastasis 
susceptibility (Chamousset et al., 2010; Crawford et al., 2007). Additionally, we 
detected DNAJC9, a DnaJ homolog that was previously isolated as a binding 
partner of RRP1B, as were the nucleolar proteins NCL, NPM, and Ki67 
(Crawford et al., 2009) that we identified here (Table 2.1). Finally, we note that 
p150 was identified in an independent proteomic analysis of purified nucleoli 
(Ahmad et al., 2009), supporting our findings.  
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Figure 2.1:  Nucleolar associations of human p150.  
 
(A) Novel nucleolus-related p150-interacting proteins identified by mass 
spectrometry are summarized. Proteins listed were not previously known to 
interact with p150 and had multiple peptides detected in two different 
experiments (E1 and E2). Full lists are in Table S1. Number of peptides (#Pep) 
and spectral counts (SpC) are indicated. (B) Purified p150-associated proteins 
prepared for mass spectrometry. Affinity-purified samples from untagged HeLa 
S3-Trex (lane 1) and HeLa S3-Trex-NTAP-p150 (lane 2) cells were analyzed on 
a silver-stained 5-20% SDS-PAGE gel. CAF-1 subunits p150, p60 and p48 are 
indicated. (C) Confocal microscopy analysis of p150 (red) and Ki67 (green) in 
HeLa S3 cells detects partial colocalization at nucleoli in the merged image 
(yellow). Fields of cells were photographed with a 63x objective. Cells had either 
been blocked in G1 phase by double thymidine treatment or released into S 
phase for 2 hours. Scale bars are 10 μm. (D) Location of ChIP primer pairs on 
the human 47S rRNA-encoding rDNA locus. (E) p150 occupancy at rDNA genes 
in asynchronous HeLa S3-Trex-shRNA cells. Also assayed were the pol II gene 
RPS20 and a gene desert from chromosome 16. Cells expressing either a 
control shRNA (sh-Luc) or the shRNA targeting p150 (sh-p150) were compared. 
Chromatin was precipitated with either non-immune rabbit sera (IgG) or anti-p150 
sera (-p150) as indicated. The mean percentages of input chromatin 
precipitated from three biological replicates are presented, with error bars 
representing standard deviations. Asterisks indicate loci at which sh-p150 caused 
a statistically significant decrease in p150 occupancy (p < 0.05). Dotted line 
shows p150 signal at the gene desert. (F) p150 occupancy in asynchronous 
HeLa cells compared with cells blocked with a double thymidine treatment. 
Asterisks indicate loci at which thymidine arrest caused a statistically significant 
increase in p150 occupancy (p < 0.05).  
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Figure 2.1:  Nucleolar associations of human p150.  
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Table 2.1:  Mass spectrometry data for NTAP-p150 associated proteins. 
  
Two independent affinity purifications (“exp1” and “exp2”) were performed with 
NTAP-p150 and untagged control cells in parallel. Proteins listed were detected 
in both NTAP-p150 preparations, with no more than a single peptide detected in 
either of the untagged control preparations. Number of distinct peptides detected 
(#peptides), total number of spectral counts (#spectral cts), sequence coverage 
(seq. coverage) and spectral counts per kD of molecular weight (cts/kD) are 
shown for both experiments. Genes identified in red encode CAF-1 subunits or 
previously known interaction partners. Genes identified in black are novel 
interaction partners, and those in black with bold font encode proteins that are 
localized to the nucleolus (NCL, NPM, MKI67, NOP58, NOLC1, RRP1B), 
participate in rRNA maturation (DDX17), or interact with RRP1B (DNAJC9).
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Table 2.1:  Mass spectrometry data for NTAP-p150 associated proteins.  
 
 
exp1# 
peptide
s 
exp1# 
spectra
l 
cts 
exp1. 
seq. 
coverag
e exp 1 cts/kD 
exp2# 
peptide
s 
exp2# 
spectra
l 
cts 
exp2. 
seq. 
coverag
e exp 2 cts/kD 
Length 
(#aa) MW Gene     
8 9 14.20% 
0.11747046
9 30 304 27.00% 
3.96789140
5 710 76615 NCL Isoform 1 of Nucleolin    
44 145 44.20% 1.356078035 33 225 38.40% 2.10425902 956 106926 CHAF1A chromatin assembly factor 1, subunit A   
3 5 21.10% 
0.15349194
2 11 187 50.90% 
6.34651281
2 294 32575 NPM1 Isoform 1 of Nucleophosmin    
13 13 4.50% 0.03624249 65 126 25.60% 
0.35127336
6 3256 
35869
5 MKI67 Isoform Long of Antigen KI-67    
25 58 47.80% 0.943196787 17 123 45.40% 2.000227668 559 61493 CHAF1B Chromatin assembly factor 1 subunit B  
21 51 63.50% 1.070169548 14 61 60.20% 1.280006715 425 47656 RBBP4 Histone-binding protein RBBP4    
2 6 4.90% 
0.10070831
5 20 51 42.70% 
0.85602067
9 529 59578 NOP5/NOP58 Nucleolar protein 5    
3 4 5.50% 
0.05351385
3 10 29 9.40% 
0.38797543
7 709 74747 
NOLC1 Isoform Beta of Nucleolar phosphoprotein 
p130  
6 7 53.40% 0.615817718 9 23 53.40% 2.023401073 103 11367 Histone H4     
3 3 7.30% 
0.03651411
9 12 22 24.20% 
0.26777020
4 740 82160 RRP1B Isoform 2 of RRP1-like protein B   
13 15 47.70% 
0.50150451
4 7 21 34.20% 
0.70210631
9 260 29910 DNAJC9 DnaJ homolog subfamily C member 9  
12 19 47.00% 0.912978713 7 19 47.00% 0.912978713 183 20811 CBX3;LOC653972 Chromobox protein homolog 3   
1 1 14.60% 0.070816514 6 13 52.30% 0.922312877 130 14121 Histone H2A     
10 11 28.50% 0.230029276 6 12 26.40% 0.250941029 425 47820 RBBP7 Histone-binding protein RBBP7    
1 1 23.50% 0.064985703 2 11 31.60% 0.714842735 136 15388 Histone H3.2     
27 30 19.00% 0.13243279 9 10 9.90% 0.044144263 1960 226530 MYH9 Myosin-9    
4 6 7.00% 
0.07474493
3 5 10 8.80% 
0.12457488
8 729 80273 DDX17 DEAD box polypeptide 17 isoform 1   
5 6 38.70% 0.269966254 3 5 21.50% 0.224971879 191 22225 CBX5 Chromobox protein homolog 5    
2 4 4.10% 0.036810042 3 5 4.40% 0.046012552 955 108666 THRAP3 Thyroid hormone receptor-associated protein 3  
3 3 17.30% 0.133725595 2 4 17.30% 0.178300793 202 22434 ASF1B Histone chaperone ASF1B    
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2.3.2:  p150 interacts with nucleolar DNA 
Based on the abundance of nucleolar proteins detected, we assessed 
whether p150 resides in the nucleolus by performing immunolocalization studies. 
Because CAF-1 localization is regulated by cell cycle progression, and is 
prominently redistributed to DNA replication foci during S phase of the cell cycle 
(Krude, 1995), we examined synchronized populations, comparing cells blocked 
at the G1/S phase border via a double thymidine block (Whitfield et al., 2002) 
and those released into S phase. We used Ki67 as a marker for nucleoli, as 
described previously (Figure 2.1, C) (MacCallum and Hall, 1999). In these 
confocal microscopy images, p150 was detected throughout the nucleoplasm, 
and in the G1/S-arrested cells a subset of p150 was colocalized with Ki67 at the 
surface of the nucleoli (Figure 2.1, C). More p150 was observed inside nucleoli in 
the cells released into mid-S phase. We conclude that a subset of cellular p150 
colocalized with the nucleolar protein Ki67, even when DNA replication is 
inhibited.  
To assess functional roles of p150, we generated human HeLa S3 cells with a 
doxycycline-inducible shRNA targeting p150 (p150shRNA-1). A time course after 
shRNA induction was analyzed by immunoblotting, confirming p150 depletion 
(Figure 2.2). Upon p150 depletion we observed partial co-depletion of CAF-1 
p60, as expected from other studies (Hoek and Stillman, 2003; Ye et al., 2003). 
In contrast, nucleolar protein levels appeared unaltered during this time course, 
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with the exception of a mild increase in UBF1 levels at late time points (Figure 
2.2, A). Over the first 72 hours there was a mild increase in the doubling time of  
the p150-depleted cells (from 26 to 33 hr), but no dramatic alteration of the cell 
cycle profile until 96 hours, when S/G2 phase cells accumulated (Figure 2.2, B-
C). Our acute depletion experiments were therefore limited to the first 72 hours 
after shRNA inductions to minimize the mild growth differences. We also 
detected no DNA damage checkpoint-mediated phosphorylations (Ciccia and 
Elledge, 2010) or apoptosis-related PARP cleavage (Duriez and Shah, 1997) 
during acute depletion of p150 (Figure 2.2, D). These data are consistent with 
previous studies in which depletion of p150 via RNAi did not activate DNA 
damage checkpoints (Hoek and Stillman, 2003; Quivy et al., 2008). Likewise, no 
PARP cleavage was observed in experiments using an alternative depletion 
reagent, in vitro diced “esiRNA” (Surendranath et al., 2013) molecules targeting 
the 3’UTR of the p150 mRNA (Figure 2.2, E). 
We then tested whether p150 is closely associated with 47S rRNA-encoding 
chromatin via chromatin immunoprecipitation (ChIP) assays (Figure 2.1, D-F), 
comparing cells expressing a control shRNA targeting luciferase with those 
expressing p150shRNA-1. In control experiments with pre-immune sera (IgG), no 
specific enrichments were observed in either cell line. In contrast, using anti-p150 
polyclonal sera, we detected enrichments at the rDNA enhancer, at multiple sites 
within the pol I transcription unit, and within the rDNA intergenic spacer (IGS) 
(Figure 2.1, E). Additionally, we examined a gene desert region, which displayed 
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a low level of p150 enrichment. Unlike the other loci tested, the levels of p150 at 
the gene desert were not significantly reduced upon p150 depletion, suggesting 
that this represents experimental background. Additionally, because p150 
contributes to genome-wide nucleosome deposition during DNA synthesis, we 
did not expect rDNA to be the only site of enrichment. Indeed, a RNA polymerase 
II-transcribed gene, RPS20, also displayed p150 enrichment, as did other Pol II 
genes (unpublished observations). We conclude that the 47S rRNA-encoding 
repeats are one of many sites of p150 localization, consistent with the confocal 
microscopy data (Figure 2.1, C) showing a subset of p150 localized to nucleoli. 
The experiments above were performed with populations of asynchronous 
cells, so that the observed signals could include contributions from CAF-1 
complexes associated with loci transiently during genome duplication in S phase 
of the cell cycle. Our confocal microscopy images suggested that p150’s 
association with nucleoli would not be limited to S phase (Figure 2.1, C). To 
explore this via ChIP, we arrested cells at the G1/S phase border via double 
thymidine treatment. In the arrested cells, p150 was still associated with 47S 
rRNA-encoding repeats (Figure 2.1, F), but punctate PCNA foci characteristic of 
mid- and late-S phase were absent (Figure 2.2, G). Indeed, at each of the 
locations within the rDNA analyzed, but not at the RPS20 gene, p150 occupancy 
was significantly increased in the thymidine-arrested cells (Figure 2.1, F). We 
conclude that p150 is associated with 47S rRNA-encoding repeats, and that 
these associations are not dependent on ongoing DNA replication. 
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Figure 2.2:  Additional characterization of p150 depletion.  
 
(A) Immunoblot analysis of nucleolar and other proteins during a time course of 
p150 depletion in HeLa S3-Trex cells harboring doxycycline-inducible p150-
shRNA1. (B) Growth curve of HeLa S3-Trex-p150-shRNA1 cells with or without 
doxycycline-mediated induction of shRNA. (C) Fluorescence-activated cell 
sorting (FACS) of propidium iodide-stained HeLa S3-Trex-p150-shRNA1 cells 
during the time course in panel B. (D) Checkpoint activation is not observed upon 
p150 depletion. Western blot analysis of the indicated stress and cell cycle 
checkpoint proteins in HeLa S3-Trex-p150-shRNA cells. Extracts from cells were 
collected at the indicated time points with or without doxycycline induction (-/+ 
Dox). The last lane contains samples that were gamma irradiated (5 Gy, IR) and 
treated with 6 µM camptothecin (CPT) for 4 hours as a positive control. Cleaved 
PARP, phosphorylated ATM, γH2AX and phosphorylated Chk1 were only 
observed in the positive control sample. (E) Immunoblot analysis of a time course 
of p150 depletion in HeLa cells with siRNAs targeting either luciferase (L) or 
p150 (P). (F) FACS analysis of siRNA-treated cells from panel E. (G) PCNA 
staining of asynchronous or thymidine-blocked cells used for the ChIP analysis in 
Figure 2.1, F. Scale bar is 20 μm. 
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Figure 2.2 Additional characterization of p150 depletion.  
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2.3.3:  p150 regulates nucleolar protein localization 
One of the nucleolar proteins identified in our mass spectrometry data is NPM 
(Figure 2.1, A), which is a nucleocytoplasmic shuttling protein important for the 
localization of multiple proteins to the nucleolus (Korgaonkar et al., 2005; Li and 
Hann, 2013). We therefore tested whether p150 depletion would also affect the 
localization of nucleolar proteins. We began this analysis with HeLa-derived cells, 
and we observed that p150 depletion indeed altered the steady-state localization 
of multiple nucleolar interaction partners we identified by mass spectrometry 
(Figures 2.3, A-B): NPM, Ki67, and nucleolar phosphoprotein Nopp140 (also 
known as Nopp130; encoded by the NOLC1 gene) (Isaac et al., 1998). 
Additionally, the Pol I transcription factor UBF1(Bell et al., 1988), the Pol I 
transcription termination/activation protein TTF1 (Längst et al., 1997; Németh et 
al., 2008), and NCL, which binds rDNA and stimulates Pol I transcription 
(Rickards et al., 2007) were also redistributed upon p150 depletion. In contrast, 
the localization of fibrillarin, a rRNA 2’-O-methyltransferase and histone H2A 
glutamine methyltransferase involved in RNA polymerase I transcription and pre-
rRNA processing (Reichow et al., 2007; Tessarz et al., 2014) remained 
unchanged by p150 depletion, indicating that nucleolar structure was not 
completely disrupted (Figure 2.3, C). Consistent with the unaltered distribution of 
fibrillarin, the overall appearance of the 47S rRNA-encoding repeats is not 
altered upon p150 depletion (see Figures 2.14 and 2.15). We note that in each of 
the cases we tested (e.g. UBF1, NCL/C23, NPM/B23, Ki67), none of the 
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relocalized proteins displayed reduced total protein levels (Figure 2.2). Protein 
relocalizations were not limited to HeLa S3 cells, because similar results were 
observed in HT1080 cells (Figure 2.4).  
We further explored our finding that TTF-1 is among several nucleolar 
proteins dispersed upon p150 depletion. TTF-1 is a DNA-binding protein that 
interacts with the enhancer, promoter, and terminator regions in the rDNA 
repeats, and stimulates both rDNA transcription and Pol I transcriptional 
termination (McStay and Grummt, 2008). Furthermore, TTF-1 promotes loop 
formation between the promoter and terminator regions (Németh et al., 2008), 
and this three-dimensional interaction is thought to be of central importance to 
rDNA gene activation (Mayer et al., 2011). We therefore hypothesized that p150 
might contribute to localization of TTF-1 to rDNA. Indeed, ChIP analyses 
demonstrated that p150 depletion reduced the level of TTF-1 at the rDNA 
terminator (Figure 2.3, D). We conclude that p150 regulates the nucleolar 
localization of multiple proteins. 
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Figure 2.3:  p150 depletion disrupts localization of multiple nucleolar 
proteins.  
 
(A) HeLa S3-Trex-p150-shRNA1 (“sh-p150”) or Luciferase-shRNA cells (“sh-
Luc”) were treated with doxycycline for 72 hours to induce shRNA expression 
and then prepared for indirect immunofluorescence, staining up to two nucleolar 
proteins simultaneously in each experiment as indicated. Fields of cells 
photographed with a 63x objective. Scale bar is 20 μm. (B) Representative 
individual cells from panel (A) were enlarged. Scale bar is 10 μm. (C) As in 
panels A and B, showing the localization of fibrillarin, which remains unchanged 
upon p150 depletion. (D) ChIP analysis of TTF-1 in HeLa S3 cells expressing the 
indicated shRNAs. Chromatin was precipitated with either non-immune rabbit 
sera (IgG) or anti-TTF-1 antibodies as indicated and occupancy at the rDNA 
terminator R1 and the GAPDH gene was measured. The mean amounts of 
precipitated chromatin from three biological replicates are presented as 
percentages of input. Error bars represent standard deviations. Asterisks indicate 
p < 0.01 comparing TTF-1 occupancy at R1 in the sh-Luc and sh-p150 samples; 
p > 0.25 for all other pairs shown. 
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Figure 2.3: p150 depletion disrupts localization of multiple nucleolar 
proteins.  
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2.3.4:  An N-terminal p150 domain incapable of CAF-1 complex formation is 
sufficient for normal nucleolar protein localization. 
To determine whether the entire p150 protein is important for nucleolar 
protein localizations, we generated cloned, stable cell lines that each express a 
different V5-epitope-tagged, shRNA-resistant p150-derived transgene (Figure 
2.5, A). These cell lines were then subjected to acute RNA-mediated protein 
depletion experiments. These complementation experiments allowed us to define 
functional domains and to determine whether p150 depletion phenotypes could 
be directly attributed to p150 loss rather than indirect effects. Immunoblot 
analyses of these cells confirmed expression of the expected protein species and 
demonstrated that we could achieve efficient depletion of endogenous p150 in 
these cells (Figure 2.5, B). We note that many of these cell lines upregulated 
transgene-encoded protein levels in response to depletion of endogenous p150, 
perhaps suggesting a compensatory mechanism.  
We tested the ability of the transgene-encoded proteins to interact with the 
CAF-1 p60 subunit via immunoprecipitation. Consistent with published data 
(Kaufman et al., 1995; Takami et al., 2007), amino acids 245-938 contained the 
p60-binding domain (Figure 2.5, C, compare lanes 4 and 10), and deletion of the 
C-terminal third of p150 (amino acids 642-938) eliminated co-precipitation of p60 
(Figure 2.5, C, compare lanes 4 and 6). We also tested transgenes for their 
ability to maintain cell proliferation over a seven-day period (Figure 2.5, D). 
Consistent with data from chicken cells (Takami et al., 2007), the C-terminal 
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region (amino acids 245-938) containing the p60 binding site was required for 
maintaining cell growth upon loss of endogenous p150. We conclude that these 
cell lines are useful tools for studying human p150 functional domains. 
We then tested the transgene-expressing cells in immunolocalization assays, 
comparing cells infected with shRNA-encoding lentiviruses to deplete 
endogenous p150, or luciferase as a control. Immunolocalization of the V5 
epitope-tagged proteins confirmed that the majority of cells in these lines 
expressed detectable transgene products (Figures 2.6 and 2.7).  We first 
confirmed that negative control cells expressing a V5-luciferase transgene and 
an shRNA targeting luciferase displayed normal nucleolar localization of Ki67 
and Nopp140, and that depletion of p150 in the same cells delocalized these 
proteins (Figures 2.6, A and 2.7, A; see also Figures 2.8-2.13). Conversely, in 
positive control cells expressing an shRNA-resistant cDNA encoding full-length 
p150 (aa 1-938), nucleolar localization of Ki67 and Nopp140 was unaltered upon 
depletion of endogenous p150, indicating functional complementation. We 
conclude that p150 depletion and not untargeted alterations caused 
mislocalization of Ki67 and Nopp140. 
We also observed that C-terminally deleted p150 transgenes (e.g. 1-641 and 
1-310) maintained Ki67 and Nopp140 localization upon depletion of endogenous 
p150 (Figures 2.6-2.13). Thus, amino acids 1-310 of p150 sufficed for Ki67 and 
Nopp140 localization, even though this domain is incapable of p60 binding 
(Figure 2.5, C, compare lanes 4 and 8), These data indicate that the N-terminal 
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310 amino acids of p150 constitute a domain which is functionally separable from 
the CAF-1 complex, that we will term p150N.  
To test for functionally important regions within p150N, we mutated previously 
described interaction motifs. These included a non-canonical PIP(Moggs et al., 
2000; Rolef Ben-Shahar et al., 2009), a HP1 binding site (Murzina et al., 1999), 
and a SIM that binds sumoylated proteins (Sun and Hunter, 2012; Uwada et al., 
2010). Deletion of the PCNA- or HP1-binding sites resulted in transgenes that 
supported less robust growth than the wild-type full-length transgene, whereas a 
point mutation within the SIM did not appear to reduce growth (Figure 2.5, D). 
In protein localization experiments analogous to those described above, cells 
expressing p150 transgenes with mutations in either the PCNA- or HP1-binding 
motifs displayed no defects in localizing Ki67, Nopp140, or TTF-1 (Figures 2.6-
2.13). In contrast, a single I99A amino acid substitution within the SIM reduced 
the ability of the p150 transgene to maintain Ki67, Nopp140 and TTF-1 
localization upon depletion of endogenous p150 (Figures 2.6-2.13). We conclude 
that the SIM domain within p150N is a key factor for the normal localization of 
several nucleolar proteins. 
Analysis of additional transgenes showed that Ki67 and Nopp140 localization 
display some difference in the regulation of their localization. Nucleolar 
localization of Ki67 was largely diminished in cells expressing a large C-terminal 
fragment of p150 (amino acids 245-938) upon depletion of endogenous p150 
(Figures 2.8 and 2.9). Therefore, p150N was necessary and sufficient for Ki67 
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localization. In contrast, nucleolar localization of Nopp140 was not only 
maintained by p150N, but by the C-terminus as well (Figures 2.10 and 2.11). 
Nevertheless, the Nopp140 localizing function within p150N depended on the 
SIM motif (Figure 2.7), and mutation of the SIM motif reduced nucleolar 
localization of Nopp140 even within the context of the full-length p150 transgene 
(Figure 2.10). These data indicate that the SIM is an important, but not unique 
domain for localizing Nopp140. Additionally, a localization pattern similar to 
Nopp140 was observed for TTF-1 (Figures 2.12 and 2.13).  
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Figure 2.4: p150 depletion alters nucleolar protein localization in HT1080 
cells.  
 
(A) HT1080-Trex-sh-Luciferase (“sh-Luc”) or HT1080-Trex-p150-shRNA1 (“sh-
p150”) cell lines were treated with doxycycline for 72 hours to induce shRNA 
expression and then prepared for indirect immunofluorescence, staining for two 
different proteins in each experiment as indicated. Images were taken with a 63x 
objective. (B) Immunoblot analysis of p150 depletion by p150-shRNA1 in 
HT1080-Trex cells. Internal loading control was alpha-tubulin (TUBA). 
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Figure 2.4:  p150 depletion alters nucleolar protein localization in HT1080 
cells.  
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Figure 2.5:  Domain analysis of human p150.  
 
(A) Diagram of transgenes introduced into HeLa cells. Colored boxes indicate the 
V5 epitope tags (yellow), PEST region (red), low complexity regions KER (blue) 
and ED (green), dimerization region (D, orange), the N-terminal PCNA interaction 
peptide (PIP, cyan), and the HP1 binding site (pink). The I99A point mutation that 
inactivates the SUMO-interaction motif (SIM, red asterisk) and silent mutations 
rendering the transgenes resistant to RNAi (shR, black asterisks) are indicated. 
Regions previously shown to be sufficient for in vitro chromatin assembly and 
p60 interaction are drawn below the top diagram. (B) Immunoblot analysis of V5-
tagged transgene-expressing cell lines, in two independent experiments (lanes 1-
10 and 11-28). Cells were infected for 72 hours with lentiviruses expressing 
either sh-Luciferase (L, odd numbered lanes) or sh-p150 (P, even numbered 
lanes) and whole cell extracts were separated on 10% SDS-PAGE gels. After 
transfer, blots were probed with anti-p150 to detect endogenous p150, anti-V5 to 
detect transgene products, and anti-tubulin (TUBA) or anti-fibrillarin (FBL) 
antibodies as loading controls. Arrowheads indicate full-length p150 protein. (C) 
Interaction between p150 transgene products and p60. Extracts from the 
indicated V5-tagged transgene-expressing cell lines were immunoprecipitated 
with anti-V5 antibodies. Input extracts (In, odd numbered lanes) and 
immunoprecipitates (IP, even numbered lanes) were resolved on 10% SDS-
PAGE gels, transferred to membranes and probed with anti-p150, V5, and p60 
antibodies. Arrowhead indicates full-length p150 protein; asterisks indicate anti-
V5 IgG bands in IP samples detected by the anti-mouse secondary antibody. 
Note that the 1-310 transgene co-migrates with the IgG heavy chain. (D) V5-
tagged RNAi-resistant p150 transgenes were tested for the ability to maintain cell 
proliferation in the presence of either sh-Luciferase (”sh-Luc”) or p150-shRNA1 
(“sh-p150”) in HeLa cells. Cells (4500) were plated in 6-well dishes and infected 
with the indicated lentivirus, and selection for infected cells began 48 hours post 
infection. Seven days post infection, cell proliferation was assessed by crystal 
violet staining. 
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Figure 2.5:  Domain analysis of human p150. 
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Figure 2.6: The p150 SUMO-interaction motif (SIM) is required to maintain 
nucleolar Ki67 localization. 
  
HeLa cell lines expressing the indicated V5-tagged transgenes (A, luciferase; B, 
1-938; C, 1-310; D, 1-310-HP1; E, 1-310-I99A; F, 1-310-PIP1; see Figure 2.5, 
A) were infected with lentiviruses encoding the indicated shRNAs (sh-luciferase 
or sh-p150) and prepared for indirect immunofluorescence 72 hours later. Scale 
bar is 20 μm. 
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Figure 2.6: The p150 SUMO-interaction motif (SIM) is required to maintain 
nucleolar Ki67 localization. 
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Figure 2.7: The p150 SIM is required to maintain nucleolar Nopp140 
localization.  
 
As in Figure 2.6, HeLa cell lines expressing the indicated V5-tagged transgenes 
were infected with lentiviruses encoding the indicated shRNAs (sh-luciferase or 
sh-p150) and prepared for indirect immunofluorescence 72 hours later. Scale bar 
is 20 μm. 
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Figure 2.7: The p150 SIM is required to maintain nucleolar Nopp140 
localization. 
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Figure 2.8:  Analysis of Ki67 localization in additional cell lines, performed 
as in Figure 2.7  
 
Additional HeLa cell lines expressing the indicated p150 transgene were 
depleted of endogenous p150 as performed in Figure 2.7.  Scale bar is 20 μm. 
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Figure 2.8:  Analysis of Ki67 localization in additional cell lines, performed 
as in Figure 2.7  
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Figure 2.9:  Densitometric analysis of Ki67 localization.  
 
Fluorescence images of individual cells from the panels in Figure 2.6 and Figure 
2.8 were scanned as shown on the left, and fluorescence intensity was plotted 
(right). Cells displaying reduced focal accumulation of Ki67 upon p150 depletion 
have plots highlighted in red. Scale bar is 10 μm. 
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Figure 2.9:  Densitometric analysis of Ki67 localization.  
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Figure 2.10: Analysis of Nopp140 localization in additional cell lines, 
performed as in Figure 2.7 (panels A-E).  
 
Additional HeLa cell lines expressing the indicated p150 transgene were 
depleted of endogenous p150 as performed in Figure 2.7.  In panel F, we 
performed a control immunofluorescence experiment in uninfected cells to 
determine whether the anti-V5 antibody recognized any cellular structures in the 
absence of a transgene. Scale bar is 20 μm. 
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Figure 2.10: Analysis of Nopp140 localization in additional cell lines, 
performed as in Figure 2.7 (panels A-E).  
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Figure 2.11:  Densitometric analysis of Nopp140 localization.  
 
Fluorescence images of individual cells from the panels in Figure 2.7 and Figure 
2.10 were scanned as shown on the left, and fluorescence intensity was plotted 
(right). Cells displaying reduced focal accumulation of Nopp140 upon p150 
depletion have plots highlighted in red. Scale bar is 10 μm. 
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Figure 2.11:  Densitometric analysis of Nopp140 localization.  
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Figure 2.12:  Analysis of TTF-1 localization performed as is figures 2.7 and 
2.8. 
 
Scale bar is 20 μm. 
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Figure 2.12:  Analysis of TTF-1 localization performed as is figures 2.7 and 
2.8. 
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Figure 2.13:  Densitometric analysis of TTF-1 localization. 
 
Fluorescence images of individual cells from the panels in Figure 2.12 were 
scanned as shown on the left, and fluorescence intensity was plotted (right). 
Cells displaying reduced focal accumulation of TTF-1 upon p150 depletion have 
plots highlighted in red. Scale bar is 10 μm. 
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Figure 2.13:  Densitometric analysis of TTF-1 localization. 
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2.3.5:  The p150 N-terminus promotes interchromosomal interactions of the 
47S rRNA-encoding repeats. 
Deep sequencing experiments have detected genomic regions preferentially 
associated with nucleoli (van Koningsbruggen et al., 2010; Németh et al., 2010). 
Among the NADs discovered were several types of repetitive DNA including 
centromeric satellite DNA, D4Z4 repetitive DNA elements from the telomeric 
regions of chromosomes 4q and 10q, and the array of 5S rDNA genes from 
chromosome 1q. Therefore, using two-color DNA FISH experiments, we tested 
whether these long-range interchromosomal associations with 47S rRNA-
encoding repeats were affected by p150 depletion. FISH experiments were 
initially performed in MCF-10A cells, because these have a flattened morphology 
we found more conducive to rDNA hybridization. In MCF10A cells expressing a 
control sh-Luciferase hairpin RNA, we observed that ~30-40% of 10q telomere, 
5S rDNA array, and alpha satellite alleles associated with 47S rRNA-encoding 
repeats (Figures 2.14, A-C). In contrast, a negative control BAC probe lacking 
NAD sequences displayed the expected background of ~10% association 
(Németh et al., 2010). In cells expressing sh-p150, we observed a statistically 
significant decrease in nucleolar associations for all three loci NAD-containing 
loci tested, but no change was observed for the negative control. To extend this 
finding beyond immortalized cell lines, we then tested whether p150-dependent 
nucleolar associations could be detected in primary human cells. Using foreskin 
fibroblasts, we observed that the association of alpha satellite DNA with nucleoli 
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was indeed significantly reduced upon depletion of p150 (Figure 2.14, D-G). In 
these cells, detection of nucleoli was more robust using an anti-fibrillarin antibody 
rather than a 47S rRNA-encoding repeat probe. We conclude that p150 is 
important for nucleolar association of several repetitive DNAs in both primary and 
transformed human cells. 
We then tested whether the p150N protein fragment would suffice for 
maintaining these chromosomal interactions. In HeLa cells expressing the control 
V5-luciferase transgene, we again observed frequent associations of alpha 
satellite DNA with the 47S rRNA-encoding repeats, which were reduced upon 
p150 depletion (Figure 2.15, A-B). A similar loss of alpha satellite-rDNA 
associations was observed in cells expressing a large C-terminal p150 fragment 
(amino acids 245-938; Figures 2.15, A and 7C). In contrast, cells expressing 
p150N (amino acids 1-310) maintained these associations upon depletion of 
endogenous p150, measured either as the total number of allele associations 
(Figure 2.15, A), or the number of alleles associated per cell (Figure 2.15, D). 
Taken together, our data indicate that the p150N domain of p150 is sufficient for 
promoting efficient nucleolar protein localizations and interchromosomal 
associations. 
We next tested how point mutations within p150N affected alpha satellite 
interactions with the nucleolus. As observed in the protein localization  
experiments (Figures 2.6 and 2.7), the I99A but not the PCNA- or HP1-binding 
site mutations reduced the nucleolar associations (Figures 2.16, A-D). To test 
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whether SUMO conjugation itself is important for nucleolar chromosome 
interactions, we used siRNAs to transiently deplete p150, or Ubc9, the E2 
enzyme required for all SUMO conjugation events in human cells (Jentsch and 
Psakhye, 2013), or SUMO2 itself. RT-PCR analysis confirmed reduction of UBC9 
and SUMO2 mRNA levels (Figure 2.16, G). The p150 depletion confirmed that 
siRNA-mediated targeting of the p150 mRNA via a different sequence than 
recognized in shRNA-mediated depletions still significantly reduced alpha 
satellite-nucleolar interactions. Additionally, we observed significantly reduced 
interactions upon either UBC9 or SUMO2 depletion. We conclude that both a 
SUMO interaction motif within the p150N domain and the SUMO conjugation 
machinery contribute to efficient nucleolar protein localizations and 
interchromosomal interactions. 
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Figure 2.14:  Higher order interactions of rDNA chromatin are altered upon 
p150 depletion.  
 
(A)  DNA FISH analysis of MCF10A-tetkrab cells expressing the indicated 
shRNAs. Three biological replicate experiments were performed, with mean % 
nucleolar association and standard deviations graphed. Probes analyzed were a 
chromosome 10q BAC (10q, n (total alleles assayed) = 332 for sh-Luc, 262 for 
sh-p150), a 5S rDNA-containing BAC (5S, n = 312 for sh-Luc, 352 for sh-p150), 
alpha satellite DNA from chromosome 17 (Sat 17, n = 288 for sh-Luc, 306 for 
sh-p150), and negative control BAC (- Control, n=314 for sh-Luc, 306 for sh-
p150) that was previously reported to be unassociated with nucleoli (Nemeth et 
al., 2010). The p-values comparing the sh-Luc and sh-p150 samples for each 
probe are indicated, with p values < 0.05 indicated in red, demonstrating 
statistical significance. (B) Fluorescence microscopy images of representative 
cells from an experiment from panel (A). rDNA is colored red, the 10q BAC is 
green and DAPI is blue. Scale bar is 5 μm. (C) Immunoblot of representative 
whole cell extracts from an experiment in panel A, with tubulin as the loading 
control. (D) Immuno-FISH analysis of primary human foreskin fibroblasts treated 
either with Luciferase control or p150-targeted sh-RNAs. Cells were treated with 
anti-fibrillarin antibodies followed by hybridization with a Sat 17 probe. N (total 
alleles assayed) = 324 for sh-Luc, 308 for sh-p150. (E) Data from panel (D), 
plotting the percentage of cells displaying the indicated numbers of Sat 17 
alleles associated with fibrillarin. n (total cells assayed) = 162 for sh-Luc, 154 for 
sh-p150. (F) Fluorescence microscopy images of representative cells from an 
experiment from panel (D). Fibrillarin is in green and the Sat 17 probe is red. 
Scale bar is 5 μm. (G) Immunoblot of representative whole cell extracts from an 
experiment in panel D, with fibrillarin as the loading control. 
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Figure 2.14: Higher order interactions of rDNA chromatin are altered upon 
p150 depletion.  
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Figure 2.15:  The p150 N-terminus is necessary and sufficient for nucleolar 
interchromosomal associations.  
 
(A) DNA FISH analysis of the association between Sat 17 and rDNA in HeLa 
cells expressing the indicated V5-tagged transgenes (Luciferase, p150N (amino 
acids 1-310), or p150C (amino acids 245-938)). The percentage of Sat 17 
alleles colocalized with the rDNA is indicated, with mean and standard deviations 
from three experiments. For V5-Luciferase cells, n (total alleles assayed) = 471 
for sh-Luc, 480 for sh-p150. For V5-p150N cells, n = 525 for sh-Luc, 489 for sh-
p150. For V5-p150C cells, n = 450 for sh-Luc, 468 for sh-p150. p values 
comparing the sh-Luc and sh-p150 samples are indicated, demonstrating 
statistically significant rescue by the p150N but not the p150C transgene. (B-D) 
Data from the experiment in panel (A) was replotted to display the number of 
Sat 17 alleles per cell associated with the rDNA. Note that these HeLa-derived 
lines have three copies of chromosome 17. For V5-Luciferase cells, n (total cells 
examined) = 157 for sh-Luc, 160 for sh-p150. For V5-p150N cells, n = 175 for sh-
Luc, 163 for sh-p150. For V5-p150C cells, n = 150 for sh-Luc, 156 for sh-p150. 
Comparisons for which p < 0.05 are indicated by asterisks, and a number sign 
indicates p < 0.01. (E) Fluorescence microscopy images of representative cells 
from an experiment from panel (A). rDNA is colored red, the Sat 17 is green 
and DAPI is blue. Scale bar is 5 μm. 
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Figure 2.15:  The p150 N-terminus is necessary and sufficient for nucleolar 
interchromosomal associations.  
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Figure 2.16: The p150 SIM and sumoylation proteins are required for 
nucleolar interchromosomal associations.  
 
(A) ImmunoFISH analysis of the association between Sat 17 and fibrillarin in 
HeLa cells expressing the indicated V5-tagged transgene derivatives of full-
length p150. The percentage of Sat 17 alleles colocalized with fibrillarin is 
indicated, with mean and standard deviations from three experiments. For PIP 
cells, n (total alleles assayed) = 510 for sh-Luc, 477 for sh-p150. For HP1 cells, 
n = 522 for sh-Luc, 513 for sh-p150, and for I99A cells, n = 486 for sh-Luc, 480 
for sh-p150. p values comparing the sh-Luc and sh-p150 samples are indicated, 
demonstrating statistically significant rescue by the PIP and HP1 but not the 
I99A transgenes. (B-D) Data from the experiment in panel (A) was replotted to 
display the number of Sat 17 alleles per cell associated with the rDNA. Note 
that these HeLa-derived lines have three copies of chromosome 17. For PIP 
cells, n (total cells examined) = 170 for sh-Luc, 159 for sh-p150. For HP1 cells, 
n = 174 for sh-Luc, 171 for sh-p150. For I99A cells, n = 162 for sh-Luc, 160 for 
sh-p150. Comparisons for which p < 0.05 are indicated by asterisks. (E) 
ImmunoFISH analysis of MCF10A cells treated with the indicated siRNAs. The 
percentage of Sat 17 alleles colocalized with fibrillarin is indicated, with mean 
and standard deviations from three experiments. n (total alleles assayed) = 328 
for si-Luciferase-treated cells, n = 346 for si-p150-treated cells, n = 324 for si-
UBC9-treated cells, and n = 342 for si-SUMO2-treated cells. p values comparing 
the sh-Luc and other samples are indicated, demonstrating statistically significant 
reductions in association by each of the three test depletions, with p values 
indicated. (F) Data from the experiment in panel (E) was replotted to display the 
number of Sat 17 alleles per cell associated with fibrillarin. Note that these 
MCF10A-derived lines have two copies of chromosome 17. (G) qPCR analyses 
of esiRNA treatments demonstrating reduced steady-state mRNA levels in the 
targeted cells. (H) Immunoblot of representative whole cell extracts from an 
experiment in panel E, with fibrillarin as the loading control. (I) Fluorescence 
microscopy images of representative cells from an experiment from panels E-F. 
Fibrillarin is colored green, the Sat 17 is red and DAPI is blue. Scale bar is 5 
μm. 
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Figure 2.16: The p150 SIM and sumoylation proteins are required for 
nucleolar interchromosomal associations.  
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2.4:  Discussion   
2.4.1:  A separable functional domain within the CAF-1 p150 N-terminus 
We show here that the N-terminal domain of p150 (amino acids 1-310) is 
sufficient to maintain nucleolar protein and interchromosomal associations, and 
thereby constitutes a distinct and separable functional domain. Because p150 
residues 1-310 cannot bind the CAF-1 p60 subunit, and lacks the previously  
described dimerization motif within p150 (Quivy et al., 2001) (Figure 2.5), these 
data suggest that the canonical three-subunit CAF-1 complex is not required for 
these novel functions. We note that previous proteomic analysis of nucleoli 
detected p150 but not p60 (Ahmad et al., 2009), consistent with the idea of 
nucleolar functions for p150 separate from CAF-1. We also note that a previous 
proteomic analysis of p150 detected interacting proteins largely non-overlapping 
with those reported here (Hoek et al., 2011), raising the possibility that 
differences in the epitope tags used or other experimental details can favor 
retention of distinct subsets of the protein interactions of p150. 
In all eukaryotic species, CAF-1 is a complex of three conserved subunits, all 
of which are required for in vitro nucleosome assembly activity (Kaufman et al., 
1995; Verreault et al., 1996). Additionally, roles outside of the CAF-1 complex 
have been described for individual subunits. For example, p60 was recently 
shown to act as a protamine deposition factor independent of CAF-1 during fruit 
fly spermatogenesis (Doyen et al., 2013). p48 is a histone H4-binding (Murzina et 
al., 2008; Song et al., 2008) subunit of many complexes involved in chromosome 
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biology (Kuzmichev et al., 2002; Martínez-Balbás et al., 1998; Zhang et al., 
1999). Two functions for p150 independent of CAF-1 have been described. First, 
p150, but not p60, is required for efficient replication of HP1-rich pericentric 
heterochromatin in mouse cells, and this activity requires the canonical HP1-
binding site on p150 (Quivy et al., 2008). Second, p150 but not p60 stimulates 
transcription from the major immediate early promoter (MIEP) of human 
cytomegalovirus (Lee et al., 2009). In the latter studies, the p150 N-terminal 310 
amino acids (p150N) were shown to be an activation domain for MIEP 
transcription (Lee et al., 2009). Although subregions within p150N were not 
tested in that system, those findings are consistent with our conclusion that 
p150N can act as a separable domain with distinct functions. Here, we show that 
human p150N has important structural roles outside of the context of viral 
infection, maintaining normal nucleolar protein localization and interchromosomal 
interactions. Therefore, the C-terminal two-thirds of human p150 essential for 
formation of the nucleosome assembly complex CAF-1 are appended to a 
separable domain that regulates the structure of the nucleolus and the 
interconnectivity of the human genome. 
 
2.4.2: The SIM domain links human p150N to nucleolar structures. 
Our studies show the p150 SIM domain is required for nucleolar 
macromolecular associations. This p150 SIM domain was previously shown to 
bind the highly homologous SUMO-2 and SUMO-3 proteins, but not SUMO-1 
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(Uwada et al., 2010). Furthermore, mutational analysis of the p150 SIM was 
shown to alter association of SUMO-2 and SUMO-3 with DNA replication foci. 
However, the converse was not true, because acute depletion of SUMO2/3 did 
not affect p150 association with replication foci. These data suggested that p150 
recruits SUMO2/3 to DNA replication foci via the SIM domain. We do not yet 
know whether those observations are related to those reported here. Our data 
suggest that the interaction of p150 with the rDNA is not limited to S phase of the 
cell cycle (Figures 2.1 and 2.2), and the p150 SIM domain appears dispensible 
for p150’s contribution to cell proliferation (Figure 2.5, D). Also, we observe that 
strong inhibition of rDNA transcription with actinomycin D does not impair the 
alpha satellite-nucleolar interaction (Figure 2.17), although in other studies 
different NAD-nucleolar interactions were variably reduced upon similar 
treatments (Németh et al., 2010). Therefore, we are currently investigating how 
these chromosome interactions are dynamic with regards to transcription and 
growth control, and whether they are cell cycle regulated. We also note that a 
large number of sumoylated proteins reside in the nucleolus (Finkbeiner et al., 
2011; Westman et al., 2010), and we are currently exploring whether particular 
protein interactions depend on the p150 SIM domain. 
A previously published protein alignment suggested that Cac1, the budding yeast 
homolog of human p150, also contains a putative SIM (Uwada et al., 2010). 
Subsequent analysis in the Hunter laboratory showed that the SIM in the N-
terminus of human p150 is a “type B” or “VIDLT” class of SIM that is often found 
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as a dominant SIM in multi-SIM proteins (Sun and Hunter, 2012). The p150 N-
terminal SIMs are also of the canonical type B in other animals, including 
mammals and the sea urchin S. purpuratus (Figure 2.18). In contrast, this SIM is 
altered from the type B consensus in frogs, zebrafish and chickens, and insects. 
The budding yeast SIM sequence lacks the characteristic aspartate at position 3 
that is critical for high affinity binding, and no apparent type B SIM sequences 
could be identified in fission yeast, worms, or the plants Arabidopsis thaliana or 
Triticum urartu. Future studies will be required to clarify whether and how 
nucleolar associations are mediated by p150 homologs in other organisms. 
In that regard, it is of particular interest that recent papers have shown a 
progressive loss of 45S rDNA copies in Arabidopsis thaliana mutants in lacking 
the CAF-1 p150 or p60 subunits (Mozgova et al., 2010). Further, these mutants 
display a loss of partitioning of silent 45S rDNA copies into the nucleoplasm 
(Pontvianne et al., 2013), while 5S rDNA remains stable in its copy number and 
localization. We do not observe altered DNA-FISH signals with a 47S-encoding 
rDNA probe in human cells (Figures 2.14 and 2.15), so we do not presently have 
evidence for a similar mechanism in humans. Also, as mentioned above, there is 
no discernable SIM in A. thaliana p150. However, we cannot rule out less 
dramatic reorganization of 47S rDNA that would have escaped detection in our 
FISH experiments, and the full range of contributions of p150 to the structure and 
function of nucleolar chromatin in human cells remains an open an interesting 
avenue for exploration.
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Figure 2.17:  Rapid inhibition of RNA polymerase I does not affect 
association of alpha-satellite DNA to the nucleolar periphery. 
 
(A) Fluorescent microscopy images detecting a pulse of incorporation of the UTP 
analog 5-ethynyl uridine (EU) (15 minutes) during treatment with the RNA Pol II 
inhibitor alpha-amanitin (20 μg/mL for 4 hours), actinomycin D (50 ng/mL for 15 
minutes, which selectively inhibits RNA polymerase I), or both.  Scale bar is 20 
μm.  (B) Graphical representation of 3 biological replicate DNA-FISH 
experiments, comparing the association of chromosome 17 alpha-satellite with 
rDNA during incubation with actinomycin D or no treatment.  
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Figure 2.17:  Rapid inhibition of RNA polymerase I does not affect 
association of alpha-satellite DNA to the nucleolar periphery. 
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Figure 2.18:  Conservation of the type B SIM domain in p150 homologs.  
 
(A) The consensus sequence is from (Sun and Hunter, 2012). Residues 
conforming to the consensus are highlighted in red. Numbers at the end of each 
sequence indicate amino acid position. (B) CENPA localization does not 
change upon p150 depletion. Indirect immunofluorescence localization of 
CENPA (green) in HeLa cells infected with lentiviruses expressing either sh-
Luciferase or sh-p150 for 72 hours, as indicated. Cells were costained with anti-
Nopp140 antibodies (magenta) to confirm nucleolar protein relocalization in cells 
depleted of p150. Fields of cells were imaged with a 63x objective.  
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Figure 2.18:  Conservation of the type B SIM domain in p150 homologs.  
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2.4.3:  Higher-order interactions of nucleolar chromatin 
Several connections between heterochromatin, centromeric DNA, and the 
nucleolus have been described previously. For example, in Drosophila, the 
nucleolar protein Modulo, a NCL homolog, affects formation of centromeric 
chromatin (Chen et al., 2012). Conversely, depletion of Drosophila HP1 causes 
dispersal of the rDNA and nucleolar proteins, including fibrillarin (Peng and 
Karpen, 2007). We note that vertebrate p150 homologs include an HP1-binding 
domain (Murzina et al., 1999) that is within the p150N domain, although we do 
not observe fragmentation of rDNA upon depletion of p150 in human cells 
(Figure 2.15). Other links between the nucleolus and centromeric DNA in 
Drosophila include recent studies showing that nucleoplasmin (NLP), a 
nucleophosmin-related protein, is required is required for centromere clustering 
and anchoring of centromeric DNA to nucleoli (Padeken et al., 2013). Also, both 
Drosophila NLP (Padeken et al., 2013) and human NPM (Foltz et al., 2006) 
interact with the centromere-specific histone CENP-A. Biochemical interactions 
between CENP-C and UBF1 (Pluta and Earnshaw, 1996) and colocalization of 
centromeric proteins with the nucleolus (Ochs and Press, 1992; Wong et al., 
2007) have also been described. Together, these data, and other data reviewed 
recently (Padeken and Heun, 2014), suggest conserved links among nucleoli, 
heterochromatin, and centromeres. However, we do not observe changes in the 
distribution of CENP-A upon p150 depletion in human cells (Figure 2.18, B). 
Therefore, the extent of p150N’s contributions to heterochromatin and 
 96 
centromere function remains to be determined. Experiments are underway to 
determine which partner proteins are involved in the ability of p150N to stimulate 
the higher order chromatin interactions of nucleoli, and to determine if these 
interactions are specific to repetitive sequences.  
 
2.5:  Materials and Methods 
2.5.1:  Preparation of nuclear extracts and affinity chromatography for 
mass spectroscopy samples.  
HeLa S3 Trex (untagged) and HeLa S3 Trex-NTAP-p150 cells were 
maintained as monolayers and then expanded to suspension cultures for large-
scale preparations.  Suspension cultures were started at a cell density of 3 x 
105/ml and maintained between 1.5 x 105-6 x 105/ml. NTAP-p150 synthesis was 
induced by addition of doxycycline (1 µg/mL) for 16-18 hrs. Untagged samples 
were also treated with doxycycline in the same fashion. Routinely 6-8 liters of 
suspension cells were grown for each harvest. Suspension cultures were 
harvested by centrifugation at 1000x g at 4°C. Pellets were used to generate 
nuclear extracts by dounce homogenization.  Briefly, suspension cells were 
collected by centrifugation at 1000 x g for 5 minutes.  Cells were washed with ice 
cold PBS, then homogenization buffer (20 mM Hepes-KOH, pH 8.0, 5 mM KCl, 
1.5 mM MgCl2), then resuspended in 1 mL of homogenization buffer per mL of 
packed cell volume. Cells were disrupted by 28 strokes of a B pestle (Wheaton, 
loose) by dounce homogenization and nuclei were pelleted by centrifugation (5 
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mins at 1000 x g) and washed with nuclei wash buffer (10 mM NaCO3, 150 mM 
NaCl).  Nuclear extracts were made by incubating nuclei with extraction buffer 
(15 mM Tris-HCl, pH 7.8, 1 mM EDTA, 400 mM NaCl, 10% sucrose, 0.1 mM 
PMSF, 1 mM DTT) for 30 mins, rotating at 4°C.  Extracts were then clarified by 
ultracentrifugation at 100,000 x g for 60 mins and then frozen in aliquots and 
stored at -80°C.  For samples analyzed by mass spectroscopy, 12.5 mg (exp. 1) 
or 25 mg (exp 2) of nuclear extract was used for affinity purification. 
Affinity purifications were performed with Streptavidin-sepharose (GE 
healthcare).  All steps were performed at 4°C.  300 µl resin was used per 25 mg 
of nuclear extract.  Extracts were diluted two-fold with Buffer A (25 mM Tris-HCl 
pH 7.5, 1 mM EDTA, 10% glycerol, 0.01% NP40) to reduce the NaCl 
concentration from 400 mM to 200 mM and rotated with the resin for 3 hours.   
Beads were washed twice for 20 mins with MS200 (100 mM Tris pH 8.5, 200 mM 
NaCl) + 50 µg/mL ethidium bromide (EtBr). Beads were then washed twice more 
with MS200 without EtBr and twice with MS50 (100 mM Tris pH 8.5, 50mM 
NaCl).  Proteins were then eluted from the beads with ME buffer (100 mM Tris 
pH 8.5, 8 M Urea). Samples were precipitated with 20% trichloracetic acid on ice 
for 30 minutes and centrifuged for 10 minutes at 16,000 x g at 4°C. The 
supernatants were removed and the pellets were washed twice with -20 °C 
acetone and air-dried. 
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2.5.2:  Mass spectroscopy 
The NTAP-p150 and untagged samples were first denatured in 8M urea 
and then reduced and alkylated with 10 mM Tris(2-carboxyethyl)phosphine 
hydrochloride [Roche Applied Science] and 55 mM iodoacetamide [Sigma-
Aldrich] respectively.  The sample was then digested over-night with trypsin 
[Promega] according to the manufacturer’s specifications.  
The protein digest was pressure-loaded onto a 250 micron i.d. fused silica 
capillary [Polymicro Technologies] column with a Kasil frit packed with 3 cm of 3 
micron C18 resin [Phenomenex].  After desalting, this column was connected to 
a 100 micron i.d. fused silica capillary [Polymicro Technologies] analytical column 
with a 5 micron pulled-tip, packed with 10 cm of 3 micron C18 resin 
[Phenomenex].  
The column was placed inline with a 1200 quaternary HPLC pump [Agilent 
Technologies] and the eluted peptides were electrosprayed directly into an LTQ 
mass spectrometer [Thermo Scientific].  The buffer solutions used were 5% 
acetonitrile/0.1% formic acid (buffer A) and 80% acetonitrile/0.1% formic acid 
(buffer B).  The 180 minute elution gradient had the following profile: 10% buffer 
B beginning at 15 minutes to 40% buffer B at 105 minutes, to 70% buffer B at 
150 minutes, to 100% buffer B from 155 minutes to 165 minutes. A cycle 
consisted of one full scan mass spectrum (400-1600 m/z) followed by 5 data-
dependent collision induced dissociation (CID) MS/MS spectra. Application of 
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mass spectrometer scan functions and HPLC solvent gradients were controlled 
by the Xcalibur data system [Thermo Scientific].  
MS/MS spectra were extracted using RawXtract (version 1.9.9) 
(McDonald et al., 2004). MS/MS spectra were searched with the Sequest 
algorithm (Eng et al., 1994) against an EBI International Protein Index (IPI) 
protein database version 3.30 (June 2007) concatenated to a decoy database in 
which the sequence for each entry in the original database was reversed (Peng 
et al., 2003). The Sequest search was performed using full enzyme specificity, 
including static modification of cysteine due to carboxyamidomethylation 
(57.02146). Up to two missed cleavages were considered.  Sequest search 
results were assembled and filtered using the DTASelect (version 2.0) algorithm 
(Tabb et al., 2002)).  The peptide identification false positive rate was kept below 
one percent. 
 
2.5.3:  shRNAs 
shRNA expression constructs were made using the system we described 
previously (Campeau et al., 2009). The shRNA for depletion of p150 
(p150shRNA-1) had the following targeting sequence: 
AGGGGAAAGCCGATGACAT. Destination vectors for expressing p150shRNA-1 
were created by recombining pENTR1A/pTER p150shRNA-1 (435-1) into pLenti 
RNAi X2 neo (w18-1) to create pLenti RNAi X2 Neo/pTER p150shRNA-1 (w23-2) 
and pLenti RNAi X2 Puro (w16-1) to create pLenti RNAi X2 Puro/pTer 
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p150shRNA-1 (pPK655). The luciferase shRNA-expressing construct pLenti X2 
Neo/pTER shLUC (w181-1) was previously described (Campeau et al., 2009). 
 
2.5.4:  p150 derivatives and other transgenes 
The p150 amino acid numbers used here are based on the published 
literature (Kaufman et al., 1995; Lee et al., 2009). Various p150 constructs were 
altered by site-directed mutagenesis to make them resistant to p150shRNA-1. 
First, we used oligonucleotides ECA552 and ECA553  to alter the p150 cDNA in 
plasmid pPK8 (Kaufman et al., 1995), generating plasmid pPK649 which carries 
the “shR” version of the p150 cDNA. RNAi-resistant V5-tagged p150 C-terminal or 
internal deletion Gateway entry constructs were generated by cloning fragments 
of pPK649 into pENTR-V5 (w71-3). Lentiviral expression vectors were made by 
LR recombination of the pENTR-based entry constructs into pLenti CMV Hygro 
(w117-1). The negative control transgene, V5-tagged luciferase, was generated 
by LR recombination of 468-1 (pENTR vector + V5-Luciferase) into w117-1 to 
generate pPK678 (pLenti CMV V5-luciferase).  
 
2.5.5:  esiRNA methods 
siRNAs were generated using the DEQOR method (Surendranath et al., 
2013), with primers designed using the DEQOR database (http://deqor.mpi-
cbg.de/deqor_new/input.html) to generate T7-tailed dsDNA templates from 
human cDNA in two rounds of PCR. In the case of the luciferase esiRNA, RNA 
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from a HeLa cell line expressing V5-luciferase was used to generate cDNA; all 
other esiRNAs derived from cDNA from normal HeLa cells. In the 1st round of 
PCR, primers specific to the gene of interest (p150, Luciferase, UBC9, or 
SUMO2) were used in the following program: 95 °C for 3 mins, 16 cycles of (95 
°C for 1 min, 65 °C -1 °C/cycle for 1 min, and 72 °C for 1 min) followed by an 
additional 15 cycles of (95 °C for 1 min, 60 °C for 1 min, and 72 °C for 1 min) and 
one final cycle at 72 °C for 5 mins. In the 2nd round of PCR, a T7 promoter-tailed 
primer was used to amplify the product of the 1st round with the following 
program: 95 °C for 2 mins, 4 cycles of (95 °C for 30 seconds, 42 °C for 45 
seconds, and 72 °C for 1 min) followed by an additional 29 cycles of (95 °C for 30 
seconds, 60 °C for 45 seconds, and 72 °C for 1 min) and one final cycle at 72 °C 
for 5 mins.  The product of the 2nd round of PCR is used to transcribe ds esiRNA 
using T7 RNAP in presence of 25 mM NTPs and 40 mM Tris pH 7.9, 6 mM 
MgCl2, 2 mM spermidine and 10 mM NaCl using the following thermocycler 
program: 37 °C for 5 hours 30 mins, 90 °C for 3 mins, Ramp 0.1 °C/second to 70 
°C, 70 °C for 3 mins, Ramp 0.1 °C/second to 50 °C, 50 °C for 3 mins, Ramp 0.1 
°C/second to 25 °C, 25 °C for 3 mins.  After transcription and annealing, products 
were digested with 2U of RQ1 DNAseI for 15 minutes at 37 °C. esiRNAs were 
then generated by digesting dsRNAs with RNAse III (Fazzio et al., 2008) and 
purified as described using Invitrogen RNA Mini Kits.  
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2.5.6:  Cell culture methods 
For inducible expression of transgenes, a HeLa S3-Trex cell line 
expressing the tetracycline repressor was established by infecting HeLa S3 cells 
with lentiviruses containing pLenti CMV TetR Blast (716-1) and selecting for 
blasticidin-resistant cells. HeLa S3-Trex cells were maintained either on plates or 
in suspension in RPMI medium with 5% tetracycline-free fetal bovine serum 
(FBS). HeLa-S3-Trex cells were infected with lentiviruses carrying CMV/TO 
promoters driving expression of NTAP-tagged p150 (pPK560) or p150-directed 
shRNAs. Individual drug-resistant clones were picked for each of these cell lines. 
The NTAP-p150-expressing clone was chosen because it expressed tagged 
protein levels similar to endogenous p150 levels, and is described previously 
(Campeau et al., 2009). p150 shRNA clones were selected based on the extent 
of p150 depletion. Inducible expression of transgenes was achieved by 
supplementing media with 1 µg/mL (NTAPp150) or 2 µg/mL (shRNAs) 
doxycycline. 
RNAi-resistant V5-tagged transgene expression constructs were 
introduced into the HeLa S3 Trex-p150shRNA-1 cell line via lentiviral infection, 
followed by hygromycin selection. Cloned MCF10A-tet-krab cell lines (Cohet et 
al., 2010) harboring p150shRNA-1 or sh-Luciferase were generated and grown in 
DMEM/F12 media (Lonza) supplemented with 5% horse serum, 20 ng/mL EGF, 
10 µg/mL Insulin, 0.5 µg/mL hydrocortisone, 100 ng/mL cholera toxin, and 
antibiotic/antimycotic solution (Life Technologies).  HT1080 cells (ATCC) were 
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maintained in DMEM with 5% tet-free FBS, and Trex and sh-RNA expressing 
cells lines were made as above.   
For double thymidine block experiments, HeLa S3 cells were blocked in 
RPMI + 5% FBS media supplemented with 2 mM thymidine for 18 hours, 
released into thymidine-free media four 9 hours and blocked again with media 
containing 2 mM thymidine for 17 hours (Whitfield et al., 2002). For serum 
starvation studies, MCF10A-tet-krab cells were cultured in complete DMEM/F12 
media as described above, or in DMEM/F12 containing only 1 mg/ml BSA and 
antibiotic/antimycotic with no additional growth factors for 96 hours. The shRNAs 
were induced by adding 2 µg/mL doxycycline to the media during the last 48 
hours.  
Human foreskin fibroblasts (HFF; a kind gift of Jennifer Benanti, (Benanti and 
Galloway, 2004)) were grown in DMEM supplemented with 10% FBS and 
antibiotic/antimycotic solution (Life Technologies).  HFF cells were maintained 
above 25% confluence at all times and were split 1:4 every 2 days.  HFF cells 
used for the immuno-FISH and DNA-FISH experiments were grown on poly-
lysine coated coverslips between PD22-30. MCF-10A and HeLa cells were 
cultured as described above on non-treated coverslips for immuno-FISH and 
DNA-FISH experiments.   
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2.5.7:  Growth analyses 
To measure growth rates during p150 depletion, HeLa S3 Trex-
p150shRNA-1 and HeLa S3 Trex-shRNA-Luciferase cells were plated at 1500 
cells per well in 48-well plates. Triplicate wells for each time point (0 to 120 
hours) were assayed with CellTiter 96 AQueous One (Promega) per 
manufacturer’s instructions. For growth analysis of cells expressing V5-tagged 
p150 or luciferase transgenes, 9000 cells per well in 6-well dishes were infected 
with lentiviruses expressing either shRNA-luciferase or p150shRNA-1 at an MOI 
of 2. After 48 hrs, drug selection for infected cells was begun (1 mg/ml G418 or 
0.5 µg/mL puromycin, respectively). After 7 days post infection, cells were 
stained with crystal violet (Campeau et al., 2009) and photographed.  
 
2.5.8:  Antibodies 
For p150, mouse monoclonals ss1 and ss48 (Smith and Stillman, 1991) 
were used for immunoblots and immunofluorescence. Additionally, rabbit 
polyclonal anti-p150 antibodies (Santa Cruz, sc-10772 and sera specifically 
generated for this study) were used for immunoblotting and ChIP. To generate 
polyclonal antibodies, a codon-optimized version of the first 200 amino acids of 
the p150 cDNA was cloned into pGEX6 (GE Healthcare) to generate pPK621. 
The codon numbering for this construct is based on the full-length p150 ORF that 
contains an additional 18 amino acids at the N-terminus not present in the 
original cDNAs (accession # NM_005483). Synthesis of the GST-p150(1-200) 
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fusion protein was induced in BL21(DE3)pLysS E. coli cells grown in LB with 35 
µg/mL chloramphenicol and 100 µg/mL ampicillin at 37 oC by addition of 0.5 mM 
IPTG at OD600 0.4 for 2 hrs. Pellets were collected, washed in ice-cold PBS, 
frozen in liquid nitrogen and stored at -80oC. Glutathione affinity chromatography 
on Glutathione Sepharose 4 Fast Flow and separation of GST from p150(1-200) 
by PreScission Protease digestion were performed in PBS at 4°C per 
manufacturer’s instructions (GE Healthcare). Additional purification of p150(1-
200) was performed by ion exchange chromatography on a 1 mL Poros 20 HQ 
column (Life Technologies). Soluble protein collected from the PreScission 
digestion was loaded onto a HQ column pre-equilibrated in HQ buffer (25 mM 
Tris pH 7.5, 1 mM EDTA, 1 mM DTT) with 100 mM NaCl and eluted using a 
gradient from 100 mM to 1 M NaCl. p150(1-200) eluted near the beginning of the 
gradient. This purified antigen was used to immunize rabbits for antisera 
production (at Pocono Rabbit Farm and Laboratory, Inc., under the approval of 
the UMASS Medical School IACUC Off-Site Animal Protocol A-1692-12). 
Antibodies to CBP (ICL, RCBP-45A), Ki67 (Novus, NB500-170), CAF1-p60 
(ss96; (Smith and Stillman, 1991)), CENPA (Abcam, ab13939), phospho(S1981)-
ATM (Rockland 200-301-400), phospho(S317)-Chk1 (Bethyl, A300-163A), 
phospho(S139)-γH2AX (Upstate, 05-636), HP1α (Millipore 05-689), 
nucleophosmin (NPM/B23, Santa Cruz, sc-32256), nucleolin (NCL/C23, Santa 
Cruz, sc-9893), Nopp140 (RS8, generous gift of U. Thomas Meier, Albert 
Einstein College of Medicine (Kittur et al., 2007)), fibrillarin (FBL, Abcam, 
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ab5821), UBF1 (Santa Cruz, sc-13125), PARP (BD Pharmingen, 556362), TTF1 
(Santa Cruz, sc-136371), Tubulin (DM1a), and V5 (Life Technologies, R96025) 
were used for immunofluorescence and immunoblots. Anti-BrdU (USBiologicals, 
B2850-01G) was used to detect BrUTP-labeled RNAs. Secondary antibodies 
were obtained from either Jackson Laboratory (FITC, Cy5) or from Life 
Technologies (AlexaFluor 488, 594, and 647). 
 
2.5.9:  Immunofluorescence 
Cells grown on Labtek cc2 8-chamber slides were fixed either in methanol 
(10 minutes) or 4% paraformaldehyde (5 minutes) as indicated, and then 
permeabilized with 0.5% Triton X-100 (5 min) at room temperature.  Samples 
were blocked in 0.5% BSA, 0.2% fish skin gelatin for 1 hour. Samples were then 
incubated with primary antibodies (1:500-1:1000) in blocking buffer (1 hour) 
followed by 3 PBS washes and then secondary antibody incubation (1:800 FITC 
and Cy5, 1:2000 Alexa Fluor 488 and Alexa Fluor 647).  Immunofluorescence 
images were taken on a Zeiss Axioplan2 microscope using Axiovision v4.6 with a 
63x objective connected to a Hamamatsu 1394 ORCA-ER HD camera. Confocal 
images were taken on a Leica SP2 microscope with a 100x objective using Leica 
imaging software, utilizing 405, 488, and 561 nm laser lines. Colocalization 
images were generated using Imaris x64 v6.1.3. Densitometry of individual 
immunostained cells were performed using TIFF files in ImageJ 1.48r (National 
Institute of Health) by constructing histograms across nucleoli of shRNA treated 
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cell lines. Pixel values were normalized to the total pixel density of the histogram 
and plotted in Prism (Graphpad software). 
 
2.5.10:  Chromatin immunoprecipitations (ChIP) 
HeLa S3-Trex-p150shRNA-1 or sh-Luciferase cells were treated with 2 
µg/ml of doxycycline for 72 hours. For each sample, approximately 3 x 107 cells 
were fixed with 1% formaldehyde for 10 minutes at room temperature and 
subsequently quenched with 0.125 M glycine. After two washes in PBS, cells 
were collected by scraping, centrifuged and then flash frozen in liquid nitrogen. 
Thawed pellets were resuspended in ChIP lysis buffer (50 mM HEPES-KOH pH 
7.5, 150 mM NaCl, 1 mM EDTA, 0.5% SDS, 0.1% sodium deoxycholate, 1% 
Triton X-100) and sonicated using a Branson Sonifier 450. After six 20 second 
pulses (power 3, 30% duty cycle), fractionated chromatin was ultracentrifuged at 
100,000 x g for 45 minutes, and the supernatant was recovered. Bradford assays 
(BioRad) were used to determine protein content in the soluble chromatin 
preparations. All samples were pre-cleared with 100 μl of Recombinant Protein G 
– Sepharose® 4B beads (Life Technologies, Grand Island, NY) pre-blocked with 
0.5 mg/ml BSA and 0.2 mg/ml sheared salmon sperm DNA in ChIP lysis buffer 
overnight at 4°C. For p150 and TTF-I analyses, 500 µg chromatin was incubated 
overnight with 5 µg of our own anti-p150 antisera or 2.5 µg of anti-TTF-I (SC-
136371, Santa Cruz Biotechnology, Inc, Santa Cruz, CA) antibody. Rabbit pre-
immune serum or mouse IgG (SC-2025, Santa Cruz Biotechnology, Inc, Santa 
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Cruz, CA) served as negative immunoprecipitation controls. Following an 
overnight incubation with 100 μl of Protein G beads, beads were washed twice 
with ChIP lysis buffer, once with high salt buffer (50 mM HEPES-KOH pH 7.5, 1M 
NaCl, 1 mM EDTA, 0.5% SDS, 0.1% sodium deoxycholate, 1% Triton X-100), 3 
times with RIPA buffer (50 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5% 
NP40, 0.5% sodium deoxycholate), and once with TE buffer containing 50 mM 
NaCl. Protein-DNA complexes were extracted from beads at 65°C in elution 
buffer (0.1 M NaHCO3, 1% SDS) for 15 minutes, followed by centrifugation at 
16,000 x g for one minute and collection of supernatants. To reverse 
crosslinking, eluted chromatin and corresponding input samples were rotated 
overnight at 65ºC. Samples were then subjected to RNAse A (80 µg for 2 hours 
at 37 °C) and proteinase K (80 µg for 2 hours at 55°C) digestions. Samples were 
extracted with phenol:chloroform:isoamyl alcohol (25:24:1) and precipitated with 
2.5 volumes of ethanol in 0.2 M NaCl plus 30 µg of glycogen. Precipitated DNA 
was resuspended in 10 mM Tris-HCl, pH 8.0. The Fast SYBR Green reagent 
(Life Technologies, Grand Island, NY) was used in ChIP-PCR studies to quantify 
p150 and TTF-1 occupancies. Primer sequences are in Table S2. The PCR 
reactions were performed using a StepOnePlus machine (Life Technologies) with 
the following program: hold 95°C for 20 minutes, followed by 40 cycles of 95 °C 
for 3 seconds, 60°C for 30 seconds. To calculate the percentage of bound DNA, 
unimmunoprecipated input chromatin from each sample was analyzed 
simultaneously.  ∆∆CT was calculated from the following formula (Life 
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Technologies): Adjusted input = Ct input – 6.644. Percent input = 100*2^ 
(Adjusted input – Ct(IP)). Three biological replicates for each experiment were 
performed, and comparisons between samples were analyzed by two-tailed, 
unpaired Student’s t-tests with equal variance (homoscedastic). 
 
2.5.11:  Visualization of 5-EU-labeled nascent RNA 
MCF-10A cells were grown in 4-well chamber slides (Fisher) overnight 
and then in some cases incubated with the RNA polymerase II inhibitor alpha-
amanitin (Sigma), the inhibitor of RNA polymerase I transcription actinomycin D 
(Sigma), or both.  Alpha-amanitin was added at 20 μg/mL for 4 hours and 
actinomycin D was added at 50 ng/mL for 15 minutes.  Pre-warmed MCF-10A 
media containing the indicated drug(s) and 500 μM of the UTP analog 5-ethynyl-
uridine (5-EU, Invitrogen) was added for 15 minutes, followed by washing with 1X 
PBS.  Cells were then fixed with 3.7% formaldehyde/ 1X PBS for 15 minutes at 
room temperature.  Following another 1X PBS wash, the cells were 
permeabilized in 0.5% Triton-X100/ 1X PBS for 15 minutes at room temperature.  
Cells were then washed again in 1X PBS before incubation with the click 
chemistry cocktail (50 mM carboxyrhodamine 110-Azide (Click Chemistry Tools), 
100 mM ascorbic acid (Sigma), and 1 mM CuSO4 (Sigma) in 100 mM Tris-Cl pH 
8.5) for 30 minutes at room temperature in the dark.  The cells were then washed 
3 times in 0.5% Triton-X100/ 1X PBS for 5 minutes in the dark and then 
incubated in 130 ng/mL DAPI in 1X PBS for 1 minute.  The chamber was then 
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manually removed and a few drops of Vectashield (Vector Labs) was added 
before a coverslip was placed on top and sealed with nail polish.  Images were 
taken on a Zeiss Axioplan2 microscope with a 63x objective. 
 
2.5.12:  Immuno-FISH and DNA-FISH Experiments 
The bacterial artificial chromosomes RP5-915N17 (1q42.13; ‘5S rDNA’), 
RP11-413F20 (10q26.3; ‘D4Z4 array’) and RP11-123G19 (10q24.1; ‘Negative 
Control’, which was previously shown to lack nucleolar localization (Németh et 
al., 2010) were obtained from the BACPAC Resource Center of Children’s 
Hospital Oakland Research Institute (CHORI). The plasmid pB containing a 5.6 
Kb EcoRI fragment of human 47S rRNA-encoding repeat was a gift from Sui 
Huang (Northwestern University School of Medicine). The chromosome 17 alpha 
satellite probe was prepared as previously described (Warburton et al., 1991). 
BAC probes were labeled using the Bioprime Labeling Kit (Invitrogen), and the 
rDNA and alpha satellite probes were labeled using the Nick Translation Mix Kit 
(Roche).  
Expression of either sh-luciferase or sh-p150 in MCF10A-tet-krab cells was 
induced with 2 μg/mL doxycycline for 72 hours, followed by fixation and storage 
in 1X PBS at 4oC for up to a week. For all transgene experiments involving 
lentivirus-encoded shRNAs, cells were infected at MOI = 7.5 with 6 μg/mL 
polybrene. 72 hours post-infection, cells were fixed and stored for up to a week in 
1X PBS at 4oC.  For other depletions, siRNAs were constructed as previously 
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described (Fazzio et al., 2008) and 500 ng of siRNAs were transfected in 1 mL 
Opti-MEM (Gibco) with 6 μL oligofectamine (Life Technologies).  Transfections 
were performed in 6-well dishes containing coverslips, and after 6.5 hours 2.5 
mLs of appropriate media were added on top of the transfection cocktail.  At 72 
hours after transfection, cells were fixed and stored for up to a week in 1X PBS at 
4oC. 
Immuno-FISH and DNA FISH experiments in MCF-10A, HFF, and HeLa 
cells were performed using previously published methods (Byron et al., 2013) 
with some modification.  Briefly, cells were grown on cover slips, permeabilized in 
0.5% Triton X-100 in CSK buffer on ice for 5 minutes, and fixed in 4% 
paraformaldehyde in 1X PBS at room temperature for 10 minutes.   For Immuno-
FISH experiments, cells were then processed using the immunofluorescence 
protocol described in these methods using an anti-fibrillarin antibody (Abcam).  
The cells were then fixed again in in 4% paraformaldehyde in 1X PBS at room 
temperature for 10 minutes before proceeding to DNA denaturation.  For DNA-
FISH experiments, after initial fixation RNA was removed by incubating the cells 
in 0.2 N NaOH in 70% ethanol for 5 minutes at room temperature before 
proceeding to genome denaturation. The genome was denatured by placing the 
coverslips in 70% formamide (Sigma)/2X SSC heated to 80oC for 2-3 minutes. 
Denaturation was quenched in ice-cold 70% ethanol for 5 minutes, followed by 
washing with ice-cold 100% ethanol and air-drying. 50 μg of labeled probe was 
mixed with 1 μg of Cot-1 (Roche), 1 μg E. Coli tRNA (Sigma), and 1 μg single 
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stranded salmon sperm DNA (Sigma) in 50% formamide (Sigma) and 50% 
hybridization buffer. Hybridization buffer is comprised of 20% dextran sulfate 
(Sigma) and 1% BSA in 4X SSC.  The probe was denatured at 80oC for 10 
minutes and then incubated underneath the coverslips in a 37oC humid chamber 
overnight. Cells were washed for 20 minutes in 50% fromamide in 2X SSC at 
37oC, then for 20 minutes in 2X SSC at 37oC, and for 20 minutes in 1X SSC at 
room temperature.  The probe was detected using either FITC conjugated to an 
anti-digoxigenin antibody (Roche) or an Alexa Fluor conjugated to streptavidin 
(Invitrogen) in 1% BSA/ 4X SSC for 60 minutes in a 37 oC humid chamber.  Cells 
were washed again in 4X SSC three times for 10 minutes at room temperature in 
the dark.  Coverslips were mounted with Vecta Shield (Vector Labs) and Z-stack 
images were taken on a Zeiss Axioplan2 microscope with a 63x objective. Z-
steps of 200 nM were taken and the maximum intensity projections generated 
using Axiovision v4.6. Association percentages for each of the three biological 
replicates were transformed into arcsine units and the unpaired Student’s t-test 
was used (with Welch’s correction) to generate p-values.  P-values < 0.05 were 
considered statistically significant. 
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CHAPTER III:  CAF-1 P150 REGULATES KI-67 LOCALIZATION 
THROUGHOUT THE CELL CYCLE 
 
3.1:  Abstract 
Chromatin Assembly Factor 1 (CAF-1) deposits histones during DNA 
synthesis. The p150 subunit of human CAF-1 contains an N-terminal domain 
(p150N) that is dispensable for histone deposition but which promotes the 
localization of specific loci (Nucleolar-Associated Domains, or “NADs”) and 
proteins to the nucleolus during interphase.  One of the p150N-regulated proteins 
is proliferation antigen Ki-67, whose depletion also decreases the nucleolar 
association of NADs.  Ki-67 is also a fundamental component of the 
perichromosomal layer (PCL), a sheath of proteins surrounding condensed 
chromosomes during mitosis.  We show here that a subset of p150 localizes to 
the PCL during mitosis, and that p150N is required for normal levels of Ki-67 
accumulation on the PCL. This activity requires the Sumoylation Interacting Motif 
(SIM) within p150N, which is also required for the nucleolar localization of NADs 
and Ki-67 during interphase.  In this manner, p150N coordinates both interphase 
and mitotic nuclear structures via Ki67.  
 
3.2:  Introduction 
Eukaryotic chromosomes must condense for segregation during mitosis, 
and then decondense and re-adopt interphase configurations in the next cell 
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cycle. However, mechanisms that link higher-order mitotic and interphase 
genome organization remain poorly understood. Notably, cellular 
heterochromatin is highly enriched at specific sites in interphase nuclei, at the 
nuclear lamina, in pericentric foci, and in perinucleolar regions (reviewed in 
(Politz et al., 2016). Therefore, a major question is how these loci are relocalized 
after each mitosis, and what mitotic molecules might aid in this. 
 Nucleolar Associated Domains (NADs) are genomic loci that interact 
frequently with the nucleolar periphery (van Koningsbruggen et al., 2010; 
Matheson and Kaufman, 2015; Németh et al., 2010; Padeken and Heun, 2014; 
Pontvianne et al., 2016).  NADs are highly enriched for repetitive DNA satellites 
and histone modifications associated with heterochromatic silencing such as 
H3K27me3, H3K9me3, and H4K20me3 (Németh et al. 2010; Politz et al. 2016).  
One protein recently shown to regulate NAD localization is the p150 subunit of 
Chromatin Assembly Factor 1 (CAF-1) (Smith et al., 2014).  CAF-1 is a highly 
conserved three-subunit protein complex which deposits histone (H3/H4)2 
tetramers onto replicating DNA during S-phase of the cell cycle (Kaufman et al., 
1995; Krude, 1995; Smith & Stillman, 1989), and is particularly important for DNA 
replication and maintenance of histone marks at heterochromatic loci (Baldeyron 
et al., 2011; Dohke et al., 2008; Houlard et al., 2006; Huang et al., 2010; Quivy et 
al., 2004, 2008; Reese et al., 2003; Sarraf and Stancheva, 2004).  In addition to 
these functions, the N-terminal domain of p150 (p150N) regulates the association 
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of NADs to the perinucleolar region, and also regulates the nucleolar localization 
of several proteins, including the proliferation antigen Ki-67 (Smith et al., 2014). 
Ki-67 also regulates heterochromatin modification (Sobecki et al., 2016) 
and affects its condensation (Kametaka et al., 2002; Takagi et al., 1999). Ki-67 is 
highly expressed in proliferating cells, minimally expressed in quiescent cells 
(Gerdes et al., 1984; Gerdes et al., 1983), and meta-analyses of numerous 
clinical studies have validated Ki-67 as a prognostic marker in grading tumors 
(Luo et al., 2015; Pezzilli et al., 2016; Pyo et al., 2016; Richards-Taylor et al., 
2016). Similar to Ki-67, p150 is also highly expressed in proliferating cells, 
minimally expressed in quiescent cells, and has been proposed as an alternative 
cellular proliferation marker in clinical studies (Polo et al., 2004). 
Recent studies have demonstrated that Ki-67 is required for formation of 
the perichromosomal layer (PCL) (Booth et al., 2014; Sobecki et al., 2016), a 
layer of proteins that surrounds all condensed chromosomes during mitosis 
(reviewed in (Van Hooser 2005).  At the PCL, Ki-67’s status as a large, charged 
protein that possesses “surfactant”-like properties keeps individual mitotic 
chromosomes dispersed rather than aggregated upon nuclear envelope 
disassembly, thereby ensuring normal kinetics of anaphase progression (Cuylen 
et al., 2016). Likewise, acute depletion experiments show that Ki-67 is important 
for maintaining mitotic chromosome structure and function (Takagi et al., 2016). 
Since p150N regulates interphase Ki-67 localization, we investigated whether 
p150N also affects Ki-67 localization during mitosis.  
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3.3:  Results  
3.3.1:  Ki-67 regulates alpha satellite localization to the perinucleolar region 
Recent studies have suggested Ki-67 regulates repetitive DNA localization 
to the nucleolus.  Ki-67 depletion decreased the nucleolar association of a LacO 
array proximal to the rDNA repeats on chromosome 13 (Booth et al., 2014), and 
the centromeric histone variant CENP-A (Sobecki et al., 2016).  To determine if 
Ki-67 also regulates satellite repeat association with the nucleolus, we 
transfected siRNAs into HeLa cells and performed immuno-FISH to visualize the 
position of alpha satellite DNA from chromosome 17 (αSat 17) relative to the 
nucleolar protein fibrillarin.  HeLa cells transfected with siRNAs directed against 
luciferase or a scramble control displayed ~45% of αSat 17 alleles associated 
with nucleoli, which represents a high-frequency interaction characteristic of a 
NAD locus (Németh et al., 2010; Smith et al., 2014; van Koningsbruggen et al., 
2010). In contrast, cells transfected with two different siRNA reagents directed 
against distinct regions of the Ki-67 mRNA displayed αSat 17 association 
frequencies to ~25% (Figure 3.1, A and B).   
We also depleted HeLa cells of nucleolin (NCL), a nucleolar protein which 
primarily localizes to the perinucleolar region (Bugler et al., 1982) and regulates 
transcription, folding, and assembly of ribosomal RNA (Ginisty et al., 1999; 
Ginisty et al., 1998; Rickards et al., 2007; Roger et al., 2002).  Depletion of NCL 
altered nucleolar morphology (Figure 3.1, B) as previously reported (Ma et al., 
2007; Ugrinova et al., 2007) but did not affect the association of αSat 17 with 
 117 
fibrillarin (Figure 3.1, A).  We conclude that in human cells Ki-67 is required for 
efficient localization of NADs to nucleoli, and that NCL is not required at least for 
alpha satellite-nucleolar interactions. 
Our results with human nucleolin depletion are somewhat different from 
those obtained in a recent study of nucleolin’s contribution to NAD localization in 
the plant A. thaliana (Pontvianne et al., 2016). As in our experiments (Fig. 1B), 
cells from nucleolin mutant (nuc1) plants also showed altered nucleolar 
morphology. However, deep sequencing of purified nucleoli revealed altered 
NAD profiles in nuc1 cells, including decreased nucleolar association of telomeric 
heterochromatin, coinciding with a 30% loss of telomere length on all 
chromosomes. It is possible that there are altered NAD associations in nucleolin-
depleted human cells that we could not have detected using an alpha-satellite 
probe specific for chromosome 17. Alternatively, there is precedence for species-
specific interactions mediated by nucleolin. For example, depletion of nucleolin 
increases centromere-nucleolar interactions in Arabidopsis (Pontvianne et al., 
2016), but decreases such interactions in Drosophila (Padeken et al., 2013).  
Interestingly, decreased telomere lengths were also observed in 
Arabidopsis fas1 and fas2 mutants (Pontvianne et al., 2016), which lack the 
homologs of the human p150 and p60 subunits of CAF-1. Another study found 
that fas1 and fas2 mutants also display decreased copy number of the 45S rRNA 
genes, along with increased nucleolar association of the remaining 45S rRNA 
genes (Pontvianne et al., 2013). We note that human p150 and Arabidobsis Fas1 
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share 29.8% amino acid identity, but Fas1 completely lacks the p150N domain, 
the N-terminal 310 amino acids of p150 previously shown to regulate human 
nucleolar structure (Smith et al., 2014). Together, these data suggest that 
p150/Fas1 regulate nucleolar structure in both plants and mammals, but also that 
there are marked mechanistic differences in how this regulation occurs in 
different organisms.  We also note that a higher percentage of the genome is 
nucleolar-associated in human cells (Dillinger et al., 2016) when compared to 
plant cells (Pontvianne et al., 2016). 
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Figure 3.1:  Alpha-satellite associations with nucleoli are reduced upon 
depletion of Ki-67 but not nucleolin. 
 
(A): Immuno-FISH analyses of the association between alpha satellite DNA from 
chromosome 17 (αSat 17, red) and fibrillarin (green) was performed in HeLa cells 
transfected for 72 hours with in vitro-diced “esiRNAs” targeting luciferase, Ki-67, 
or nucleolin (NCL) (black bars), or with synthetic duplex siRNAs (checked bars) 
targeting Ki-67 or a scrambled sequence control (si-Scr). The percentage of αSat 
17 alleles co-localized with fibrillarin is indicated, with means and standard 
deviation error bars from three replicate experiments. p values comparing 
association frequencies in cells treated with esi-Luc (N=669 alleles) vs. esi-Ki-67 
(573 alleles), and si-SCR (N=540 alleles) with si-Ki-67 (N=567 alleles) are 
indicated.  (B):  Representative FISH images of cells analyzed in panel (A).   
Scale bar is 10 µm.  (C):  Immunoblot analyses of cells from panel (A).  Blots 
were probed with antibodies recognizing Ki-67, α-Tubulin (loading control), NCL, 
or fibrillarin (loading control), as indicated. 
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Figure 3.1:  Alpha-satellite associations with nucleoli are reduced upon 
depletion of Ki-67 but not nucleolin. 
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3.3.2 A subset of p150 co-localizes with Ki-67 foci during mitosis and early 
G1 phases 
Ki-67 has three distinct nuclear localization patterns, which appear at 
distinct cell-cycle periods.  First, Ki-67 localizes to the nucleolus during 
interphase (Cheutin et al., 2003; Traut et al., 2002; Verheijen et al., 1989), and a 
subset co-localizes with p150 at the perinucleolar region (Smith et al., 2014).  
Second, Ki-67 localizes to the PCL during mitosis (Gerdes et al., 1984; Gerdes et 
al., 1983; Verheijen, et al., 1989). In contrast to the chromosome-associated 
state of mitotic Ki-67, mitotic phosphorylation evicts the majority of CAF-1 from 
mitotic chromosomes and inhibits its nucleosome assembly activity (Keller and 
Krude, 2000; Marheineke and Krude, 1998; Matsumoto-Taniura et al., 1996; 
Murzina et al., 1999). However, mass spectrometric analyses suggested that a 
mitotic chromosome-associated subset of p150 exists (Ohta et al., 2010), but its 
relationship to the PCL had not been directly tested. To analyze this we took 
advantage of the fact that Ki-67 localization to the PCL remains visibly 
unchanged even after extraction with 2 M NaCl and treatment with either RNase 
A or DNase I (Sheval and Polyakov, 2008), indicating the structural stability of 
the PCL is independent of the chromatin it surrounds. We performed 
immunofluorescence on RPE1-hTERT cells that were digested with either RNase 
A, DNase I, or mock digested, and then high-salt extracted.    As previously 
reported, Ki-67 remained on the PCL throughout mitosis even after DNA or RNA 
digestion, as shown for prophase (Figure 3.2), metaphase (Figure 3.3), and 
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anaphase (Figure 3.4).  As expected, p150 as well as Ki67 could be easily 
detected on anaphase chromosomes presumably because at that stage the 
mitotic phosphorylations of CAF-1 are removed, triggering bulk re-association 
with chromatin and reactivation of nucleosome assembly activity (Keller and 
Krude, 2000). In contrast, during prophase or metaphase a large amount of p150 
evicted into the nucleoplasm made it difficult to determine whether p150 localized 
to the PCL.  The combination of high-salt extraction and DNase I digestion 
however revealed that a subset of p150 localized to the PCL during all phases of 
mitosis.  
The third Ki-67 localization pattern occurs after cytokinesis and early in G1 
phase. At this stage, Ki-67 localizes to hundreds of distinct foci (du Manoir et al., 
1991; Isola et al.,1990) that co-localize with heterochromatic satellite repeats 
(Bridger et al., 1998).  These foci are transient and appear to be intermediates in 
the process of reformation of nucleoli as cells transition from mitosis to 
interphase (Saiwaki et al., 2005).  Because a subset of p150 is in the mitotic PCL 
(Figures 3.2-3.4), we sought to determine if p150 also co-localized with early G1 
Ki-67 foci. To do this, we performed immunofluorescence on early G1 RPE1-
hTERT cells digested with nucleases or mock digested as previously described 
(Figure 3.6).  In all three conditions, a subset of p150 foci in early G1 cells co-
localized with Ki-67 foci, as indicated by line scan analyses. These data suggest 
that a subset of p150 travels together with Ki67 during exit from mitosis, as PCL 
components transit towards reforming nucleoli.   
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Figure 3.2:  A subset of p150 localizes to the PCL during prometaphase 
 
RPE1-hTERT cells in prometaphase were either untreated or digested with 
RNase A or DNase I as indicated, and then high-salt extracted. Cells were 
stained with DAPI to detect DNA (blue), and with antibodies recognizing p150 
(green), and Ki-67 (red).  Note the DNase I-treated cells lack DAPI staining.  
Scale bar is 10 µm.  
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Figure 3.2:  A subset of p150 localizes to the PCL during prometaphase 
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Figure 3.3:  A subset of p150 localizes to the PCL during metaphase 
 
RPE1-hTERT cells in metaphase were either untreated or digested with RNase A 
or DNase I as indicated, and then high-salt extracted. Cells were stained with 
DAPI to detect DNA (blue), and with antibodies recognizing p150 (green), and Ki-
67 (red).  Note the DNase I-treated cells lack DAPI staining.  Scale bar is 10 µm.
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Figure 3.3:  A subset of p150 localizes to the PCL during metaphase 
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Figure 3.4:  A subset of p150 localizes to the PCL during anaphase 
 
RPE1-hTERT cells in anaphase were either untreated or digested with RNase A 
or DNase I as indicated, and then high-salt extracted. Cells were stained with 
DAPI to detect DNA (blue), and with antibodies recognizing p150 (green), and Ki-
67 (red).  Note the DNase I-treated cells lack DAPI staining.  Scale bar is 10 µm.
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Figure 3.4:  A subset of p150 localizes to the PCL during anaphase 
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Figure 3.5:  RNase A mediated degradation and western blot of DNase I 
treated PCL preparation.  
 
(A): Positive control for RNase A treatment. RNA from untreated and RNase A-
treated cells analyzed in Figures 3.2, 3.3, 3.4, and 3.6 were purified using Trizol 
reagent and analyzed on a 1% agarose gel. (B):  Western blot of mitotic HeLa S3 
cells (Input lane, 20 µg) or mitotic HeLa S3 cells digested with DNase I and salt 
extracted as in Figure 3.2 (2 µg, 4 µg, 8 µg, 16 µg as indicated).  Blot was probed 
with antibodies recognizing Ki-67 (top) and p150 (bottom).  Numbers on the right 
indicate migration of marker proteins of indicated molecular weight x 10-3..
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Figure 3.5:  RNase A mediated degradation and western blot of DNase I 
treated PCL preparation.  
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Figure 3.6:  A subset of p150 localizes to Ki-67 foci during early G1 of 
interphase. 
 
RPE1-hTERT cells were either untreated or digested with RNase A or DNase I 
as indicated, and then high-salt extracted. Cells were stained with DAPI to detect 
DNA (blue), and with antibodies recognizing p150 (green), and Ki-67 (red). Pairs 
of recently divided cells featuring hundreds of Ki-67 foci characteristic of early G1 
are shown here. Line scans (right-hand panels) of individual cells (yellow 
triangles in merged images) were used to assess co-localization of p150 with Ki-
67 signal.  Scale bar is 10 µm.
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Figure 3.6:  A subset of p150 localizes to Ki-67 foci during early G1 of 
interphase. 
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3.3.3:  p150 regulates Ki-67 accumulation on the Perichromosomal Layer  
Our previous work demonstrated that p150 is required for normal steady-
state accumulation of Ki-67 in the nucleolus during interphase (Smith et al., 
2014). Because Ki-67 is essential for the formation of the PCL in mitotic cells 
(Booth et al., 2014; Sobecki et al., 2016), we tested whether p150 also regulated 
Ki-67 localization during mitosis.  Via immunofluorescence, we examined Ki-67 
distribution in HeLa S3 cells expressing an inducible shRNA directed against 
either luciferase (Luc) or p150 (Figure 3.7, A).  As expected, we found Ki-67 
robustly associated with the PCL during all phases of mitosis in the negative 
control cells expressing sh-Luc.  In contrast, cells expressing sh-p150 displayed 
less Ki-67 staining on the PCL, as demonstrated in the exposure times matched 
with the sh-Luc samples.  When exposure times were increased, Ki-67 was 
detected on the PCL, indicating that the PCL was not entirely disassembled upon 
p150 depletion.   When the Ki-67 fluorescence was quantified in prometaphase 
cells from three biological replicates, cells expressing sh-p150 displayed, on 
average, a 3.5-fold decrease in fluorescence intensity compared to the control 
cells expressing sh-Luc (Figure 3.7, B).   To test whether this effect of p150 
depletion could result from global masking of epitopes on the PCL, we co-stained 
some samples with an antibody recognizing the mitotic histone modification H3-
S28ph (Goto et al., 1999; Goto et al., 2002).  As shown in the prometaphase cell 
in Figure 3A, this antibody stained cells expressing sh-Luc or sh-p150 equally 
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well, suggesting that p150 regulates Ki-67 accumulation on the PCL rather than 
affecting overall epitope accessibility on mitotic chromosomes.   
To explore how p150 may be regulating Ki-67 localization, we tested 
whether p150 is required for maintaining steady-state levels of Ki-67. Our 
previous work demonstrated that Ki-67 steady-state levels were not affected 
upon p150 depletion in asynchronous cells (Smith et al., 2014).  To distinguish 
whether p150 regulates the steady-state protein levels of Ki-67 during mitosis, 
extracts from mitotic-arrested cells expressing sh-Luc or sh-p150 were collected 
and analyzed by immunoblotting (Smith et al., 2014) (Figure 3.7, C and D).  Total 
levels of Ki-67 in mitotic samples normalized to actin signals were not 
significantly changed upon p150 depletion (Figure 3.7, C and D), indicating that 
p150 is not required for maintaining steady-state levels of Ki-67 during mitosis. At 
the beginning of mitosis, Ki-67 localization to the PCL occurs in conjunction with 
hyperphosphorylation of the Ki-67 protein (Endl and Gerdes, 2000; MacCallum 
and Hall, 1999; Takagi et al., 2014a).  These phosphorylations are important for 
PCL localization, as treatment of mitotic cells with protein kinase inhibitors results 
in dephosphorylation of Ki-67 and relocalization of Ki-67 away from the PCL to 
distinct nuclear foci (MacCallum and Hall, 1999).  Therefore, we tested whether 
p150 regulates Ki-67’s mitotic phosphorylation status by reprobing the 
immunoblots of mitotically-arrested cell extracts with antibodies that specifically 
recognize Ki-67 phosphorylated on Cdk consensus sites within the Ki-67 internal 
repeat structure (Takagi et al., 2014). However, we detected no statistically 
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significant changes upon p150 depletion (Figure 3.7, C and D).  Therefore, p150 
does not appear to regulate the steady-state levels or phosphorylation of Ki-67 
during mitosis.    
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Figure 3.7:  p150 regulates Ki-67 localization during mitosis 
  
(A): HeLa S3 cells from the indicated cell cycle stages expressed an shRNA 
directed against luciferase (sh-Luc) or p150 (sh-p150) for 72 hours and were 
stained with DAPI to visualize DNA (blue) and antibodies against Ki-67 (green).  
Exposure times for Ki67 are indicated on each image, and in the sh-p150 
expressing cells different exposure times are shown to illustrate reduced Ki-67 
accumulation on the PCL. As a positive control for antibody accessibility, cells in 
prometaphase were also stained with antibodies recognizing the mitotic marker 
histone H3-S28-phosphate (red). Scale bar is 10 µm.  (B):  Quantified corrected 
total cellular fluorescence of cells from three biological replicate experiments of 
cells expressing sh-luc (red, N=150) or sh-p150 (blue, N=147).  (C):  Immunoblot 
analysis of extracts from shRNA-expressing cells described in (A) arrested in 
mitosis (12 hours in 100 ng/mL nocodazole followed by shaking off mitotic cells). 
Blots were probed with antibodies recognizing p150 (top), Ki-67 (upper middle), 
phospho-Ki-67 (lower middle), and actin (loading control, bottom). Numbers on 
the right indicate migration of marker proteins, in kDa.  (D): Quantification of the 
Ki-67 and phospho-Ki-67 blots from (C), normalized to actin signal (N=3). 
Quantification was performed using the BioRad ChemiDoc system.
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Figure 3.7 p150 regulates Ki-67 localization during mitosis  
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3.3.4:  p150 regulates the formation of Ki-67 foci in early G1 phase 
Because p150 regulates the localization of Ki-67 to the nucleolus during 
interphase (Smith et al., 2014) and to the PCL during mitosis (Figure 3.7, A), we 
wanted to examine whether p150 is also required for the formation of the 
punctate Ki-67 foci seen at the beginning of G1 phase.  To answer this question, 
we induced expression of sh-Luc or sh-p150 for 60 hours, and then synchronized 
cells by adding 100 ng/mL nocodazole for the final 12 hours of shRNA 
expression.  After vigorously shaking mitotic cells off the plate, cells were washed 
three times in PBS and released into nocodazole-free media.  Based on FACS of 
a time course after release (Figure 3.8, B), G1 cells were collected at 120 
minutes post release, and stained with antibodies directed against Ki-67 and 
NCL (Figure 3.8, A).  In the sh-Luc samples, hundreds of punctate Ki-67 foci 
were visible, while NCL was detected within the newly reformed nucleoli.  In 
contrast, sh-p150 samples featured disrupted NCL localization, and dispersal of 
Ki-67 foci.  Together, our data suggest that the contribution of p150N to 
interphase Ki-67 and NCL localization (Smith et al. 2014) results from events that 
begin in M and/or G1 phase. In this manner, p150 regulates Ki-67 localization 
throughout the cell cycle.   
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Figure 3.8:  p150 regulates Ki-67 localization during early G1 phase of 
interphase 
 
(A):  HeLa S3 cells that expressed an shRNA directed against luciferase (sh-Luc) 
or p150 (sh-p150) for 72 hours were synchronized in mitotsis (12 hours in 100 
ng/mL nocodazole followed by shaking off), and released into drug-free media for 
two hours to enrich for early G1 cells.  Cells were stained with DAPI to visualize 
DNA (blue) and antibodies against Ki-67 (green) and NCL (red).  Scale bar is 10 
µm.  (B):  FACS histograms showing cell-cycle profiles of propdium-iodide 
stained HeLa S3 samples from Figure 3.8, E.  Hela S3 cells expressed sh-Luc or 
sh-p150 for 60 hours before treatment with 100 ng/mL nocodazole for 12 hours.  
Mitotic cells were then shaken off, washed three times with PBS, and released 
into media.  Time points were taken every 20 minutes for 3 hours, and 
histograms generated using FlowJo V10.2.  
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Figure 3.8:  p150 regulates Ki-67 localization during early G1 phase of 
interphase 
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3.3.5:  The SIM within the N-terminus of p150 is required for Ki-67 
localization to the PCL 
To map p150 domains required for regulating Ki-67 accumulation on the 
PCL, we utilized previously published HeLa cell lines stably expressing V5-
epitope tagged, sh-RNA resistant, p150-derived transgenes (Smith et al., 2014).  
These V5-transgene cell lines were acutely depleted of endogenously-encoded 
p150 via lentiviral expression of sh-p150 for 72 hours prior to 
immunofluorescence analysis of Ki-67.  The C-terminal two-thirds of p150 serves 
as the scaffold for binding the other two subunits of the CAF-1 complex, and 
thereby is essential for CAF-1’s nucleosome assembly activity (Kaufman et al., 
1995; Takami et al., 2007).  In contrast, p150’s N-terminus is dispensable for 
nucleosome assembly (Kaufman et al., 1995) but is necessary and sufficient to 
maintain Ki-67 localization to the nucleolus during interphase (Smith et al., 2014).  
We found that depletion of p150 in HeLa cells expressing either Luciferase or a 
p150 transgene encoding the C-terminus (amino acids 311-938) displayed 
reduced Ki-67 localization to the PCL (Figure 3.9, A). In contrast, cells 
expressing either full-length p150 (aa 1-938) or only the N-terminus (p150N, aa 
1-310) maintained normal amounts of Ki-67 on the PCL (Figure 3.9, A).  
Therefore, the p150 N-terminus regulates mitotic Ki-67 abundance in a manner 
independent of the chromatin assembly activity of the CAF-1 complex.   
p150N contains several known interaction motifs, including a non-canonical 
PCNA-interacting peptide (PIP) (Moggs et al., 2000; Rolef Ben-Shahar et al., 
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2009), a heterochromatin protein 1-binding domain (Murzina et al., 1999), and a 
sumoylation-interacting motif (SIM) (Sun and Hunter, 2012; Uwada et al., 2010). 
Notably, the SIM in p150N is required for normal Ki-67 localization to the 
nucleolus during interphase (Smith et al., 2014).  We therefore determined if 
transgenes encoding full-length p150 with mutations in the three motifs described 
above supported normal Ki-67 accumulation during mitosis.  The cell lines 
expressing p150 transgenes with mutations in the PIP and HP1 domains 
maintained normal Ki-67 levels on the PCL. However, cells expressing a p150 
transgene with a single amino acid mutation (I99A) that disrupts the SUMO-
binding activity of the SIM (Uwada et al., 2010) displayed reduced levels of Ki-67 
on the PCL (Figure 3.9, A).  Together, our data indicate that the SIM motif within 
the N-terminus of p150 is required for the normal accumulation of Ki67 on the 
PCL during mitosis.  
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Figure 3.9:  The SIM within the N-terminal domain of p150 is sufficient to 
maintain Ki-67 localization to the PCL 
 
(A): HeLa cells in prometaphase expressing the indicated shRNA-resistant p150 
transgene were infected with lentiviruses encoding the indicated shRNAs (sh-Luc 
or sh-p150) for 72 hours, and then stained with DAPI to visualize DNA (blue) and 
antibodies against Ki-67 (green).   Note that upon expression of sh-p150, cells 
expressing luciferase (V5-Luc), the p150 C-terminus (V5-(p150-311-938)), or 
p150 with a I99A point mutation in the SIM motif required longer exposure times 
to detect Ki-67 on the PCL.  Scale bar is 10 µm.  (B): Immunoblots of cell extracts 
described in (A), expressing either sh-Luc (L) or ph-p150 (P). Blots were probed 
with antibodies recognizing p150 (top), V5 transgenes (middle), and fibrillarin 
(loading control, bottom). Note the depletion of endogenous p150 in sh-p150 
lanes, and that V5-tagged transgene expression often increased in these lanes, 
as we had observed previously (Smith et al., 2014). 
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Figure 3.9:  The SIM within the N-terminal domain of p150 is sufficient to 
maintain Ki-67 localization to the PCL 
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3.4:  Discussion 
 These data and our previous studies suggest a hierarchical 
relationship between p150N and Ki-67 in regulating nuclear architecture across 
the cell cycle (Figure 3.10).  p150 and Ki-67 both co-localize during mitosis and 
interphase (Figures 3.2-3.4, and 3.6; (Smith et al., 2014)), regulate NAD 
localization (Figure 3.1; (Booth et al., 2014; Smith et al., 2014; Sobecki et al., 
2016), and have established roles in regulating heterochromatin (Quivy et al., 
2008; Sobecki et al., 2016).  It is noteworthy that p150 is required for the 
formation of punctate Ki-67 foci in early G1 of the cell cycle, as previous studies 
have demonstrated that these foci co-localize with heterochromatic satellite 
repeats typically enriched within NADs (Bridger et al., 1998).  Because ablation 
of these foci results in mislocalization of NAD elements, we hypothesize that the 
function of these foci may be to guide heterochromatin-rich NADs back to the 
nucleolar periphery.  However, additional evidence, such as the deep-
sequencing of the DNA elements contained within these foci, is required to 
further support this hypothesis.   
p150N appears to function upstream of Ki-67 in this hierarchy, as p150N 
is required for efficient Ki-67 association with the PCL during mitosis (Figure 3.7) 
and with the nucleolus during interphase (Smith et al., 2014).  p150N is 
dispensable for nucleosome assembly by CAF-1, indicating that p150’s role in 
regulating Ki-67 localization is independent of histone deposition.  During both 
mitosis and interphase, the SIM within p150N is required for Ki-67 localization 
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(Figure 3.9;(Smith et al., 2014)), suggesting that this action involves an as yet 
unidentified sumoylated protein. These data suggest that future studies should 
explore the contributions of the p150N domain and its putative sumoylated 
binding partners to the relationship between Ki-67 and p150 in regulating mitotic 
and interphase nuclear structure.   
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Figure 3.10:  p150 regulates Ki-67 localization throughout the cell cycle: a 
summary of dependency relationships 
 
(A):  HeLa S3 cells were stained with DAPI to visualize DNA (blue) and 
antibodies against Ki-67 (green) to demonstrate Ki-67 staining patterns 
throughout the cell cycle.  (B):  Hierarchy of known proteins controlling 
localization to the perichromosomal layer during mitosis.  Proteins dependent on 
Ki-67 include pescadillo (PES-1; Sobecki et al. 2016), as well as nucleolin (NCL), 
NIFK, and the cPERPs (Booth et al., 2014). (C):  p150 is required for Ki-67 
localization to punctate foci during early G1 (Figure 3.8).  (D):  p150N is required 
for localization of the Ki-67 protein and NAD loci to nucleoli during interphase 
(Smith et al., 2014). 
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Figure 3.10:  p150 regulates Ki-67 localization throughout the cell cycle: a 
summary of dependency relationships 
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3.5:  Materials and Methods 
3.5.1:  Cell culture 
HeLa S3 cells containing the Trex CMV/TO promoters driving either sh-
Luc or sh-p150 expression (Campeau et al., 2009) were maintained in RPMI 
media with 5% tetracycline-free fetal bovine serum (FBS), 2 mM L-glutamine, 
and antibiotic/antimycotic solution (Life Technologies).  shRNA expression was 
induced by supplementing media with 2 µg/mL doxycycline for 72 hours prior to 
fixation or processing.  Mitotic cells were enriched by adding 100 ng/mL 
nocodazole for 12 hours (hours 60-72 of the doxycycline treatment) and then 
freed from the cell culture flask surface by vigorous shaking.  To enrich for early 
G1 cells, shaken mitotic cells were washed three times with PBS, plated onto 
poly-lysine coated cover slips in drug-free media, and samples were taken at 
specified time points.  HeLa cells continuously expressing the V5-tagged p150 
transgenes (Smith et al., 2014) were maintained in DMEM and supplemented 
with 10% FBS, 2 mM L-glutamine, and antibiotic/antimycotic solution (Life 
Technologies).  RPE1-hTERT cells (a generous gift from Judith Sharp) were 
maintained in 50:50 DMEM-F12 media supplemented with 10% FBS, 7.5% 
sodium bicarbonate, 2 mM L-glutamine, and antibiotic/antimycotic solution (Life 
Technologies).   
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3.5.2:  Depletion Reagents 
For lentiviral depletion (Smith et al., 2014), cells were infected at MOI = 
7.5 with 6 µg /mL polybrene for 72 hours.  Lentivirus reagents were synthesized 
as previously described (Campeau et al., 2009; Smith et al., 2014). esiRNA 
reagents were generated as previously described (Fazzio et al., 2008; Smith et 
al., 2014), using primers listed in Table 2 to generate dsRNA.  For esiRNA 
transfection, 500 ng of siRNAs were transfected in 1 ml Opti-MEM (Life 
Technologies) with 6 µl of Oligofectamine (Life Technologies). After 6.5 h, 2.5 ml 
of media was added on top of the transfection cocktail and cells were processed 
after 72 hours. For synthetic siRNA transfection, 10 µL of 5 µM scramble 
(Ambion, AM4611) or Ki-67 (Ambion, Catalog #4392420-s8796) siRNAs were 
diluted in 400 µL Opti- MEM (Life Technologies) with 5 µL RNAiMAX (Invitrogen) 
and incubated at room temperature for 10 minutes.  The siRNA cocktail was then 
slowly added to 6-well dishes containing 800 µL Opti-MEM, and 6 hours later 2.5 
mL of appropriate media (lacking antibiotics) was added.  Note that the esiRNA 
directed against Ki-67 targets the Ki-67 repeat region within exon 13 while the 
synthetic siRNA targets nucleotides 559-577 (CGUCGUGUCUCAAGAUCUAtt) 
within exon 6.
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Table 3.1:  Primers for esiRNA synthesis  
 
This table shows the forward and reverse primers used for generating PCR 
fragments to particular targets used in Chapter III.  These amplified targets were 
eventually in vitro transcribed and digested using RNAse III in order to make 
esiRNA depletion reagents.
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Table 3.1:  Primers for esiRNA synthesis 
 
Target Forward Primer Reverse Primer 
Luciferase gcgtaatacgactcactataggAACAAT
TGCTTTTACAGATGC 
gcgtaatacgactcactataggAGGCAGA
CCAGTAGATCC 
NCL gcgtaatacgactcactataggGCGAC
GAAGATGATGAAGATGA 
 gcgtaatacgactcactataggGTGAGTT
CCAACGCTTTCTCC 
Ki-67 gcgtaatacgactcactataggGTGCTG
CCGGTTAAGTTCTCT 
gcgtaatacgactcactataggGCTCCAAC
AAGCACAAAGCAA 
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 3.5.3:  Immunofluorescence and Immuno-FISH 
Cells were plated on poly-lysine (Sigma) coated coverslips for 24 hours 
prior to manipulation.  For immunofluorescence experiments, fixation and 
permeabilization was performed in 6-well tissue culture dishes to minimize 
displacement of mitotic cells.  After aspiration of media, cells were immediately 
fixed with 4% paraformaldehyde/PBS for 10 minutes at room temperature.  Cells 
were then gently washed with ice-cold PBS and permeabilized with 0.5% Triton 
TX-100/PBS on ice for 5 minutes.  Cells were then washed twice with room 
temperature PBS and then incubated in blocking buffer (1% BSA/PBS) for 5-30 
minutes in a 37 °C humid chamber.  After blocking, cells were incubated with 
primary antibody in blocking buffer for 2 hours in a 37 °C humid chamber.  
Coverslips were then transferred to Coplin jars and washed three times with PBS 
on a rotating platform for 10 minutes at room temperature.  After washing, cells 
were incubated with secondary antibody in blocking buffer for 1 hour in a 37°C 
humid chamber.  Coverslips were then transferred to Coplin jars and washed 
three times with PBS on a rotating platform for 10 minutes at room temperature.  
After the final washing step, cells were transferred to a Coplin jar containing 
DAPI (50 ng/mL) in PBS for 2 minutes.  Coverslips were mounted with Vecta 
Shield (Vector Labs) and images were taken on a Zeiss Axioplan2 microscope 
with a 63x objective.  Corrected Total Cell Fluorescence (CTCF) was quantified 
using the Image J “measure” feature and background subtracted from an area of 
the image without a cell.  Images were all captured using the same exposure 
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time across 3 biological replicates, and the unpaired Student’s t-test was used to 
generate p-values. Immuno-FISH was performed as previously reported (Smith 
et al., 2014).  Association percentages for each of the three biological replicates 
were transformed into arcsine units and the unpaired Student’s t-test was used 
(with Welch’s correction) to generate p-values. P-values < 0.05 were considered 
statistically significant. All statistical analysis was performed using Graphpad 
Prism 6. 
 
 155 
Table 3.2:  Antibodies used for immunofluorescence and western blotting 
 
This table shows the origin and dilution of every antibody used in Chapter III.  
Note that the dilution is dependent on the application of the antibody, and that 
western blot dilutions are greater than that of immunofluorescence. 
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Table 3.2:  Antibodies used for immunofluorescence and western blotting 
 
Epitope Species Manufacturer Catalog # Immunofluorescence 
Dilution  
Western 
Blot 
Dilution 
Fibrillarin Rabbit Abcam Ab5821 1:500 1:2000 
H3S28ph Mouse 
(Clone 
HTA28) 
Sigma H9908 1:100  
Ki-67 Rabbit Abcam Ab66155 1:500 1:2000 
NCL Mouse 
(Clone 
364-5) 
Abcam Ab136649 1:250 1:1000 
p150 Rabbit (Campeau et 
al., 2009) 
  1:2000 
p150 Mouse 
(ss1) 
(Smith and 
Stillman, 
1991) 
 1:500  
p150 Mouse 
(ss48) 
(Smith and 
Stillman, 
1991) 
 1:500  
Phospho-
Ki-67 
Rabbit (Takagi et al., 
2014) 
  1:5000 
V5 Mouse Thermo R960-25 1:1000 1:2000 
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3.5.4:  Nuclease Digestion  
RPE1-hTERT cells were utilized for these experiments rather than HeLa 
cells because they are sufficiently adherent during detergent permeabilization/ 
nuclease digestion/ high salt extraction.  Nuclease digestion was performed as 
previously reported (Sheval and Polyakov, 2008), with some modification.  Cells 
were plated onto poly-lysine coated coverslips in 6-well dishes at least 24 hours 
before manipulation, and all subsequent steps were performed with solutions 
containing 100 µM PMSF. Cells were washed once with Digestion buffer (10 mM 
Tris-HCl, pH 7.6, 5 mM MgCl2, 1 mM CuSO4), then incubated in 1% Triton TX-
100/ Digestion buffer for 10 minutes at 4 °C.  Cells were then gently washed with 
digestion buffer and incubated in 100 µg/ml DNase I/ Digestion buffer, 100 µg/ml 
RNAse A/ Digestion buffer, or mock digested (“untreated”) in Digestion buffer in a 
37°C humid chamber for 30 minutes. Proteins were then extracted by incubating 
for 10 minutes in Extraction buffer (2M NaCl, 10 mM EDTA, 20 mM Tris-HCl, pH 
7.6) at 4°C.  Cells on coverslips were immediately fixed as described above, or 
RNA samples were processed using Trizol (Invitrogen).  Briefly, 1 mL Trizol was 
added directly to the plate and cells were homogenized by pipetting.  After 
incubating for 5 minutes at room temperature, samples were stored at -80 °C 
until further processing.  After thawing, 200 µL Chloroform was added and 
samples were shaken vigorously for 15 seconds before incubation at room 
temperature for 2 minutes.  Samples were then centrifuged at 13000 x g for 15 
minutes at 4 °C.  The aqueous phase was transferred to a fresh tube and 1 
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volume of isopropanol was added and mixed well by vigorous shaking.  Samples 
were then incubated at room temperature for 10 minutes before centrifugation at 
13000 x g for 15 minutes at 4 °C.  Samples were then washed with 75% ethanol 
and resuspended with nuclease-free water.  10% of recovered samples were run 
on a 1% agarose gel to compare RNA digestion efficiency.  Early G1 cells were 
selected by choosing pairs of cells which appeared significantly smaller than 
surrounding cells and featured hundreds of Ki-67 foci (Croft et al., 1999; Isola et 
al., 1990; du Manoir et al., 1991).  Line scans were performed using the RGB 
Profiles Tool plugin for Image J. 
 
3.5.5:  Western blotting 
15 µg of protein were loaded and run through a either Tris-HCl 
polyacrylamide gradient gel (20-5%) for asynchronous samples, or through a 
NuPAGE™ Novex™ 3-8% Tris-Acetate Protein Gel (Thermo Fischer) for 
mitotically-arrested samples.  Protein samples were then transferred to a PVDF 
membrane at 20 volts for 17 hours at 4°C in order to maximize the transfer of 
high molecular weight Ki-67.  Chemiluminescence was acquired using the Biorad 
ChemiDoc system, and quantified using Biorad Image Lab V 5.2.1
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CHAPTER IV:  UTILIZATION OF CRISPR/CAS9 GENE EDITING 
TECHNOLOGY TO GENERATE CELL LINES EXPRESSING ENDOGENOUS, 
EPITOPE-TAGGED KI-67 FOR FUTURE STUDIES 
 
4.1:  Abstract 
CAF-1 p150 and Ki-67 both regulate the structure of the human nucleus 
throughout the cell cycle.  Both proteins regulate the localization of 
heterochromatic satellite repeats to the periphery of the nucleolus during 
interphase, and the structure of the PCL during mitosis.  Despite extensive 
research exploring the nature of each protein, no study has yet explored the 
genome-scale localization of p150 or Ki-67 in a cell-cycle dependent manner.  In 
the case of Ki-67, several obstacles exist in mapping genome-scale enrichment, 
notably the lack of commercially available antibodies able to IP the Ki-67 protein.  
In this Chapter we will describe the use of CRISPR/Cas9 genome editing 
technology to integrate a fluorescent protein and epitope into the endogenous Ki-
67 locus.  This insertion does not perturb the localization of Ki-67 throughout the 
cell cycle, and allows for the quantitative IP of the endogenous protein. This cell 
line will be a valuable tool in studying Ki-67 genome-wide enrichment in the 
future, and demonstrates that CRISPR/Cas9 technology can be used to 
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overcome obstacles that have traditionally hindered progress in performing 
molecular biology research.   
 
4.2:  Introduction  
Chapters II and III demonstrated that p150 and Ki-67 are required for the 
localization of some NAD elements to the nucleolar periphery (Matheson and 
Kaufman, 2016; Smith et al., 2014).  In order to better understand the full extent 
of each protein’s role in regulating nuclear structure, chromatin 
immunoprecipitation coupled with high throughput next generation deep 
sequencing (ChIP-seq) should be performed to identify the precise genomic 
localizations of each protein during the cell cycle.  In addition to possibly opening 
new avenues of exploration involving these proteins, these experiments will also 
help to confirm several previously proposed hypotheses.  For example, in 
Chapter III we provided evidence that p150 co-localizes with hundreds of 
punctate Ki-67 foci early in G1 of the cell cycle (Matheson and Kaufman, 2017).  
We hypothesized that these foci are bound to heterochromatic satellite repeats in 
early G1, and that p150 and Ki-67 guide these elements to the nucleolar 
periphery in order to reestablish heterochromatin domains after cellular division.  
p150 already has a well-established role in regulating heterochromatin structure, 
including localizing HP1 (Houlard et al., 2006; Huang et al., 2010; Murzina et al., 
1999; Quivy et al., 2004, 2008; Roelens et al., 2016) and replicating H3K9me3 
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(Loyola et al., 2009; Sarraf and Stancheva, 2004; Uchimura et al., 2006), and 
therefore may play a role in localizing heterochromatin domains within the 
nucleus.   In support of this hypothesis, previous studies have shown that early 
G1 foci of Ki-67 co-localize with satellite repeats, such as centromeric alpha 
satellite, telomeric repeats, and Sat III (Bridger et al., 1998), all of which are 
highly enriched within mapped NAD data sets (Dillinger et al., 2016; van 
Koningsbruggen et al., 2010; Németh and Längst, 2011; Németh et al., 2010).  If 
we were able to perform ChIP-seq for Ki-67 in cells synchronized in early G1, 
late G1, and G2, we could directly test this hypothesis by comparing the overlap 
between data sets.                     
However, difficulties in performing ChIP-seq with Ki-67 arise due to the 
lack of high quality, commercially available Ki-67 antibodies suitable for IP.  This 
may be due in part to the large size of the Ki-67 protein isoforms (345 and 395 
kDa) (Figure 4.1) and their notable sensitivity to proteolysis (Schluter et al., 
1993).  One study reported the ChIP of Ki-67 using an monoclonal antibody they 
developed to target the 9th exon of Ki-67 (Bullwinkel et al., 2006).  While this 
study successfully showed enrichment of Ki-67 on areas within the rDNA, the 
enrichment was relatively poor (0.008% IP vs. 0.002% nonspecific) and only 
examined a few repetitive elements.  However, with the development of 
CRISPR/Cas9 genome editing technology, we now have the ability to engineer 
the insertion of a ChIP-compatible epitope within the endogenous Ki-67 gene. 
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Clustered regularly interspaced short palindromic repeats (CRISPRs) and 
CRISPR associated proteins (Cas) have been mapped to the genomes of 
hundreds of different archaea and bacteria species.  In 2005, three separate 
groups discovered these sequences were also present in the genomes of 
bacteriophages (Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 2005), 
leading to the hypothesis that CRISPRs were part of a bacterial adaptive immune 
system.  While three different versions of this immune system have so far been 
described (reviewed in (Bhaya et al., 2011)), type II has been adapted to 
selectively edit the genomes of organisms from yeast to humans (reviewed in 
(Singh et al., 2017)).  The CRISPR type II system has been widely adopted due 
to its simplicity, requiring only a 20 nucleotide short guide RNA (sgRNA) and the 
sgRNA-directed endonuclease Cas9 in order to induce double stranded breaks 
(DSBs) at target DNA sequences (Cong et al., 2013; Garneau et al., 2010; 
Gasiunas et al., 2012; Jinek et al., 2012; Mali et al., 2013).  The sgRNA directs 
homology-dependent dsDNA cleavage by Cas9 at 3 nucleotides from the 
terminal end of the protospacer associated motif (PAM) (Gasiunas et al., 2012).  
In order to selectively edit the endogenous genome, a repair template is 
introduced with homology to the genome and mutations where desired.  After 
cleavage near the PAM sequence occurs, the DSB is repaired using either the 
non-homologous end joining (NHEJ) or homology-directed repair (HDR) 
pathways. In the event that HDR is used to resolve the DSB, the mutated repair 
template may be utilized, resulting in the incorporation of the desired mutations 
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directly into the genome.  Through CRISPR/cas9 genome editing technology, we 
proposed to incorporate a ChIP-compatible epitope into the endogenous Ki-67 
gene in order to facilitate further study of this protein.   
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Figure 4.1:  Diagram of isoform 1 (395 kDa) of Ki-67   
Ki-67 contains an FHA domain near its N-terminus (red), a PP1 binding site 
(orange), 16 different Ki-67 canonical repeat domains (green), and a C-terminal 
LR domain.  Amino acid (aa) locations for each domain are given for Ki-67 
isoform 1, however isoform 2 also contains all of the  domains described within 
the diagram. (Schluter et al., 1993)
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Figure 4.1:  Diagram of isoform 1 (395 kDa) of Ki-67   
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4.3:  Results  
4.3.1:  Design of repair template 
We first decided to edit the genome of the HeLa S3 cell because many of 
our previous studies regarding Ki-67 and p150 have been performed in this line 
(Matheson and Kaufman, 2016; Smith et al., 2014).  We chose to use the epitope 
3xV5 (henceforth referred to as V5) because we have successfully used this 
epitope previously for both IP and IF. A gene encoding a fluorescent molecule 
was also added to the repair template, in order to facilitate future microscopy 
studies, and to allow for FACS-mediated isolation of tagged clones.  The 
fluorescent protein mCherry was selected due to its photostability compared to 
other monomeric fluorescent proteins (Shaner et al., 2004).  However, due to the 
repetitive nature of the DNA sequence encoding mCherry, several silent 
mutations were introduced across the gene in order to decrease the overall 
repetition of the repair template, as repetitive elements can hinder synthesis.  A 
short (Gly-Gly-Ser-Gly)x2 linker between the Ki-67 protein and the mCherry-V5 
insert was used in order to decrease the probability of interfering with Ki-67 
function.  The C-terminal LR domain is required but not sufficient for localization 
to both nucleolar chromatin and the PCL (Cuylen et al., 2016; Saiwaki et al., 
2005) and so we decided to insert the mCherry_V5 tag at the C-terminal end of 
the protein before the stop codon (Figure 4.2).  We used the Zhang lab (MIT) 
optimized guide RNA CRISPR design algorithm (http://crispr.mit.edu/) (Xu et al., 
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2015) to identify several potential guide RNAs near the beginning of the 3’UTR of 
Ki-67.  Once sgRNAs were chosen, silent mutations were made within the repair 
template at the PAM sequence and sgRNA region in order to decrease continued 
Cas9 cleavage after successful integration of the repair template.  
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Figure 4.2:  Diagram of mCherry_V5 insert  
This Diagram shows part of the repair template used to edit the C-terminus of Ki-
67.  The endogenous protein-coding region appears in capital letters, the PAM 
sequence is underlined and highlighted in yellow, the rest of the guide RNA is 
highlighted in green, the short  (Gly-Gly-Ser-Gly)x2 linker is highlighted in light 
blue, the modified mCherry is highlighted in red, and the V5 epitope is highlighted 
in magenta.  Note that the endogenous stop TGA codon was moved to the end of 
the C-terminal insert.   
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Figure 4.2:  Diagram of repair template  
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4.3.2:  Isolation and confirmation of homozygous insert clones 
 HeLa S3 cells were transfected with plasmids containing Cas9, the C-
terminal targeting sgRNA, and the repair template described in the previous 
section.  After two days of puromycin selection in order to remove non-
transfected cells, mCherry-positive single cells were sorted into a 96-well plate.  
These cells were expanded until enough cells could be used for IF screening.  
Cells were plated onto lysine-coated coverslips in order to maintain attachment of 
mitotic cells, fixed, permeabilized, and then stained with an antibody directed 
against the V5 epitope.  The 11 fastest growing clones were screened first in 
order to gauge the localization of the mCherry and V5 signal.  Out of the 11 
clones, 3 showed mCherry/V5 signal within the cytosol, and 1 clone showed 
mCherry/V5 signal within the nucleus, suggesting random insertion of the repair 
template. The remaining 7 clones all showed mCherry and V5 co-localization 
within the nucleolus, suggesting successful insertion of the repair template into 
the C-terminal region of Ki-67.   
The brightest of these clones (Figure 4.3, A.) also showed that the repair 
template was homozygously inserted when the clone genomic DNA was 
examined via PCR (Figure 4.3, B.).  When screening by PCR, ideally primers 
should be positioned outside of the repair template.  This is to ensure that the 
PCR product does not originate from a random insertion of the repair template 
somewhere within the genome. However, due to the large size of the mCherry-
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V5 repair template (2 kb), PCR primers were designed to flank the C-terminal 
stop codon of Ki-67.  Although a PCR product of these primers could yield an 
amplification product from a non-specific insertion event, these primers would 
allow for the examination of the endogenous locus.  In lane 1 of the agarose gel 
in Figure 4.3 B., the parental line shows a single PCR product at 286 bp.  The 
PCR product in lane 2 appears to be around 1057 bp, the size of the expected 
amplification product of the locus with the mCherry-V5 insert.  Due to the lack of 
a 286 bp product in this lane, we can conclude that all endogenous Ki-67 loci 
underwent HDR.  When mitotic cells from this clone were observed in 
prometaphase, metaphase, and anaphase (Figure 4.4), the V5 and mCherry 
signal also co-localized at the PCL.  Together, these data indicate that this clone 
contains a homozygous insert of the repair template at all Ki-67 loci, and that the 
tagged Ki-67 localizes to its appropriate cell-cycle specific destinations.   
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Figure 4.3:  Isolation and validation of homozygously repaired clone 
(A):  Fluorescent microscopy images of a tagged (Ki-67_mCherry_V5) and 
untagged HeLa cell both in interphase.  These cells were stained with an 
antibody directed against V5 (green) and DAPI to detect DNA.  Note that in the 
HeLa (Ki-67_mCherry_V5) images the mCherry (red) and V5 signals co-localize 
at the nucleolus, while the untagged control images show no specific mCherry or 
V5 signal. Matched exposure times were used for each cell line.  Scale bar is 10 
µm.  (B):  2% Agarose gel showing PCR products from a reaction using primers 
flanking the insertion site of the repair template.  Untagged wild type DNA should 
result in a 286 bp product, while the (Ki-67_mCherry_V5) insert should yield a 
product of 1057 bp.  Note that the (Ki-67_mCherry_V5) lane has only PCR 
products around the 1057 size, suggesting that this clone features a homozygous 
insert of the repair template at all three Ki-67 gene loci.  
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Figure 4.3:  Isolation and validation of homozygously repaired clone  
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Figure 4.4:  Ki-67_mCherry_V5 localizes to the PCL during mitosis  
Immunofluorescent images of mitotic untagged HeLa cells and the HeLa (Ki-
67_mCherry_V5) clone from Figure 4.3. These cells were stained with an 
antibody directed against V5 (green) and DAPI to detect DNA.  Note that in the 
HeLa (Ki-67_mCherry_V5) images the mCherry (red) and V5 signals co-localize 
at the mitotic chromosomal periphery (presumably at the PCL), while the 
untagged control images show no specific mCherry or V5 signal localization. 
Matched exposure times were used for each cell line.    
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Figure 4.4:  Ki-67_mCherry_V5 localizes to the PCL during mitosis  
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4.3.3:  Immunoprecipitation of Ki-67 using the V5 epitope 
The homozygous-insert confirmed clone was next used to perform IP 
using an antibody directed against the V5 epitope.  400 μg of nuclear extract 
from the untagged parental cell line and the mCherry_V5 line were pre-cleared 
with beads, and then incubated with 2 μl of monoclonal anti-V5 antibody for 18 
hours.  After successive washing steps, bound protein was boiled off the beads 
in SDS-lysis buffer and run on a 20-5% gradient Tris-HCl gel.   In order to 
transfer the maximum amount of high molecular weight Ki-67 protein, the gel was 
transferred to a PVDF membrane at 20 volts for 17 hours at 4 °C.  When the 
blots were probed with a rabbit anti-Ki-67 antibody, high molecular weight Ki-67 
can be observed in both the input lanes for the untagged and tagged samples 
(Figure 4.5).  The untagged samples show robust signal in the unbound lane and 
virtually no high molecular Ki-67 signal in the bound lane, suggesting that the 
antibody does not IP untagged Ki-67.  The opposite is observed in the tagged 
samples:  the unbound lane shows some Ki-67 signal, however the signal in the 
bound lane is saturated.  This demonstrates that the anti-V5 antibody is sufficient 
to quantitatively IP endogenous Ki-67 protein in the mCherry_V5 cell line.  Future 
studies should next explore whether this cell line would be suitable for ChIP 
experiments, in order to determine the genomic enrichment of Ki-67 in a cell-
cycle specific manner.        
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Figure 4.5:  Immunopurification of Ki-67_mCherry_V5 
Western blot of the input (4%), unbound (4%), and bound (100%) fractions of an 
immunoprecipitation experiment performed with untagged HeLa cells and the (Ki-
67_mCherry_V6) clone shown in Figures 4.3 and 4.4.   Immunoprecipitation was 
performed using a V5 antibody (Thermo) and western blots probed with 
antibodies directed against Ki-67.  Note that the unbound fraction of the 
untagged cells features high molecular weight Ki-67 and no detectable Ki-67 
enrichment in the bound lane.  In contrast, the (Ki-67_mCherry_V5) unbound 
lane shows a depletion of Ki-67 signal and a saturation of high molecular weight 
Ki-67 signal in the bound lane.   
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Figure 4.5:  Immunopurification of Ki-67_mCherry_V5 
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4.4:  Discussion         
We have successfully used CRISPR/cas9 gene editing technology to 
introduce a mCherry_V5 epitope into the C-terminus of all endogenous Ki-67 loci 
in a cloned HeLa S3 cell line.  This insertion does not interfere with the 
endogenous localization of Ki-67 to the nucleolus during interphase, nor to the 
PCL during mitosis.  Further, the V5 epitope is sufficient to quantitatively IP 
endogenously-encoded Ki-67 protein, and future studies should focus on using 
this cell line to perform ChIP-seq in a cell-cycle dependent manner. 
During mitosis Ki-67 and p150 both localize to the PCL (Matheson and 
Kaufman, 2017; Verheijen et al., 1989b), a characteristic which could prove to be 
a valuable tool in further examining the structure of the condensed mitotic 
chromosomes.  Many labs have long explored the organization of the mitotic 
chromosomes (Bak et al., 1977; DuPraw, 1966; Marsden and Laemmli, 1979).  
However, it was not until the recent development of chromosome conformation 
capture coupled with high throughput next generation deep sequencing (Hi-C) 
(Belton et al., 2012; Lieberman-Aiden et al., 2009) that progress was made in 
mapping mitotic chromosome organization.  The Dekker lab performed Hi-C 
studies with HeLa cells arrested in metaphase and found that topologically 
associating domains (TADs) were not present within the condensed 
chromosomes (Naumova et al., 2013).  Through polymer model simulations, the 
Dekker lab hypothesized that the mitotic chromosomes are organized as a linear, 
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longitudinally compressed array of consecutive chromatin loops (Naumova et al., 
2013).  While this study revealed much about the macrostructure of the mitotic 
chromosome, there are still many questions to be answered.  One of these 
questions may be answered by performing ChIP-seq on Ki-67_mCherry_V5 in 
order to determine the loci frequently associated with the exterior of the 
condensed mitotic chromosomes.  We hypothesize that the exterior domains of 
the mitotic chromosomes are enriched for heterochromatic satellite elements that 
will eventually reassociate with the periphery of the nucleolus as NADs.  Studies 
have shown that both p150 and Ki-67 have minimal DNA-binding activity during 
prophase and metaphase due to hyperphosphorylation, but regain DNA-binding 
ability at the beginning of anaphase (Endl and Gerdes, 2000; MacCallum and 
Hall, 1999, 2000; Marheineke and Krude, 1998).  This process is better 
described for Ki-67: at the beginning of anaphase, Ki-67 recruits PP1γ to 
facilitate dephosphorylation, coinciding with a shift to an immobile state, and a 
reestablishment of DNA binding activity  (Endl and Gerdes, 2000; MacCallum 
and Hall, 1999; Saiwaki et al., 2005; Takagi et al., 2014b).  Therefore, 
synchronization protocols should be utilized to arrest cells in anaphase in order 
to capture chromatin interactions with Ki-67_mCherry_V5. 
Future studies should also use the reagents described within this chapter 
to tag endogenous Ki-67 in other cell lines, further exploring the role Ki-67 in 
regulating nuclear structure in noncancerous cells.  This chapter also 
demonstrates that CRISPR/cas9 technology can be used to overcome hurdles 
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which have traditionally hindered progress in studying the molecular functions of 
various proteins.  Future studies should continue to utilize CRISPR/cas9 to 
selectively mutate specific subdomains within Ki-67.  For example, Ki-67 contains 
an HP1 binding motif within its LR domain in the C-terminus (Kametaka et al., 
2002).  Since the NADs are enriched for heterochromatic satellite repeats, 
CRISPR/cas9 technology could be utilized to disrupt the HP1 binding motif and in 
order to determine if it is required for the localization of the NADs.  The speed, 
ease of use, and low cost of CRISPR/cas9 technology will allow future studies to 
rapidly investigate the molecular nature of Ki-67 and elucidate its role in 
regulating human nuclear structure.  
 
4.5:  Materials and Methods  
4.5.1:  CRISPR/cas9 design and reagents  
sgRNAs were designed using the Zhang lab (MIT) optimized guide RNA 
CRISPR design algorithm (http://crispr.mit.edu/) (Xu et al., 2015) and cloned in to 
the pX330_Puro plasmid (a gift from T. Fazzio) (Pyzocha et al., 2014).The 
sgRNA oligos were 5’-CACCGTTCACTGTCCCTATGACTTC-3’ and 5’-
AAACGAAGTCATAGGGACAGTGAAC-3’.  The repair template was purchased 
as a gBlock (Integrated DNA Technologies) and cloned into pCR2.1 (Thermo).  
The gBlock contained 774 bp coding the (mCherry_V5 insert), and 613 bp of 
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DNA homologous to the regions flanking either side of the Ki-67 stop codon 
(Figure 4.2).  The entire 2000 bp repair template is as follows:   
TCGGTAGTCCTAGAAAATGCATATATAAGATAGATTTTTTCCAGTAAGAAGCT
TGTAGCCATGCTTTTCACCATGGTTCCTCTCCCTTAGCCAAGGGGTGAGAAC
TACTGCAAGAGTAAAGGCCAAGGCAGGTCTCCTGCATGCAAGTTGGGCATG
CTTCTGTCTACAGGGGTTCCTTGGTTTAGGAGACCCAAAAGACTTAATCCTG
GTTGGATTCACTTTTTCTGAGTGACATTTTTTAGTTTGTGAAAATGTGTGCAT
CGATGAAGAAATTTTATTATGAATTAGCTTAAAAATGCATTAGGAACTTCTGT
ATGAAAAGATCACATTATTTAAGTGTAAAAAAACTGCATAATAAAAGCAGTTC
AAGTCAAGAAAAACAATGTTAATGGAATATATTTTAAAACTTATTTCCAACCT
CAAAATTAATTTTCTGCAACTAAGGACCTGCATAATACCTAGTAAGCCTTTGG
GGTTTTGCAGAGGAGGTCGATTCTAAAAATGGGTGTTTAAATTACTTAAGAG
TTCTATTTTTTTTCTTCCCACACAGGCTGAGGACAATGTGTGTGTCAAGAAAA
TAAGAACAAGGAGCCACAGAGATAGCGAGGATATTGGTGGTTCTGGTGGTG
GTTCTGGTGTGAGCAAAGGCGAAGAAGATAACATGGCGATTATTAAAGAATT
TATGCGCTTTAAAGTGCATATGGAAGGCAGCGTGAACGGCCATGAATTTGA
AATTGAAGGCGAAGGCGAAGGCCGCCCGTATGAAGGCACCCAGACCGCGA
AACTGAAAGTGACCAAAGGCGGCCCGCTGCCGTTTGCGTGGGATATTCTGA
GCCCGCAGTTTATGTATGGCAGCAAAGCGTATGTGAAACATCCGGCGGATA
TTCCGGATTATCTGAAACTGAGCTTTCCGGAAGGCTTTAAATGGGAACGCGT
GATGAACTTTGAAGATGGCGGCGTGGTGACCGTGACCCAGGATAGCAGCC
TGCAGGATGGCGAATTTATTTATAAAGTGAAACTGCGCGGCACCAACTTTCC
GAGCGATGGCCCGGTGATGCAGAAAAAAACCATGGGCTGGGAAGCGAGCA
GCGAACGCATGTATCCGGAAGATGGCGCGCTGAAAGGCGAAATTAAACAG
CGCCTGAAACTGAAAGATGGCGGCCATTATGATGCGGAAGTGAAAACCACC
TATAAAGCGAAAAAACCGGTGCAGCTGCCGGGCGCGTATAACGTGAACATT
AAACTGGATATTACCAGCCATAACGAAGATTATACCATTGTGGAACAGTATG
AACGCGCGGAAGGCCGCCATAGCACCGGCGGCATGGATGAACTGTATAAA
GGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGTGACAGAAAA
ATCGAACTGTTAAAAATATAATAAAGTTAGTTTTGTGATAAGTTCTAGTGCAG
TTTTTGTCATAAATTACAAGTGAATTCTGTAAGTAAGGCTGTCAGTCTGCTTA
AGGGAAGAAAACTTTGGATTTGCTGGGTCTGAATCGGCTTCATAAACTCCAC
TGGGAGCACTGCTGGGCTCCTGGACTGAGAATAGTTGAACACCGGGGGCT
TTGTGAAGGAGTCTGGGCCAAGGTTTGCCCTCAGCTTTGCAGAATGAAGCC
TTGAGGTCTGTCACCACCCACAGCCACCCTACAGCAGCCTTAACTGTGACA
CTTGCCACACTGTGTCGTCGTTTGTTTGCCTATGTCCTCCAGGGCACGGTG
GCAGGAACAACTATCCTCGTCTGTCCCAACACTGAGCAGGCACTCGGTAAA
CACGAATGAATGGATGAGCGCACGGATGAATGGAGCTTACAAGATCTGTCT
TTCCAATGGCCGGGGGCATTTGGTCCCCAAATTAAGGCTATTGGACATCTG
CACAGGACAGTCCTATTTTTGATGTCCTTTCCTTTCTGAAAATAAAGTTTTGT
GCTTTGGAGAATGACTCGTGAGCACATCTTTAGGGACCA 
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4.5.1:  Cell culture 
HeLa S3 cells were maintained in RPMI medium (Gibco) with 10% fetal 
bovine serum (FBS), 2 mM L-glutamine, and antibiotic/antimycotic solution (Life 
Technologies).  CRISPR/cas9 transfection protocol adapted from (Hainer et al., 
2016).  24 hours before transfection, 200,000 cells were plated into 6 well dishes.  
Two to four hours prior to transfection, medium was aspirated, cells were washed 
twice with PBS, and 1 mL antibiotic-free medium was pipetted over the cells. 
During transfection 3 μg pX330_Puro containing a sgRNA, 3 μg of pCR2.1 
containing the repair template, and 24 μl Fugene HD (Promega) was added to 
100 μl OptiMEM (Gibco) and incubated at room temperature for 10 minutes prior 
to slowly pipetting on top of the cells.  14-16 hours post transfection, cells were 
trypsinized and plated onto a 10-cm dish with serum-containing media.  48 hours 
post transfection, cells were washed twice with PBS and media containing 0.5 
μg/mL puromycin (Thermo) was pipetted over cells.  Cells were incubated in 
puromycin for an additional 48 hours, before being trypsinized and sorted by a 
BD FACSAria II Cell Sorter.  mCherry-positive single cells were sorted into 96-
well dishes in standard media, and expanded until enough cells could be used to 
screen via immunofluorescence. 
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4.5.2:  Immunofluorescence and microscopy   
 
Cells were plated on poly-lysine (Sigma) coated coverslips for 24 hours 
prior to manipulation.  For immunofluorescence experiments, fixation and 
permeabilization was performed in 6-well tissue culture dishes to minimize 
displacement of mitotic cells.  After aspiration of media, cells were immediately 
fixed with 4% paraformaldehyde/PBS for 10 minutes at room temperature in the 
dark.  All subsequent steps were performed in the dark as much as possible in 
order to avoid bleaching the mCherry signal.  Cells were then gently washed with 
ice-cold PBS and permeabilized with 0.5% Triton TX-100/PBS on ice for 5 
minutes.  Cells were then washed twice with room temperature PBS and then 
incubated in blocking buffer (1% BSA/PBS) for 5-30 minutes in a 37 °C humid 
chamber.  After blocking, cells were incubated with mouse anti-V5 antibody 
(1:1000 dilution, Thermo) in blocking buffer in a 37 °C humid chamber for 60 
minutes.  Coverslips were then transferred to coplin jars and washed three times 
with PBS on a rotating platform for 10 minutes at room temperature.  After 
washing, cells were incubated with donkey anti-mouse Alexa 488 secondary 
antibody in blocking buffer for 1 hour in a 37°C humid chamber.  Coverslips were 
then transferred to Coplin jars and washed three times with PBS on a rotating 
platform for 10 minutes at room temperature.  After the final washing step, cells 
were transferred to a Coplin jar containing DAPI (50 ng/mL) in PBS for 2 minutes.  
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Coverslips were mounted with Vecta Shield (Vector Labs) and images were 
taken on a Zeiss Axioplan2 microscope with a 63x objective 
 
4.5.3:  Isolation of genomic DNA and PCR 
In order to harvest genomic DNA for further PCR analysis, FACS-sorted 
clones in 96-well dishes were grown to approximately 75% confluency, before 
passaging and transferring three-quarters of the cells into a 24-well dish.  The 
remaining cells in the 96 well plate allowed to grow back to confluency, before 
trypsinization and transfer to a 1.5 ml eppendorf tube.  Cells were then 
centrifuged at 500 x g for 5 minutes at 4°C and resuspended in ice cold PBS.  
Cells were then centrifuged again before being resuspended in 200 μl in freshly 
made DNA digest buffer (100 mM Tris HCl pH = 8.0, 250 mM NaCl, 25 mM 
EDTA, 0.5% SDS, 1 mg/mL Proteinase K).  After thoroughly mixing the cells in 
the buffer, the Eppendorf tubes were placed in a 50 °C rotating chamber and left 
overnight.  The next morning, 200 μl of TE buffer was added to the Eppendorf 
tubes, before the addition of 400 μl of Phenol Chloroform isoamyl alcohol in a 
25:24:1 ratio (Thermo).  The cells were vortexed for 10 seconds before being 
centrifuged at 3000 x g for 10 minutes at room temperature.  The aqueous layer 
was then precipitated with 1/25 volume 5 M NaCl, 1.5 μl glycogen (Sigma, 20 
mg/mL), and 2.5 volumes of ethanol.  After 60 minutes at -20°C, the Eppendorf 
tubes were centrifuged at maximum speed for 20 minutes at 4°C.  The genomic 
DNA pellet was washed once with 80% ethanol before being briefly dried and 
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resuspended in 15 μl buffer TE.  Approximately 200 ng of genomic DNA was 
used per PCR reaction with primers 5’-TTGCAGAGGAGGTCGATTCT-3’ and 5’- 
ATTCAGACCCAGCAAATCCA-3’ to amplify a fragment flanking the stop codon 
of Ki-67.        
 
4.6.3:  Immunoprecipitation  
5 x106 untagged or (Ki-67_mCherry_V5) tagged HeLa cells were plated 
onto three 15-cm tissue culture plates.  The next day, cells were trypsinized, 
transferred to 50 ml conical tubes, and centrifuged at 1000 x g for 5 minutes at 
4°C.  Cells were successively washed with cold PBS and 5 mL hypotonic buffer 
(20 mM Hepes-KOH, pH 8.0, 5 mM KCl, 1.5 mM MgCl2) with 10 mM 
Iodoacetamide (IAA, Sigma).  Cells were then resuspended in 1 mL hypotonic 
buffer and transferred to a Cells were disrupted by 28 strokes of a B pestle 
(Wheaton, loose) by dounce homogenization. Nuclei were pelleted by 
centrifugation for 5 minutes at 1000 x g and washed with nuclei wash buffer (10 
mM NaCO3, 150 mM NaCl). The pellet was then incubated in nuclei with 
extraction buffer (15 mM Tris-HCl, pH 7.8, 1 mM EDTA, 400 mM NaCl, 10% 
sucrose, 0.1 mM PMSF, 1 mM DTT) for 30 mins in a rotating platform at 4 °C.  
Extracts were then clarified by ultracentrifugation at 100,000 x g for 60 minutes, 
and Bradford (BioRad) assays were performed to determine the protein 
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concentration of the nuclear extract.  Nuclear extracts were aliquoted into 500 μg 
and flash frozen in liquid nitrogen before storage at -80 °C. 
 For immunoprecipitation, 50 μl of protein A magnetic beads (NEB) were 
used per 400 μg of nuclear extract.  The beads were first transferred to a lobind 
tube (Eppendorf) and washed three times with A200 buffer (25 mM Tris pH 7.5, 1 
mM EDTA, 200 mM NaCl, 0.01% NP-40, 10 mM IAA, 0.1 mM PMSF).  During 
the washing steps, a vial of aliquoted nuclear extract was thawed on ice, and 
then 10% (50 μg) was set aside to serve as an input sample.  A200 and A0 (25 
mM Tris pH 7.5, 1 mM EDTA, 0 mM NaCl, 0.01% NP-40, 10 mM IAA, 0.1 mM 
PMSF) was added to 400 μg of nuclear extract until a final concentration of 200 
mM NaCl was achieved.  This diluted nuclear extract solution was then 
transferred to a Lobind tube containing half of the beads (25 μl) and rotated for 
30 minutes at 4 °C in order to pre-clear the solution.  The pre-cleared solution 
was then transferred to the remaining 25 μl of beads with 2 μl mouse anti-V5 
antibody (Thermo) and rotated overnight at 4 °C.  The next morning, 10% of the 
solution was reserved to serve as the “unbound” sample.  The beads were 
washed six times with A200 buffer for 5 minutes at 4 °C.  After the sixth wash, the 
beads were resuspended in 25 μl 2X SDS lysis buffer (100 uM Tris HCl pH 6.8, 
4% SDS, 12% glycerol, 2% 2-mercaptoethanol, 0.008 bromophenol blue) and 
boiled for 5 minutes.  4% of the input samples, 4% of the unbound, and 100% of 
the bound samples were loaded onto a Tris-HCl polyacrylamide gradient gel (20-
5%).  Protein samples were then transferred to a PVDF membrane at 20 volts for 
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17 hours at 4°C in order to maximize the transfer of high molecular weight Ki-67, 
and were sequentially blotted for Ki-67 (Abcam, Ab66155, 1:2000 dilution) and 
p150 ((Campeau et al., 2009), 1:2000 dilution). 
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CHAPTER V: DISCUSSION 
 
5.1:  Scientific Questions Addressed by this Dissertation  
This dissertation attempted to answer a fundamental question of cellular 
biology: how is nuclear structure reestablished after cellular division?  At the 
beginning of mitosis, nuclear structure is dramatically altered as chromatin is 
condensed in order to facilitate equal distribution of genetic material to daughter 
cells.  At the beginning of telophase, chromatin decondensation is initiated and 
the nucleus begins the process of reestablishing interphase nuclear structure.  
One critical sub-nuclear structure which is disassembled during mitosis and 
reassembled de novo after cytokinesis is the nucleolus (reviewed in (Hernandez-
Verdun, 2011).  The nucleolus is comprised of thousands of different proteins 
and RNAs organized around the nucleolus organizer regions (NORs) of the five 
acrocentric chromosomes in human (reviewed in (Pederson, 2011; Sirri et al., 
2008)).  In addition to the NORs, thousands of distinct regions within the genome 
make contact with the nucleolar periphery and are called nucleolar associated 
domains (NADs) (Dillinger et al., 2016; van Koningsbruggen et al., 2010; Németh 
et al., 2010; Pontvianne et al., 2016).  The NADs are enriched for satellite 
heterochromatin and the purpose of their localization to the perinucleolar (PN) 
region is hypothesized to maintain the transcriptionally silenced state within these 
loci (reviewed in (Matheson and Kaufman, 2015; Padeken and Heun, 2014)).       
This dissertation specifically explored how heterochromatin-rich NAD loci 
are localized to the PN region at the beginning of a new cell cycle.  In the 
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process of trying to answer this question, I discovered that proteins p150 and Ki-
67 play a critical role in regulating the localization of some NADs.  This discovery 
yielded many more questions:  Where does p150 localize throughout the cell 
cycle?  Do p150 and Ki-67 co-localize at specific phases of the cell cycle?  Which 
domains within the p150 protein regulate NAD and Ki-67 localization?  In the 
following chapter I will discuss experimental results which may answer these and 
other questions, put these results in the context the published literature, and 
discuss how future studies can build upon these results.  
 
5.2:  Summary of Major Results and Conclusions 
5.2.1:  p150 regulates the localization of some NADs 
Immunoprecipitation of p150 and identification of novel binding partners 
via mass spectrometry (Co-IP-MS) revealed that p150 interacts with several 
nucleolar proteins (Table 2.1).  Since many of these proteins are responsible for 
shuttling protein and RNA across the nucleolar border, it was hypothesized that 
p150 may also be responsible for nucleolar protein localization. As predicted, 
upon depletion of p150 in some cancer cell lines, several p150-interacting 
nucleolar proteins are mislocalized to the nucleoplasm (Figure 2.3 and 2.4).  
However, p150 is not required for the nucleolar localization of every novel 
binding partner, as p150 depletion fails to mislocalize the pre-ribosomal rRNA 
processing protein FBL (Figure 2.3 and 2.4).  Additionally, the localization of the 
rDNA arrays within the NORs do not appear to change upon p150 depletion, 
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suggesting that the macrostructure of the nucleolus remains stable upon p150 
depletion (Videos 1.1 and 1.2).   In order to determine if NAD localization is 
regulated by p150, DNA FISH-IF was utilized to examine the localization of 
several NAD elements in relation to the nucleolus as marked by FBL staining.  
The NADs examined included the 5S rDNA array on chromosome 1, the D4Z4 
macrosatellite array on chromosome 10, and the centromeric alpha satellite 
region of chromosome 17.  The localization of each NAD decreased by 
approximately 50% upon depletion of p150, while a control region on 
chromosome 10 previously reported to have little association with the nucleolus 
showed no change in association (Figure 2.14). 
There are several possibilities as to how p150 regulates NAD localization.  
The first is that p150 regulates NAD localization in conjunction with replication of 
heterochromatin during mid and late S-phase of the cell cycle.  The NADs are 
highly enriched for heterochromatin silencing marks, including H3K9me3 (van 
Koningsbruggen et al., 2010; Németh et al., 2010), of which p150 also has a 
well-established role in replicating during chromatin assembly (Loyola et al., 
2009; Reese et al., 2003; Sarraf and Stancheva, 2004).  It is possible that 
depletion of p150 interferes with replication of heterochromatin silencing marks 
within the NADs, resulting in mislocalization of NAD loci away from the PN 
region.  However, domain-analysis of p150 showed that the N-terminal 310 
amino acids (p150N) is necessary and sufficient to maintain normal rates of NAD 
association (Figure 2.15).  p150N is dispensable for chromatin assembly, as the 
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C-terminal region of the protein acts as the scaffold for p60 and p48 interaction 
(Kaufman et al., 1995).  It is therefore probable that p150 regulates NAD 
localization outside the context of chromatin assembly, but there are several 
caveats to consider before drawing such a conclusion.  Although p150N cannot 
perform chromatin assembly independently, we currently have no evidence that it 
cannot participate in chromatin assembly.  It is possible that the N-terminus can 
still associate with replication foci during S-phase, as it contains a PCNA 
interacting peptide (PIP) (Rolef Ben-Shahar et al., 2009).  Another caveat to 
consider is that these experiments occur in a depletion setting of p150, meaning 
there are still residual p150-containing CAF-1 complexes within the cells.  This 
baseline amount of p150-containing CAF-1 is enough to maintain relatively 
normal cell growth rates, including chromatin assembly, in cancer cell lines. This 
may also allow p150N to associate with CAF-1 containing replication foci during 
S-phase and successfully replicate heterochromatin marks within the NAD 
elements. In order to rule out this possibility, experiments should be performed to 
determine if p150N can independently localize to replication forks during S-
phase.  If p150N can independently localize the replication forks, new cells lines 
will need to be generated using CRISPR/cas9 in order to mutate endogenous 
regions within p150.  Another possible mechanism is that p150 may act as a 
shuttle of NAD elements to the nucleolar periphery at the beginning of the cell 
cycle.  If p150N cannot localize to replication-foci during S-phase, then this 
mechanism seems plausible and likely.   
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5.2.2: The SIM within p150N regulates NAD localization  
In order to determine which domains within p150N are important for 
regulating NAD localization, HeLa cells expressing full length transgenes of p150 
were generated with mutations within three distinct motifs within the N-terminus.  
These mutations disrupted a HP1 binding domain, a PIP box, and a sumoylation 
interacting motif (SIM).  Only the cell line expressing the SIM mutation failed to 
rescue NAD localization upon depletion of endogenous p150, suggesting that the 
SIM is required for regulating the localization of NADs (Figure 2.16).  Additionally, 
depletion of SUMO2 or the SUMO E2 ligase UBC9 disrupted NAD localization, 
suggesting that the interaction of p150 with a sumoylated protein may facilitate 
NAD localization.   
Two questions remain to be answered in order to further our knowledge of 
this mechanism:  what is the identity of the sumoylated protein or proteins 
interacting with p150, and when do these interactions occur?  The process of 
identifying the sumoylated binding partners of p150 can be accomplished by 
performing Co-IP-MS in cell lines in which the SIM has been mutated using 
CRISPR/cas9 genome editing, and comparing it to a control cell line which lacks 
these mutations.  Novel binding partners bound to the control line, but not the 
SIM mutant line, could be further analyzed to confirm that the interaction is 
facilitated through interaction of SUMO with the SIM within p150N.  These 
experiments should be performed in the presence of cysteine protease inhibitors 
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in order to inhibit the action of SUMO specific proteases (SENPs), which can 
often catalyze de-conjugation of SUMO proteins during cell lysis (reviewed in 
(Kumar and Zhang, 2015)).  Since the original Co-IP-MS experiment which 
identified novel p150-interacting proteins failed to include cysteine protease 
inhibitors (Table 2.1), the possibility remains that the sumoylated p150-interacting 
protein or proteins may not be included within these results.   
Several studies have shown that the SIM within p150N has an important 
role during S-phase of the cell cycle.  One study demonstrated that p150 
depletion or ablation of the p150N SIM inhibits recruitment of SUMO2/3-
conjugated proteins to replication foci (Uwada et al., 2010). Another showed that 
p150 directly interacts with sumoylated MBD1, and that this interaction is 
required for the replication of heterochromatin silencing marks and localization of 
HP1 (Uchimura et al., 2006).  Since MBD1 is the only known sumoylated protein 
which directly interacts with p150, studies should examine whether MBD1 
depletion can reproduce NAD mislocalization.  It is crucial to identify when 
sumoylated proteins interact with p150 in regulating NAD localization in order to 
determine if this mechanism is directly tied to chromatin assembly during S-
phase.  If the sumoylated p150-interacting protein has been identified through 
MS, a straightforward method would be to synchronize cells at various phases of 
the cell cycle and probe whole cell lysates to determine when the p150-
interacting protein is sumoylated.  The possibility also remains that this 
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interaction could occur at several points during the cell cycle, and so further 
experiments described in the following sections would be required.    
 
5.2.3:  Ki-67 regulates NAD localization 
In order to discover other proteins involved in p150-mediated regulation of 
NAD localization, novel p150-interacting proteins identified in the IP-MS 
experiments were further analyzed (Table 2.1).  These proteins were depleted in 
HeLa cells and then the association rates of the alpha satellite on chromosome 
17 with the nucleolus were compared to control cells (Figure 3.1).  Depletion of 
the most abundant protein discovered in the Co-IP-MS experiments, Ki-67, was 
also found to reduce the association of the alpha satellite NAD in a manner 
similar to that of p150 depletion (Figure 3.1, A and B).  Conversely, upon NCL 
depletion the association of the NAD increased.  In addition, the morphology of 
the nucleolus was altered upon NCL depletion:  FBL signal became more 
dispersed, but still maintained a clear and distinct boundary with the nucleoplasm 
(Figure 3.1, A and B).  This suggests that disruption of nucleolar macrostructure 
cannot recapitulate the decrease NAD association observed during p150 and Ki-
67 depletion, and that an increase in nucleolar surface area may correlate with 
an increase in NAD localization.  Of note, both Ki-67 and NCL nucleolar 
localizations are also regulated by p150 (Figures 2.3 and 2.4).  The SIM within 
p150N is specifically required for the nucleolar localization of Ki-67 (Figures 2.6, 
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2.8, and 2.9), suggesting that p150 may be acting upstream of Ki-67 in regulating 
NAD localization. 
Like p150, Ki-67 has a well-established role in regulating heterochromatin 
structure, but the mechanism of this regulation is ill-defined.  Ki-67 directly 
interacts with HP1 within its C-terminus LR domain (Figure 4.1) (Kametaka et al., 
2002), and overexpression of Ki-67 homologs in human cells induces the 
formation of dense ectopic heterochromatin regions (Sobecki et al., 2016; Takagi 
et al., 1999).  Depletion of Ki-67 results in the relocalization of H3K9me3 
heterochromatin domains within the nucleus, and the disruption of centromere 
and rDNA NOR localization with the nucleolus (Booth et al., 2014; Sobecki et al., 
2016).  Several classes of genes enriched within the NADs show increased 
expression after Ki-67 depletion, further suggesting that Ki-67 may regulate both 
the localization and transcriptional silencing of NAD elements (Sobecki et al., 
2016).   While Ki-67 may be a prime suspect as the sumoylated p150-interacting 
protein, only one study has also shown that Ki-67 is sumoylated at lysine 1517 in 
response to heat shock (Golebiowski et al., 2009).  Future studies should attempt 
to Co-IP p150 and Ki-67, with and without SENP digestion in order to gauge the 
importance of sumoylation in facilitating this interaction.  If Ki-67 is confirmed to 
be the sumoylated protein interacting with p150 in facilitating NAD localization, 
future studies should also attempt to identify the precise sumoylation site, and 
the phase of the cell cycle during which this interaction occurs.  CRISPR/cas9 
 197 
could be utilized to mutate these endogenous sites in order to gauge nucleolar 
localization of Ki-67, as well as localization of NAD elements.   
 
5.2.4:  p150 localizes to distinct Ki-67 foci during early G1 of the cell cycle 
After cytokinesis and early in G1, Ki-67 localizes to hundreds of distinct 
foci (Verheijen et al., 1989a) which co-localize with heterochromatin satellite 
repeat elements typically enriched within NADs (Bridger et al., 1998).  Based on 
this co-localization and observations that these foci migrate to reforming nucleoli 
(Saiwaki et al., 2005), I hypothesized that Ki-67 acts to guide heterochromatin to 
the nucleolar periphery as a mechanism to re-establish NAD structure after 
mitosis. Since I previously predicted that p150 may also be serving as a shuttle 
for these heterochromatin domains, I wanted to determine if a subset of p150 co-
localized with Ki-67 loci.  To address this prediction, cells were stained for both 
Ki-67 and p150, and early G1 cells were observed based on their Ki-67 
morphology. A clear subset of p150 formed punctate foci which co-localized with 
Ki-67 foci (Figure 3.6), however the majority of p150 signal still remained in the 
nucleoplasm.  When these cells were digested with either RNAse A or DNAse I, 
the Ki-67 and p150 foci remained intact (Figure 3.6).  This suggests that the 
structural integrity of these foci is not reliant upon the presence of either RNA or 
genomic DNA.  While it would be expected that removal of RNA from 
transcriptionally silent heterochromatin may not interfere with the structure of 
these foci, removal of genomic DNA perhaps contradicts the hypothesis that 
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these foci directly interact with heterochromatin in order to shuttle their 
localization back to the nucleolus. This does not rule out the possibility that RNA 
and/or DNA are required for the establishment and not the maintenance of these 
foci.  Since the presence of Ki-67 foci was used as a marker for cells in early G1, 
early ablation of these foci would not be readily detectable within this assay. In 
order to determine if the establishment of these foci is dependent upon RNA or 
DNA, cells should first be synchronized in mitosis, released, digested with the 
appropriate nuclease, and then stained for p150 and Ki-67.  While this 
experiment may be difficult to perform, as mitotic arrested cells lacking genomic 
DNA may not proceed through cytokinesis and enter the next cell cycle, these 
results could prove enlightening and confirm one of my major hypotheses.  I 
predict that this experiment would show a distinct lack of Ki-67/p150 foci after 
DNAse I digestion, as the association of Ki-67 and p150 to heterochromatin after 
telophase may be a critical step in establishing Ki-67/p150 foci.  However, if the 
Ki-67/p150 foci remain intact despite mitotic DNAse I digestion, this would 
provide evidence that Ki-67 and p150 may not be shuttling heterochromatin to 
the PN region.   
Since very little is known of about these foci, multiple experiments should 
be carried out in order to determine both the function and composition of Ki-
67/p150 foci.  First, ChIP-seq experiments should be performed in early G1-
arrested cells by IP of Ki-67 in order to identify the regions within the genome 
enriched within these foci.  ChIP-seq by IP of p150 may also yield interesting 
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results, but as the bulk of p150 resides outside of Ki-67 foci, these results may 
not be helpful in elucidating foci function.  I would predict that the Ki-67 ChIP-seq 
results would show enrichment on heterochromatin and other domains highly 
enriched within the NAD data sets.  It is possible, however, that these foci do not 
directly interact with chromatin, and that their function could be completely 
unrelated to regulating NAD localization.  Since these foci have been observed to 
translocate to the nucleolus (Saiwaki et al., 2005), perhaps their function is 
related to regulating the nucleolar accumulation of proteins and/or RNAs after 
mitosis.  To test this possibility, Co-IP-MS and RIP-seq studies should be carried 
out to identify other protein and RNA components of these foci.                 
 
5.2.5:  p150 localizes to the PCL 
During mitosis, Ki-67 localizes with many other nucleolar proteins to the 
periphery of the condensed chromosomes in a structure known as the 
perichromosomal layer (PCL) (reviewed in (Van Hooser et al., 2005).  This layer 
is hypothesized to ensure equal distribution of nucleolar proteins to daughter 
cells and to facilitate rebuilding of the nucleoli after cytokinesis (Booth et al., 
2014; Sobecki et al., 2016).  One study also demonstrated that Ki-67 acts as a 
surfactant to ensure separation of condensed chromosomes during mitosis 
(Cuylen et al., 2016).  Due to observations that Ki-67 and p150 colocalize at the 
nucleoli and within early G1 foci, I also predicted that a subset of p150 would 
localize to the PCL during mitosis.  Previous work has shown that subunits of the 
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CAF-1 complex are hyperphosphorylated at the beginning of mitosis, 
corresponding with ejection of CAF-1 from chromatin and a loss of chromatin 
assembly function (Marheineke and Krude, 1998).  At the beginning of anaphase, 
CAF-1 subunits are dephosphorylated, coinciding with re-association with mitotic 
chromosomes and acquisition of chromatin assembly function (Marheineke and 
Krude, 1998).  As expected, when cells were stained with p150 and Ki-67, p150 
co-localized with Ki-67 during anaphase (Figure 3.4).  However, prometaphase 
and metaphase cells featured the majority of p150 signal in the nucleoplasm 
(Figures 3.2 and 3.3), making it difficult to determine if a subset of p150 localized 
to the PCL during these phases.  In order to remove this background, cells were 
digested with RNAse A or DNAse I, and then soluble proteins extracted with a 
high salt solution.  While digestion with RNAse A did remove some p150 in the 
nucleoplasm, digestion of the genome with DNAse I clearly showed that a subset 
of p150 co-localizes with Ki-67 at the PCL during early mitosis (Figures 3.2-3.4).  
Because this localization occurs independently of the presence of genomic DNA, 
we can be sure that p150 is localizing to the PCL and is not associating with 
chromatin. 
The function of bulk p150 localization to the PCL during anaphase may be 
linked to ensuring an equal distribution of CAF-1 molecules to each daughter cell 
after cytokinesis.  The function of p150 localization to the PCL in early mitosis 
remains speculative at this point.  During early mitotic phases, the majority of 
CAF-1 has been ejected from the condensed chromosomes and has lost 
 201 
chromatin assembly functionality.  This means that the function of early mitotic 
p150 localization to the PCL most likely occurs outside of a chromatin assembly 
context.  Future studies should try to confirm this by mapping the domains within 
p150 which are required for early mitotic PCL localization.  The localization of 
p60 during early mitotic phases should also be examined in order to determine if 
a subset of the entire CAF-1 complex also localizes to the PCL.  One possible 
function for this localization could be that a subset of p150 is required to 
associate with the PCL in order to facilitate gross association of reactivated CAF-
1 complex at the beginning of anaphase.  While this hypothesized function is 
difficult to test, future sections within this chapter will show evidence that early 
mitotic p150 localization may be linked to regulating the structure of the PCL.      
 
5.2.6:  p150 regulates the formation of Ki-67 foci in early G1 of the cell cycle 
   Since p150 depletion regulates the localization of Ki-67 to the nucleolus, 
I hypothesized that p150 may also be required for the localization of Ki-67 to 
punctate foci during early G1 of the cell cycle.  This was a difficult hypothesis to 
test, as Ki-67 and p150 are the only known protein constituent of the early G1 
foci and thus the only markers to visualize this sub-nuclear structure.  To 
overcome this, cells were synchronized in mitosis and released, and an enriched 
population of cells depleted of p150 were compared to control cells expressing a 
shRNA directed against luciferase.  All control cells appeared as two small cells 
in close proximity to one another, with NCL signal localized primarily to the 
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nucleolus, and Ki-67 signal appearing as hundreds of punctate foci.  In contrast, 
cells depleted of p150 also appeared in groups of two small cells, but showed 
dispersed NCL and Ki-67 signal within the nucleoplasm (Figure 3.8).  This 
suggests that p150 does regulate the formation of Ki-67 foci in early G1 of the 
cell cycle. 
There are many possibilities as to how p150 regulates the formation of 
early G1 foci.  For example, CAF-1 re-association with chromatin during 
anaphase may facilitate p150-mediated Ki-67 recruitment and the establishment 
of these foci at the beginning of the next cell cycle.  Another possibility is that Ki-
67 may actually recruit p150 to the early G1 foci, and that both proteins may be 
required to maintain foci structural integrity.  To test this possibility, depletion of 
Ki-67 should be performed while monitoring the presence of p150-foci in early 
G1-synchronized cells.  Future studies should also map the domains within p150 
required to maintain Ki-67 foci formation in order to determine if this function is 
linked to chromatin assembly.  Since Ki-67 nucleolar localization requires the 
SIM with p150N, I would also predict that the SIM is required for Ki-67 foci 
formation.  If this proves to be true, IF should be utilized to determine if SUMO 
proteins reside within the early G1 foci, and western blotting should be used to 
determine if Ki-67 is sumoylated at this point in the cell cycle.  Additionally, 
depletion of sumo proteins and UBC9 should be used to explore whether 
sumoylation is required to maintain the formation of these foci. 
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5.2.7:  p150 regulates Ki-67 localization to the PCL during mitosis 
  Since p150 depletion affects the localization of Ki-67 to the nucleolus and 
to foci during early G1 of the cell cycle, I hypothesized that p150 may also be 
required for Ki-67 localization to the PCL during mitosis.  Upon depletion of p150 
in HeLa S3 cells, Ki-67 localization to the PCL dramatically decreased compared 
to control cells with matched mitotic phase and exposure time (Figure 3.7, A).  
When the Ki-67 fluorescence of 297 prometaphase cells across three biological 
replicates were quantified, the p150 depleted cells featured a 3.5 fold decrease in 
Ki-67 fluorescence intensity (Figure 3.7, B).  This result is different than previous 
Ki-67 mislocalization upon p150 depletion in that mitotic Ki-67 mislocalization is 
partial.  However, this still demonstrates that p150 is required for normal levels of 
Ki-67 localization to the PCL, supporting the hypothesis that early mitotic p150 
localization to the PCL may be linked to regulating PCL structure. 
Why would a histone chaperone with chromatin assembly function 
regulate a mitotic structure?  Previous studies have demonstrated that the 
majority of CAF-1 loses chromatin assembly functionality during mitosis 
(Marheineke and Krude, 1998). This observation supports the hypothesis that 
p150 regulation of PCL structure may occur independently of chromatin 
assembly, and evidence of this will be discussed in the following section.  Yet 
another possibility is that, while the majority of CAF-1 is hyperphosphorylated 
and unable of performing chromatin assembly, a subpopulation of CAF-1 may 
escapes phosphorylation and localizes to the PCL with chromatin assembly 
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function intact.  In order to test this hypothesis, antibodies which detect the 
hyperphosphorylated form of p150 should be developed.  These antibodies 
should then be utilized to determine if the p150 subpopulation localized to the 
PCL are hyperphosphorylated.  These studies could be performed by using IF or 
by isolating purified PCL structures and probing for the presence of 
phosphorylated p150 via western blotting (Figure 3.5).  If the PCL-localized p150 
lacks hyperphosphorylation, purified PCL should be analyzed to determine if the 
bound p150 retains in vitro chromatin assembly function.  Mitotic chromatin 
undergoes many changes throughout mitosis (reviewed in (Antonin and 
Neumann, 2016)), and the prospected that a subset of CAF-1 retains chromatin 
assembly function in order to modify the periphery of the mitotic chromosomes 
and recruit PCL proteins is not out of the realm of possibility.    
 
5.2.8:  The SIM within p150N is required for normal Ki-67 localization to the 
PCL 
In order to determine if p150 regulates PCL structure through chromatin 
assembly, I performed experiments to map the domains within p150 required for 
localizing Ki-67 to the PCL.  It was found that the N-terminal 310 amino acids, 
which is incapable of facilitating chromatin assembly, was also critical in 
regulating Ki-67 localization to the PCL (Figure 3.9, A).  Moreover, the SIM within 
the N-terminus is also important for regulating PCL structure (Figure 3.9, A), and 
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therefore the p150N SIM is important for regulating Ki-67 localization throughout 
the cell cycle.   
As discussed in previous sections, experiments should be carried out to 
determine if p150N can associate with residual CAF-1 capable of chromatin 
assembly function during mitosis.  Additionally, experiments should examine the 
sumoylation status of Ki-67 during mitosis to determine if the SIM within p150N 
directly interacts with sumoylated Ki-67.  Ki-67 can be sumoylated at 
Lys1517(Golebiowski et al., 2009), but the functionality of this modification or 
others with regards to Ki-67 activity remains unknown.  If Ki-67 is sumoylated 
during mitosis and directly interacts with the p150N SIM, this interaction may 
yield clues as to the mechanism which regulate Ki-67 localization.  For example, 
unbound SUMO modifications can serve as a signal for polyubiquitylation 
mediated proteasome degradation(Sun et al., 2007; Uzunova et al., 2007).  While 
my experiments show that depletion of p150 does not affect the expression level 
or phosphorylation of Ki-67 (Figure 3.7, C and D), an unbound SUMO conjugate 
within Ki-67 may interact with other proteins to induce mislocalization.  
       
5.3:  Future Directions 
5.3.1:     Further investigation into NAD structure and function  
This dissertation has demonstrated that 3 different NADs are regulated by 
p150, and that one of these NADs is also regulated by Ki-67. Other studies have 
shown that Ki-67 regulates the localization of a NAD proximal to the rDNA repeat 
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array on chromosome 13 and centromere association with the nucleoli (Booth et 
al., 2014; Sobecki et al., 2016).  While this dissertation and these studies suggest 
that p150 and Ki-67 may regulate overall NAD localization, future studies should 
seek to map the precise loci subject to p150 and Ki-67 regulation.  This 
dissertation hypothesizes that p150 and Ki-67 are within the same pathway in 
regulating NAD localization, as depletion of p150 regulates the nucleolar 
localization of both Ki-67 and NADs.  However, it is possible that p150 and Ki-67 
may regulate NAD localization through independent mechanisms.  One way to 
test this hypothesis would be to perform NAD-seq in cells depleted of p150 or Ki-
67.  We could then compare these data sets to determine which NADs are 
specifically regulated by p150 or Ki-67, and further study where differences 
occur.  If there are significant differences between the changes in NAD 
composition after p150 or Ki-67 depletion, these proteins may be acting in 
different pathways.  In this case, Co-depletion of both proteins followed by NAD-
seq should be utilized in order to determine if one protein is dominant over the 
other, or if there is a synergistic effect in regulating NAD structure.   
These experiments would also allow us to determine if p150 and Ki-67 
regulate all NAD localizations, or just a subset.  Both proteins have well 
established roles in regulating heterochromatin structure, and the NADs are 
highly enriched for heterochromatin associated silencing marks.  However, there 
are several classes of genes within the NAD data sets that are not typically 
associated with heterochromatin.  In HeLa cells, these include zinc finger, 
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olfactory receptor, and defensin genes (Németh et al., 2010).  While these genes 
are typically silenced in HeLa cells, their localization to the PN region may be 
regulated by a different mechanism responsible for lineage-specific nuclear 
organization.   
In a recent study Ki-67-depleted cells showed an increase in expression of 
many genes enriched within the NAD data sets (Sobecki et al., 2016).  This 
supports the hypothesis that mislocalization of NAD elements corresponds with a 
loss of transcriptional silencing.  This further bolsters the idea that the PN region 
acts as an organizational hub to maintain transcriptional silencing of 
heterochromatin (reviewed in (Matheson and Kaufman, 2015; Padeken and 
Heun, 2014)).  While many recent studies have focused on studying the PN 
region and NADs, it is still unknown whether NAD localization induces 
heterochromatin formation, or vice versa.  One study showed that insertion of a 
5S rDNA array proximal to a reporter gene was sufficient to target the reporter 
gene to the PN region and induce silencing (Fedoriw et al., 2012a).  However, 
since most 5S rDNA repeats are transcriptionally silenced, it is unknown whether 
the silencing of the reporter gene was a consequence of PN localization or 
proximity to a 5S rDNA repeat.  Several groups studying lamina associated 
domain (LAD) targeting and heterochromatin formation have reported that 
ectopic localization of reporter genes to the nuclear lamina (NL) resulted in a 
decrease in reporter expression.  This was accomplished through inserting a 
LacO array proximal to a reporter gene, and fusing LacI with an inner NL protein 
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(Dialynas et al., 2010; Finlan et al., 2008; Reddy et al., 2008).  Ectopic targeting 
of a reporter gene to the PN region may prove more difficult, as the nucleolus is 
not bound by a solid structure or membrane.  Future investigators may choose to 
utilize CRISPR/cas9 technology to explore how PN targeting affects 
heterochromatin formation.  For example, a fluorescently-tagged and catalytically 
inactive Cas9 exonuclease could be fused to a protein which localizes to the PN 
region, such as NCL or NPM.  These cells could then be transfected with guide 
RNAs that target any locus within the genome.  This method would bypasses the 
need to mutate endogenous loci with PN targeting sequences like the 5S rDNA, 
and would allow for quick screening of many distinct loci.  Highly transcribed loci 
could then be targeted to the PN region, and RT-qPCR and ChIP-qPCR could be 
used to monitor gene expression and heterochromatin silencing mark occupancy.  
However, in the event that this methodology does not robustly target DNA to the 
PN region, utilization of LacO arrays and LacI fusion proteins may be attempted. 
        
5.3.2:  When does p150 regulate Ki-67 localization during the cell cycle? 
We can now conclude that a subset of p150 colocalizes with and regulates 
the localization of Ki-67 throughout the cell cycle.  There are several possibilities 
as to when this regulation occurs:  p150 may regulate Ki-67 localization to the 
PCL during mitosis, to foci during early G1, to the nucleoli during late G1, or 
some combination of these possibilities.  Determining the precise phase at which 
this regulation occurs will be difficult, as the localization during one phase of the 
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cell cycle may affect the localization at other phases.  For example, let’s assume 
that p150 specifically regulates Ki-67 localization to early G1 foci. Mislocalization 
of early G1 Ki-67 foci upon p150 depletion could result in the mislocalization of 
Ki-67 to the nucleoli, as G1 foci localization may be a prerequisite for nucleoli 
localization later in the cell cycle.  This in turn could result in mislocalization of Ki-
67 to the PCL during mitosis, as nucleolar localization may be required for PCL 
localization during prophase.  This “chicken or egg” causality dilemma will make 
determining the exact point of regulation difficult to determine, however there are 
several ways to infer when the regulation may be occurring.  For example, if Ki-
67 is the sumoylated protein directly interacting with the SIM of p150N, probing 
cells arrested in mitosis, early G1, and late G1 for Ki-67 sumoylation may reveal 
when this interaction occurs.  However, this assumes that Ki-67 is only 
sumoylated at specific points during the cell cycle, and that interaction with p150 
occurs concurrently with the regulation of Ki-67 localization.   
Regardless of when p150-mediated regulation of Ki-67 localization occurs, 
it will be difficult to explore this question using the current shRNA system.  This 
system requires the depletion of p150 to occur over at least 48 hours, and all 
experiments shown in this dissertation take place over 72 hours to ensure 
maximum knockdown.  During this depletion, the cells divide 2-4 times, meaning 
that little could be gained by arresting cells at particular phases of the cell cycle 
and asking about localization.  One technology that could be employed to 
overcome these obstacles involves using CRISPR/cas9 genome editing to 
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homozygously insert a sequence encoding an auxin inducible degron (AID) to a 
terminus of the p150 gene (see methods in (Natsume et al., 2016)).  Upon 
addition of auxin to this cell line, p150 could be rapidly depleted over the course 
of a few hours.  These cells could first be arrested at specific points of the cell 
cycle, and then p150 degradation induced in order to gauge the effect on Ki-67 
localization.  Another method could include using a cell line with a fluorescently 
tagged Ki-67 gene, and utilizing live cell imaging to gauge Ki-67 localization in 
real time as p150 is degraded.  AID systems currently stand at the best possible 
method for determining when p150 regulates the localization of Ki-67 during the 
cell cycle.   
Although I have no experimental evidence to support this hypothesis, I 
predict that p150 regulates Ki-67 localization at the beginning of prophase or 
anaphase.  During mitosis, both p150 and Ki-67 are hyperphosphorylated, 
corresponding to changes in their molecular functionality.  At the beginning of 
prophase, p150 hyperphosphorylation corresponds with ejection from mitotic 
chromatin and a loss of chromatin assembly function (Marheineke and Krude, 
1998).  Ki-67 remains bound to the nucleoli despite the condensation of all 
chromosomes at the beginning of prophase.  Upon hyperphosphorylation by 
cdc2/cylin B and protein kinase C, Ki-67 loses DNA binding ability and relocalizes 
to the PCL (Endl and Gerdes, 2000; MacCallum and Hall, 1999, 2000; Saiwaki et 
al., 2005).  It is possible that the subset of PCL-localized p150 recruits the 
mobile, phosphorylated Ki-67 during prophase, and depletion of p150 inhibits this 
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recruitment.  At the beginning of anaphase, both proteins are dephosphorylated 
and regain some of their lost functionality.  For p150, this corresponds with a 
regain of chromatin assembly activity and bulk association to the PCL and mitotic 
chromatin (Marheineke and Krude, 1998).  Ki-67 recruits PP1γ to facilitate 
dephosphorylation, coinciding with a shift to an immobile state, and 
reestablishment of DNA binding activity (Endl and Gerdes, 2000; MacCallum and 
Hall, 1999, 2000; Saiwaki et al., 2005; Takagi et al., 2014a).  It is also possible 
that bulk reassociation of p150 to the PCL and chromatin is required to maintain 
Ki-67 localization to the PCL, or to re-establish Ki-67 binding of chromatin.  While 
it is also possible that p150 regulates Ki-67 localization at other points in the cell 
cycle, mitosis is an appealing phase to investigate due to the post translational 
modifications of both proteins corresponding to loss of function and 
relocalization.    
 
5.4:  Concluding Remarks 
This dissertation has established that Ki-67 and p150 both regulate NAD 
localization to the PN region.  In addition, p150 co-localizes with Ki-67 throughout 
the cell cycle, and p150 regulates Ki-67 localization to the PCL, early G1 foci, 
and to the nucleolus.  These novel regulatory functions of p150 have been 
mapped to the SIM within the N-terminus of p150.  This suggests that p150 
interacts with a sumoylated protein or proteins in mediating NAD and Ki-67 
localization, however the identity of these proteins are currently unknown.  Future 
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studies should strive to identify these sumoylated proteins, as well as the phases 
within the cell cycle that p150 actively regulates Ki-67 localization.  Future 
studies should also explore the structure and function of the NADs in relation to 
p150 and Ki-67 mediated regulation.  The PN region serves as an organizational 
hub of heterochromatin that is successfully constructed de novo after every 
cellular division. A better understanding of the regulation of this sub-nuclear 
structure will provide greater insight into how nuclear structure is reestablished 
after cellular division.
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